stock_ABT r_down	purchase:1 recently:1 insider:1 company:1 director:1 record:1 disclosed:1 largest:1 medical-device:1 stock:1
stock_ABT r_down	exclusive:1 being:1 global:1 adjusted:1 through:1 contributions:1 its:3 $:3 rose:1 disclosed:1 damages:1 infringement:1 results:2 new:1 14.6:1 --:2 warned:2 injectable:1 infringed:1 deal:1 acquired:1 related:1 second:1 growth:1 projections:1 year:1 viral:1 said:2 decision:1 comments:1 outside:1 above:1 international:1 net:1 terms:1 business:1 million:1 agreement:1 possibility:2 reported:1 panel:1 last:1 launch:1 taking:1 against:1 products:1 maker:1 patents:1 comment:1 fourth-quarter:1 outlook:2 61:3 multiple-sclerosis:2 pregnancy:1 throughout:1 three:1 suit:1 injury:2 final:1 mostly:1 drugs:1 brand:1 specialty:1 liver:2 doctors:2 analyst:2 posted:1 rights:1 signed:1 n't:1 patients:2 were:1 distribution:2 treated:1 health-care:1 share:1 sales:4 warning:1 drug:2 have:1 information:1 court:1 patent:1 topped:1 also:2 details:1 income:1 test:1 company:6 's:3 earnings:1 price:1 forecasts:1 fueled:1 letter:1 services:1 average:1 disease:1 serious:2 2008:1 came:1
stock_ABT r_down	product:1 help:1 business:1 writes:1 opportunities:1 new:1 its:1 expand:1
stock_ABT r_down	comment:1 available:1 all:1 set:1 certain:1 agreed:1 drug:1 inflated:1 defendants:1 well:1 unit:1 settlement:1 develop:1 $:1 consumers:1 pay:1 class-action:1 insurance:1 other:1 which:1 suit:1 test:1 entered:1 molecular:1 third-party:1 firm:1 used:1 allegedly:1 drugs:1 price:3 million:1 contract:1 part:1 125:1 diagnostics:1 prices:1 immediately:1 law:2 11:2 prescription:1 wholesale:3 average:3 companies:3 according:1 reports:1 n't:1 settle:1 were:1 making:1 payers:1 gene:1 published:1
stock_ABT r_up	heart:1 smaller:2 outcomes:2 approval:1 vessel:2 seen:1 its:1 said:1 positive:1 system:1 same:1 attack:1 version:2 safety:1 low:3 rates:3 health:1 has:1 treatment:1 company:1 following:1 death:1 immediately:1 care:1 include:1 stent:2 release:1 2.25:1
stock_ABT r_up	vaults:1 help:2 into:1 manage:2 regulatory:1 second:1 diabetics:1 long:1 said:1 review:1 system:3 comments:1 approved:1 their:1 which:2 expected:1 has:2 stock:1 's:1 received:2 track:1 company:1 continuous:3 levels:3 prices:1 approval:3 than:1 diabetes:2 comparison:1 tracking:2 later:1 allows:3 disease:2 patients:2 'd:2 analysts:1 following:1 starting:1 came:1
stock_ABT r_down	upper:1 major:1 help:1 sends:1 manage:1 back:1 years:1 report:1 second:1 through:1 arm:1 size:1 information:1 said:2 cardiac:1 designed:1 rate:1 trial:2 stent:3 since:1 system:3 been:1 its:1 adverse:1 outside:1 clinical:1 safety:1 treatment:1 performance:1 has:1 sensor:1 events:1 first:1 available:2 quarter:1 drug-eluting:1 evaluate:1 company:1 continuous:1 overall:1 wireless:1 levels:1 driven:1 low:1 device:1 approval:1 approved:1 diabetes:1 received:1 regarding:1 tracking:1 prescription:1 target:1 fully:2 no:1 allows:1 disease:2 placed:1 patients:1 out:1 2007:1 receiver:1 five:1 works:1 starting:1 published:1
stock_ABT r_up	heart:1 agency:1 hoping:1 prepared:1 into:1 share:1 ``:1 owned:1 price:1 held:1 daily:1 talks:1 further:1 its:1 unit:1 out:2 information:2 stent:3 review:1 stake:2 regulatory:2 two:1 been:1 approve:1 spokesman:1 source:1 citing:1 asking:1 device:1 market:1 which:1 between:1 has:2 issue:1 50-50:2 pending:1 more:2 updated:1 buy:2 's:3 comments:2 business:1 company:2 product:1 but:1 drug-coated:1 joint:1 letter:2 report:2 indicates:1 now:1 must:1 '':1 convert:1 issues:1 off:1 reported:1 amid:1 launch:1 companies:1 equal:1 drug:1 final:1 without:1 venture:1 usually:1 stages:1 resolution:1 maker:1 first:1
stock_ABT r_up	focus:2 trade:1 ended:1 session:1 aggressive:1 its:4 blocked:2 impact:1 whose:1 rallied:1 cut:6 $:5 board:1 has:1 earnings:1 sued:1 around:2 expects:1 joint:3 they:1 international:1 report:1 during:1 ending:1 day:1 --:2 companies:2 cholesterol:2 small:1 higher:1 better-than-expected:2 financial:1 deal:2 competition:2 sign:1 see:1 officials:1 expect:1 year:2 investment:2 out:1 closer:1 said:4 rate:6 profit:4 shares:2 current:1 state:1 does:1 health:1 got:1 firms:2 boost:2 across:1 exercise:1 million:4 popular:2 step:1 active:2 care:1 prospects:1 cautious:1 country:1 30:1 according:1 drug:5 prior:1 maker:3 divide:1 presence:1 splitting:1 60:1 take:2 pharmaceutical:2 next:1 their:3 suit:1 taken:1 more:1 salary:1 relieved:2 becoming:1 acquire:1 but:3 expected:2 neutral:1 sharply:1 filed:1 buying:1 up:1 value:3 n't:1 below:1 venture:3 were:1 1.5:1 medication:2 investors:1 turned:1 against:1 days:1 states:2 reports:4 have:2 rally:3 partner:1 relatively:1 heft:2 end:3 evenly:2 generic:2 indexes:1 also:1 build:2 company:2 stock:1 's:8 peaks:1 highs:2 device:1 court:2 stocks:2 2008:1 building:1 realized:1 transaction:1 off:4 medical:1 alleging:2 options:1 federal:2 2007:2 21:1 banks:2 overseas:2 '07:2 filing:1 latest:1
stock_ABT r_up	oncology:2 divide:2 heartburn:2 health-care:2 sales:2 drug:2 year:2 its:2 end:2 $:4 generic:1 had:2 their:2 treatment:2 which:2 's:4 drugs:2 million:2 joint:2 editing:1 info:1 pipeline:2 last:2 rights:4 receive:2 value:2 while:2 maintain:2 products:2 venture:2 changes:1 maker:2 experimental:2 evenly:2
stock_ABT r_down	2007:2 million:2 's:2 $:2 11.3:2
stock_ABT r_down	comment:2 heart:2 already:2 proposed:1 scan:1 issued:2 guidelines:3 safety:2 discover:1 devices:3 have:2 's:1 throughout:1 makers:2 market:2 before:2 bearing:2 long:1 appear:2 guidance:3 tougher:1 comments:1 response:1 better:2 needed:2 potential:2 5:1 details:1 6:1 draft:5 coated:2 after:1 problems:2 blood:1 approval:2 analyst:1 12:1 longer:2 concerns:1 official:1 submitted:2 n't:2 stents:5 does:2 drug-coated:3 studies:2 order:2 view:2
stock_ABT r_down	bondholders:1 issued:1 over:1 executive:1 existing:1 bring:1 renegotiate:1 talks:1 still:1 before:1 grappling:1 stent:2 guidance:1 better:1 under:1 has:1 bonds:1 refinance:1 effects:1 years:1 loss:1 regarding:1 did:1 companies:1 leave:1 --:1 repayment:1 view:1 guidelines:2 submitted:1 year:2 coated:1 makers:1 facing:1 said:2 appear:1 ways:1 does:1 safety:1 new:2 terms:1 million:2 deliver:1 reported:1 doctors:1 article:1 convertible:1 study:1 annual:1 drug-coated:2 surprises:1 studies:1 comment:1 major:1 already:1 bearing:1 approval:1 wider:1 market:2 conference:1 top:1 two:1 been:1 next:2 needed:1 draft:3 way:1 option:1 drugs:1 company:3 released:1 demand:1 hopes:1 analyst:1 include:1 developing:1 official:1 up:1 devices:3 n't:2 could:1 heart:2 liabilities:1 scan:1 full-year:1 have:2 any:1 detail:1 intends:1 potential:1 which:2 gets:1 's:4 plans:1 published:1 problems:1 device:1 weekend:1 ago:1 longer:1 stents:2 order:1
stock_ABT r_down	heart:2 another:1 show:1 dwindle:1 declines:1 into:1 month:1 past:1 not:2 through:1 devices:2 have:1 carry:2 led:1 research:1 employment:1 risk:2 row:1 death:2 takes:2 monthly:1 stent:2 support:2 two:2 grow:1 better:2 their:1 only:1 drug:1 helps:2 digging:1 9,000:1 expected:1 consecutive:1 attack:2 bare-metal:2 patients:2 more:2 do:2 repeat:2 jobs:1 greater:2 deeper:1 views:2 pockets:1 expirations:1 trials:1 registry:1 doctors:1 report:1 article:1 one:1 procedures:2 than:4 acquisitions:1 patent:1 approach:1 lost:1 third:1 covering:2 --:3 avoiding:2 companies:1 analysis:2 stents:2 near:1 drug-coated:2 published:1 studies:4 notion:2 mergers:1
stock_ABT r_up	proposed:1 less:1 being:2 results:2 existing:1 clot:1 held:2 including:1 during:2 centers:2 issues:1 impact:1 death:1 9,000:1 stent:5 capabilities:1 should:2 better:1 investigational:1 treatment:2 bypass:1 struck:1 main:1 do:1 hit:1 risk:1 emergency:1 survival:1 endorsement:1 fat:1 cheaper:1 possibly:1 nearly:1 they:1 not:2 artery:1 continued:2 advanced:1 heightened:1 --:7 clots:2 fewer:1 large:1 chamber:1 cholesterol:1 release:1 did:1 registry:1 works:1 investigators:1 set:1 significantly:1 related:1 second:3 surgery:4 avoided:1 even:1 said:1 two-year:1 back-up:2 prop:1 increase:1 flushing:2 programs:1 patient:1 pumping:1 expansion:1 small:1 arteries:1 key:1 others:2 analyzed:1 article:3 strong:1 both:1 rare:1 battling:1 attacks:1 involved:1 study:11 annual:3 according:2 drug:3 trial:1 amount:1 retreating:1 drug-coated:1 published:3 safely:1 skids:1 first:2 major:2 although:1 skilled:1 due:1 another:1 open:1 conference:3 additional:1 positive:3 system:1 their:1 reduction:1 clinical:3 treat:1 type:1 more:4 procedures:1 treated:2 plunge:2 comparison:1 started:1 company:1 but:1 gap:1 well-run:1 disruption:1 wake:1 gain:2 authors:1 known:1 episode:1 cases:1 than:2 showed:5 avoiding:2 getting:1 devices:1 n't:2 patients:5 can:1 were:1 similar:1 heart:9 dangerous:1 associated:1 have:2 angioplasty:2 300,000:1 alongside:2 site:2 performed:2 follow-up:1 seen:1 hospitals:2 any:1 no:1 generic:1 40:1 adverse:1 other:1 which:3 meeting:1 performance:2 attack:2 bare-metal:1 events:1 fuels:1 used:1 's:12 chance:1 blood:3 significant:1 cardiac:1 such:1 data:4 lower:1 placement:1 longer:1 effective:1 released:5 considered:1 disease:1 stents:3 mass:1 came:2 typical:1
stock_ABT r_up	still:1 after:1 's:2 launch:1 --:1 stent:1 met:1 months:1 expectations:2 believes:1 top:1 far:1 said:1 sales:1 drug-coated:1 hit:1 has:1 company:1 market:1 official:1
stock_ABT r_down	lifted:1 said:1 's:2 publicly:1 after:1 possible:1 oil:1 recession:1 sensitive:1 while:1 fell:1 rising:1 shares:1 time:1 prices:1 return:1 stocks:1 economically:1 first:1
stock_ABT r_up	give:1 surrounding:1 conference:1 decline:1 generic:1 negative:1 which:1 expected:2 effectiveness:1 presentation:1 gaining:1 's:2 prescriptions:1 drugs:1 most:1 boost:1 last:1 possibly:1 rival:1 study:1 drug:1 products:1 cholesterol:1 following:1 medical:1
stock_ABT r_down	pay:1 shock:1 's:4 investors:1 do:1 season:1 attention:1 companies:1 results:1 n't:1 their:1 interested:1 trading:1 earnings:1 want:1 coming:1 might:1 options:1 market:1
stock_ABT r_up	disclosure:1 cancer:2 developed:1 number:1 '':1 lung:2 determine:1 seen:1 its:2 signals:1 said:1 $:2 no:1 trials:1 able:1 spokesman:1 9:2 has:1 's:1 ``:1 patient:1 users:1 though:1 company:1 after:1 inhaled:2 day:1 cause:1 whether:1 warned:1 n't:1 experimental:1 insulin:2 small:1 comes:1
stock_ABT r_down	exotic:1 major:1 gather:1 financial:1 producer:1 physicians:1 spring:1 meetings:2 bankers:1 sales:1 ministers:1 device:1 examine:1 officials:1 confirm:1 have:1 fees:1 years:1 's:1 industries:1 educational:1 consumer:1 mortgage:1 players:1 ways:1 avoid:1 manufacturers:1 returns:1 next:1 their:1 swath:1 drug:1 sponsoring:1 earnings:1 way:1 under:1 gets:1 across:1 economy:1 week:1 conferences:1 finish:1 first-quarter:1 finance:1 attend:1 government:1 season:1 after:1 free:1 nation:1 earnest:1 income-tax:1 doctors:1 prices:1 hold:1 weekend:1 wide:1 worsening:1 central:1 largest:1 countries:1 --:2 starts:1 medical:1 housing:1 likely:1 reports:2 trips:1 credit:1 future:1 consulting:1 retail:1 starting:1 filing:1
stock_ABT r_down	paths:1 adjusted:1 want:1 contributors:1 money:1 polled:1 health-care:2 share:2 sales:2 days:1 individual:1 have:1 go:1 managing:1 its:2 better:1 management:1 $:2 title:1 informal:1 had:1 due:2 per:2 anyone:1 their:1 earnings:6 largest:2 expected:3 skills:1 improve:1 higher:4 rather:1 's:2 increased:2 though:1 company:2 continuing:1 slated:2 early:2 job:1 others:1 report:4 world:2 post:1 wanted:1 than:1 formal:1 advance:1 largely:2 --:3 many:1 medical:2 companies:1 according:1 devices:2 large:1 career:1 products:2 analysts:1 time:1 1.20:1 route:1 came:1 1.24:1
stock_ABT r_down	due:1 higher:1 cents:1 allergy:1 share:2 sales:2 trade:1 61:1 see:1 session:1 40:1 recently:1 its:1 unit:1 whose:1 giant:1 $:1 profit:1 devices:1 stake:1 projected:1 shares:1 earnings:3 which:1 largest:1 expected:2 bought:1 health-care:1 's:3 increased:1 first-quarter:2 boosted:1 company:1 slated:1 early:1 report:3 world:1 strong:1 active:1 posted:1 heavyweight:1 largely:1 --:1 medical:1 climbed:1 companies:1 according:1 drug:1 growth:1 products:1 analysts:1 1.44:1 quarter:1 consumer:1 first:1
stock_ABT r_down	help:2 move:1 dollar:2 results:2 years:1 hopes:2 session:1 shares:2 medical-products:1 its:6 setbacks:1 whose:2 based:2 $:8 rose:3 had:2 expectations:1 treatment:1 quarterly:1 include:1 earnings:3 executive:1 permission:3 focus:2 therapy:3 background:1 international:2 during:1 trade:1 continued:1 areas:2 showed:1 level:1 --:3 companies:1 fewer:2 shielded:1 become:2 quarter:1 rheumatoid:5 view:2 successful:2 worldwide:1 set:1 woes:1 reported:1 competition:1 slowdown:2 see:1 actively:1 trading:1 expected:4 year:2 substantially:1 's:6 said:4 profit:1 recorded:1 patients:1 comments:1 research:1 increase:1 bracing:2 health:1 affecting:1 new:4 net:4 announced:1 available:1 earlier:1 exchange:3 got:2 million:4 weak:2 expansion:2 conglomerate:1 met:1 regulatory:3 approval:5 strong:2 declining:2 care:1 reaction:1 houses:1 industry:1 months:1 reports:1 foreign:3 products:1 first:3 comment:1 alliance:3 tone:1 cancer:2 blockbuster:2 60:2 active:1 throughout:1 pharmaceutical:2 use:3 there:1 due:2 been:1 rates:2 treat:1 biggest:2 upbeat:1 lowest:1 advance:2 drugs:3 company:6 taken:1 construction:1 favorable:2 somewhat:1 prices:1 surged:1 analyst:1 has:2 17:1 solid:1 plunged:1 while:1 growth:3 counting:2 could:2 cents:4 received:1 share:4 sales:5 helped:2 currency:2 drug:8 partner:3 accounting:1 34:7 marking:3 compared:1 generic:1 45:2 thanks:2 also:1 details:1 income:3 higher:4 gaining:2 first-quarter:4 arthritis:6 important:3 coming:1 such:4 stocks:2 ago:1 largely:1 charges:3 amid:2 disease:2 part:3 2007:1 consumer:1
stock_ABT r_down	says:1 -analyst:4 show:2 into:1 mind:1 results:2 one:3 pops:1 currency:2 good:1 rarely:1 impact:3 often-overlooked:2 said:1 bottom:1 chief:1 their:2 potential:2 earnings:4 between:1 markets:2 do:2 ``:1 currencies:1 's:1 exchange:4 company:1 spate:2 but:1 key:2 consideration:1 line:1 difference:1 investor:1 analyst:2 recent:2 '':1 peril:2 --:3 strategist:1 foreign:2 ignore:2 bad:1 so:2 can:1 quarter:1 wrote:1 mean:1
stock_ABT r_down	cents:2 share:2 period:1 helped:2 ended:1 accounting:2 compared:1 $:2 same:1 earnings:4 income:1 units:2 8:1 net:1 higher:4 first-quarter:2 business:2 million:2 early:1 reported:2 five:2 gain:2 posted:1 120:1 --:2 31:1 sale:2 reports:2 2007:1 21:1 quarter:1
stock_ABT r_down	executive:1 adjusted:2 businesses:1 shares:2 its:7 impact:1 asthma:2 stent:1 distributed:1 expectations:1 analyst:1 quarterly:2 has:2 remaining:1 earnings:3 distribute:2 results:2 five:1 background:1 --:2 slide:1 including:1 raised:2 quarter:3 dip:2 arrival:1 set:1 deal:3 some:2 devices:1 second-quarter:2 year:1 first-quarter:1 said:2 comments:1 forecast:2 new:2 cost-cutting:2 business:1 key:2 major:2 last:2 drug:2 drug-coated:1 efforts:2 experimental:2 first:3 comment:1 outlook:1 maintained:2 licensing:1 throughout:1 market:1 per:2 pharmaceutical:1 additional:1 expected:1 cardiology:1 company:3 delivery:2 wake:2 goals:1 benefits:2 completes:1 target:2 showed:2 signed:2 following:2 heart:1 share:2 sales:6 helped:1 full-year:2 reports:1 have:1 accounting:1 seen:1 develop:2 also:1 details:2 units:1 higher:1 product:3 's:2 after:1 levels:1 prepares:1 sale:1 stents:1 '08:2 2008:2 gain:1
stock_ABT r_up	major:1 health-care:1 primary:1 50:1 vessel:1 its:1 said:2 system:2 comparing:1 stent:2 43:1 late:1 adverse:1 clinical:1 treatment:1 secondary:1 meeting:1 events:1 's:1 company:1 eight:1 cardiac:1 artery:1 recent:1 loss:1 endpoint:2 study:1 months:2 disease:1 trial:1 nine:1 were:1 reduced:2
stock_ABT r_up	available:1 psoriasis:1 said:1 's:6 state-run:1 --:1 should:1 severe:1 made:1 treatment:1
stock_ABT r_up	development:1 financial:1 ...:2 energy:1 trade:1 '':1 not:1 trading:1 accounting:1 further:1 its:1 succeeds:1 pharmaceutical:1 story:1 said:2 additional:1 provide:1 agency:2 42:1 appointed:1 late:1 also:2 citing:1 treatment:1 midday:1 profile:1 flat:1 ``:1 continues:1 's:1 plans:1 uncertainties:1 evaluate:1 company:1 were:1 rejected:1 favorable:1 letter:1 known:1 president:3 years:1 data:1 downgraded:1 received:1 name:1 effective:1 vice:3 19:1 old:1 drug:3 chief:2 products:1 officer:2 cholesterol:1 following:1 meet:1 senior:2 corporate:1 maker:2
stock_ABT r_up	's:2
stock_ABT r_down	comment:1 heart:1 punches:1 headed:1 being:1 win:1 coming:1 ``:1 number:1 competition:1 years:1 '':1 device:1 officials:1 's:1 its:4 market:1 out:1 n't:3 said:4 asthma:2 generic:1 stent:1 make:1 regulatory:2 two:1 should:1 leave:1 does:1 details:1 statement:1 forward:1 new:1 has:2 roll:1 failure:1 development:1 specialist:2 product:1 premium:1 efficacy:2 could:1 but:1 results:1 delivery:2 met:2 step:1 key:1 preliminary:1 prices:1 approval:1 analyst:1 carried:1 count:1 down:1 main:2 target:2 versions:1 --:2 represent:1 study:3 companies:1 harder:1 drug:4 filing:1 preparation:1 maker:1 drug-coated:1 cholesterol:1 first:1 studies:1 fetch:1 experimental:2 late-stage:2
stock_ABT r_up	oncology:1 certain:1 all:1 ended:1 have:1 its:1 pharmaceutical:1 said:1 based:1 dividing:1 support:1 research:1 current:1 their:1 treatment:1 remaining:1 's:2 organizations:1 company:2 commercial:1 joint:1 they:1 received:2 pipeline:1 rights:3 receive:1 value:1 future:1 products:1 payments:1 venture:1 healthcare:1 evenly:1
stock_ABT r_down	because:2 letter:2 companies:4 move:2 some:2 assumptions:2 experts:2 signed:2 have:2 parties:2 fine:2 makers:2 fifth:1 out:2 leaders:2 renewed:2 end:2 would:2 credit:4 profit:2 expired:2 legislation:2 research:2 write:2 confident:2 'll:2 details:1 certain:2 print:2 weeks:2 has:2 might:2 pan:2 development:2 's:1 urging:2 extend:2 read:2 tax:4 forecasts:3 members:2 not:2 off:2 beginning:1 84:2 recent:2 ago:2 both:2 made:2 wise:2 ahead:2 yet:2 allows:2 drug:4 n't:2 federal:2 costs:2 2007:2 2008:4 restored:2
stock_ABT r_down	saying:1 right:1 infringed:1 requested:1 focus:2 trade:1 held:1 see:1 session:1 another:1 terms:1 settlement:2 its:2 arbitration:2 whose:1 said:1 infringe:1 shares:1 various:1 under:1 expected:1 has:1 do:1 's:1 company:1 between:1 agreement:1 active:1 panel:2 appeal:1 --:1 companies:2 n't:3 stents:2 drug-coated:1 2005:1 found:1 patents:2
stock_ABT r_down	cents:2 companies:1 share:2 trade:1 active:1 see:1 session:1 whose:1 shares:1 forecast:1 according:2 earnings:2 expected:2 stock:1 's:1 option:1 report:1 post:1 second-quarter:1 fiscal:2 third:1 excluding:1 --:1 51:1 36:1 costs:1 analysts:2 quarter:1
stock_ABT r_down	adults:2 show:1 well:1 reduce:1 ``:1 trade:1 '':1 see:1 session:1 makers:1 significantly:1 whose:1 said:1 shares:1 symptoms:1 potentially:1 treatment:1 biggest:2 new:1 effectiveness:1 impairment:1 shows:1 gaining:2 core:1 product:1 's:3 company:1 safe:1 overall:1 results:1 expected:1 selective:1 active:1 amp:2 stocks:2 data:1 declining:2 improve:2 effective:1 study:2 work:2 companies:1 disorder:1
stock_ABT r_down	medication:1 significantly:1 primary:1 seizure:1 dosing:1 chronic:1 daily:1 talks:1 its:2 2.5:1 taken:1 litigation:1 said:2 $:1 twice:1 generic:1 shares:1 version:1 health:1 low:1 closed:1 medicine:1 versus:1 sell:1 pain:2 efficacy:1 company:1 back:1 met:1 lowered:1 care:1 down:1 endpoint:1 attempt:1 showed:1 --:1 drug:1 trial:1 settle:1 ongoing:1 placebo:1
stock_ABT r_up	case:1 sued:1 $:2 patent:1 prior:1 connection:1 involving:1 infringement:1
stock_ABT r_up	comment:4 heart:1 major:4 version:1 findings:1 certain:4 move:1 trade:1 quotes:1 slip:2 years:4 watched:2 blockbuster:4 its:1 fifth:1 adds:1 details:1 22:1 23:1 stent:9 two:4 shares:1 than:1 clinical:1 5:1 4:1 6:1 new:2 events:4 stock:2 potentially:1 updated:1 safe:1 's:3 climbs:2 showing:1 after:4 outperformed:5 released:4 2:2 updates:1 closely:2 device:5 last:1 stocks:3 data:4 analyst:1 11:1 lower:1 15:1 effective:1 investigator:1 avoiding:4 study:6 official:1 according:5 while:1 figures:1 drug-coated:6 climb:1 more:1 came:4
stock_ABT r_up	suggested:1 outlook:1 retail:1 spending:1 data:1 sales:1 sobering:1 gave:1 stocks:1 consumer:1 than:1 fell:1 more:1
stock_ABT r_up	over:1 specialist:1 liabilities:1 said:1 's:1 bonds:1 --:1 refinance:1 million:1 years:1 two:1 next:1 leave:1 confident:1 can:1 renegotiate:1 facing:1 terms:1 convertible:1 still:1 could:1
stock_ABT r_down	over:2 executive:1 ended:2 year-earlier:1 its:1 previous:2 25:1 20:1 $:12 headline:1 stent:5 late:2 4:1 indicating:1 updated:1 which:2 showing:2 overall:2 early:2 updates:1 background:1 --:1 morning:1 quarter:5 trading:1 year:1 81:3 174:2 profit:2 jumped:2 comments:1 net:1 recently:3 million:7 reported:3 reports:2 a.m.:1 analysts:1 drug-coated:5 published:1 maker:1 comment:1 fourth-quarter:4 revenue:3 period:1 reached:2 throughout:1 start:1 top:1 due:2 cents:2 more:1 flat:4 company:4 year’s:1 than:1 posted:4 solid:3 18:2 official:2 up:1 devices:1 while:2 were:1 launched:2 heart:1 almost:1 cited:1 share:5 sales:6 accounting:2 compared:1 also:1 earnings:2 fourth:3 income:1 interview:1 worldwide:1 's:8 price:2 said:3 72:1 70:1 device:2 president:1 fiscal:5 largely:2 charges:2 medical:1 chief:1
stock_ABT r_down	one-year:1 formerly:1 being:1 measure:1 related:1 three:1 '':1 known:1 maintained:1 used:1 including:1 drug:4 year:1 patient:2 reducing:1 technology:1 its:1 reasons:1 out:1 said:2 end:1 additional:1 two:1 response:1 symptoms:1 also:1 clinical:3 pivotal:1 details:1 which:1 according:1 effectiveness:1 ``:1 after:2 's:6 overseers:1 arthritis:1 rejected:1 studies:1 background:1 active:1 rejection:1 appropriate:1 month:1 approved:1 population:2 four:1 last:1 rheumatoid:1 study:6 disease:1 throughout:1 discontinued:2 n't:2 trial:1 patients:2 were:1 long-term:1 cholesterol:2 treated:1 taking:1 experimental:2 imaging:1
stock_ABT r_down	sector:3 major:2 adults:1 campaign:2 nurses:1 money:1 seats:1 condition:1 two:2 spine:1 election:2 have:1 parties:2 7th:1 watchdog:2 contributions:3 its:2 decade:2 said:1 group:2 federal:2 hospitals:1 45:1 detail:1 recommending:1 makers:1 majority:2 health:4 treatment:1 which:1 collected:1 figures:1 insurers:1 congressional:1 more:2 's:5 removes:1 gap:2 affecting:1 running:1 channeling:2 significant:2 new:1 device:1 includes:1 than:2 presidential:1 cycle:2 regarding:1 presidency:1 55:1 6th:1 medical:1 according:3 drug:1 doctors:1 --:1 donations:3 painful:1 time:2 professional:1 candidates:2 suppliers:1 first:2
stock_ABT r_up	heart:2 domestic:2 sales:2 three:1 pushed:2 remove:1 have:2 year:2 jury:1 250:1 still:2 market:4 arteries:1 $:3 federal:1 pay:1 divided:2 due:2 long:2 pioneer:2 concerns:2 safety:2 ruled:1 has:2 worth:2 more:2 's:2 may:2 becomes:2 million:1 but:2 device:4 article:1 1.83:2 must:1 billion:2 sidelines:2 last:2 crowded:2 industry:2 devices:1 stents:2 drug-coated:2 published:1 patents:1
stock_ABT r_up	says:1 17:1 exists:1 trades:1 some:1 upside:1 likes:1 options:1
stock_ABT r_down	because:1 help:1 site:1 baby:1 cans:1 have:1 go:1 makers:1 pharmaceutical:1 copycat:1 rivals:1 lots:1 lawsuits:1 two:1 far:1 2:2 pair:1 formula:1 entered:1 has:1 define:1 product:2 's:3 fend:1 government:1 may:1 release:1 involving:1 recalled:1 investigation:1 legally:1 press:1 article:1 posted:1 made:1 off:1 antitrust:1 --:1 could:1 according:1 drug:1 air:1 can:2 published:1 small:1 powder:1
stock_ABT r_up	large:1 scrambling:1 used:1 widely:1 warnings:1 drugs:1 epilepsy:1 companies:1 try:1 also:1 add:1 convince:1 risks:1 behavior:1 variety:1 not:1 other:1 conditions:1 class:1
stock_ABT r_up	adults:5 cancer:2 certain:1 reports:2 children:5 said:5 young:5 comments:1 makers:1 other:3 treat:3 between:3 include:1 details:1 development:3 arthritis:3 's:10 drugs:3 factor:2 possible:3 took:2 blockers:2 link:3 background:1 lymphoma:3 made:1 --:3 30:2 disease:3 drug:1 tumor:2 cancers:3 investigating:4 makes:3 reviewing:1
stock_ABT r_down	medication:1 cancer:1 into:1 period:1 seizure:1 have:1 exclusivity:1 settlement:1 its:2 unit:1 sell:2 said:2 group:1 generic:3 children:1 version:1 substitute:1 entered:1 500:1 's:2 risk:1 drugs:1 arthritis:1 agreement:1 heighten:1 license:1 whether:1 disease:1 drug:1 filing:1 investigating:1 adolescents:1 maker:1
stock_ABT r_down	11:1 epilepsy:1 plans:1 language:1 drugs:1 labels:1 warning:1 finalizing:1 behavior:1 include:1
stock_ABT r_down	development:1 show:1 --:1 studies:1 arthritis:1 drug:1 patients:1 under:1 rheumatoid:1 unit:1 late-stage:1
stock_ABT r_down	force:1 says:1 speculators:1 energy:2 probe:2 broader:1 follow:1 its:1 market:1 index:1 negative:3 shares:1 wander:2 traders:1 include:1 other:1 role:1 new:1 territory:3 into:3 modestly:1 arthritis:1 agencies:1 favorable:1 although:1 news:1 stocks:3 advance:1 task:1 study:1 drug:1 commodities:1 speculation:2 rheumatoid:1
stock_ABT r_up	giant:1 said:1 $:2 covering:1 patent:1 producing:1 over:1 methods:1 products:1 4:2 basic:1 biotechnology:1 settled:1 dispute:1
stock_ABT r_up	partner:1 story:1 already:1 's:3 like:1 drugs:1 cholesterol:1 ``:1 sale:1 identified:1 '':1 12:1 using:1 amp:2 pill:1 published:1
stock_ABT r_up	11:1 division:1 's:3 company:1 according:1 leave:1 world-wide:1 president:1
stock_ABT r_down	help:1 success:1 --:1 certain:1 medical:1 genes:1 companies:1 treatments:1 focus:1 determine:1 continue:1 identify:1 key:1 scientists:1 falling:1 find:1 those:1 more:1
stock_ABT r_down	setback:1 years:1 bring:1 another:1 throughout:1 its:1 market:1 sell:1 information:1 raise:1 initial:1 two:1 delay:2 application:1 details:1 which:2 new:1 dealt:1 stock:1 good:1 's:4 price:1 after:2 rejected:1 regulators:1 five:1 designed:1 background:1 analyst:1 reaction:1 attempt:1 launch:1 could:1 months:1 drug:2 plus:1 cholesterol:2 more:1 asked:1 comes:1
stock_ABT r_down	heart:1 less:1 likely:2 repeat:1 have:1 need:1 reached:1 decade:1 arteries:1 stent:1 attack:1 market:1 more:1 after:1 earlier:1 released:1 not:1 procedures:1 die:1 study:1 according:1 drug-coated:1 were:2 clogged:1 treated:1 first:1
stock_ABT r_down	heart:2 set:1 less:2 likely:4 repeat:2 have:2 further:1 need:2 reached:2 data:1 decade:2 before:1 arteries:2 publication:1 stent:4 ease:1 attack:2 concerns:1 safety:1 market:2 more:2 after:3 earlier:1 early:1 released:1 not:1 article:1 procedures:2 approved:1 die:2 study:3 according:2 n't:1 2003:1 patients:1 drug-coated:2 were:5 claims:1 clogged:2 first:2 treated:3 could:1 published:1
stock_ABT r_down	900,000:2
stock_ABT r_up	developed:2 move:1 focus:2 trade:1 session:1 committed:2 p.m.:1 its:8 roots:1 previous:1 whose:1 certainly:1 stent:5 had:2 late:1 has:3 gains:1 rise:1 anticipated:1 not:1 --:3 companies:1 surrendering:1 see:1 trading:1 targets:1 really:1 said:2 shares:4 research:2 looking:2 pioneer:1 new:1 increasing:2 approves:2 therapies:2 slight:1 sold:2 story:1 regulators:1 lucrative:2 active:1 article:1 rises:2 watchers:1 many:1 industry:1 drug-coated:1 published:2 approve:1 dive:2 presence:2 previously:1 one:1 simply:1 approval:2 use:1 been:2 expected:1 ``:2 selling:2 drugs:2 company:1 dreary:1 developing:2 devices:1 n't:1 following:1 biotech:1 expanding:1 '':2 something:1 technology:1 rather:1 pills:2 chemical:2 potential:1 widely:1 performance:1 development:2 's:6 collaboration:1 after:3 regular:1 biologic:2 stocks:1 approved:1 expand:2 paces:1 medical:1 disease:1 traditional:2 implied:1 time:2
stock_ABT r_up	domestic:3 trade:1 session:1 comments:1 its:6 before:1 impact:1 whose:1 asthma:3 $:4 stent:6 than:5 under:1 worth:3 10.5:1 now:1 advanced:1 name:1 --:2 companies:1 grab:1 quarter:1 deal:1 successfully:2 see:1 slice:1 shares:2 seller:1 leader:3 seventh:1 active:1 approval:8 beginning:1 declining:2 gained:3 received:1 study:2 drug:4 trial:1 expecting:1 analysts:1 drug-coated:4 rose:2 first:1 comment:1 one:1 phase:2 article:1 market:8 additional:1 remains:1 top:1 pharmaceuticals:2 expected:2 more:5 selling:4 company:3 biggest:2 analyst:1 10:3 official:1 2010:1 can:1 published:1 heart:3 file:2 1.8:3 0.6:1 have:1 seen:3 sells:1 different:1 detail:1 also:2 potential:3 details:1 which:2 completed:2 gaining:2 begin:4 's:6 after:2 device:3 stocks:2 billion:4 lower:1 attempt:1 third:2 sale:1 clears:2 2009:1
stock_ABT r_down	280,000:2
stock_ABT r_up	receiving:1 plans:1 300,000:2 stent:1 create:1 million:1 300:1 up:1 $:1 investment:1 most:1 outside:2 subsidiary:1 spinoff:1 new:1 hold:1 its:2 assets:1
stock_ABT r_down	cancer:3 dollar:2 leads:1 another:1 rally:2 aggressive:2 its:1 said:1 offering:1 system:1 next:1 climbs:2 test:3 new:2 week:1 begin:1 oil:2 form:1 very:1 dips:2 breast:2 covered:1 news:1 stocks:3 approved:1 vaccine:1 drug:1 patients:1 healthcare:1 called:1 upward:1
stock_ABT r_up	major:1 already:1 bounce:1 makers:1 market:1 around:1 pharmaceutical:1 appear:1 negative:1 surveillance:1 looking:1 costs:1 several:1 's:3 risk:1 problems:1 pressure:1 tracks:1 boosting:1 news:1 stocks:1 rallied:1 fund:1 could:1 companies:1 according:1 drug:1 traders:2 products:1 exchange-traded:1 medical-device:1
stock_ABT r_down	20:1 $:1 company:1 million:1 shares:1 insiders:1 's:1 bought:1
stock_ABT r_up	sector:3 focus:2 trade:1 session:1 motions:2 signs:1 whose:1 stent:4 second-quarter:1 under:2 has:2 details:1 spun:2 11:6 overall:1 despite:1 judge:2 --:1 companies:1 summary:2 slide:1 quarter:2 financial:1 trend:1 declines:1 turbulent:1 competition:2 see:1 year:2 said:2 federal:2 shares:1 denied:2 falling:1 increasing:2 issue:1 coated:1 decline:1 pressure:2 active:1 article:1 sending:2 employees:2 reports:1 trial:2 drug-coated:2 published:1 stabilization:1 brought:2 market:3 terminated:2 raise:1 their:1 suit:2 expected:1 company:4 favorable:1 filed:2 prices:2 former:2 case:2 second:2 devices:2 heart:2 share:2 drug:2 saw:1 class-action:2 earnings:1 which:2 higher:1 product:1 's:7 combat:2 bellwethers:1 after:1 forecasts:1 fell:2 stoke:2 stocks:1 judgment:2 ago:2 off:2 largely:1 amid:1 2008:1 came:1
stock_ABT r_down	oncology:1 shot:1 over:1 dollar:3 results:3 session:1 its:4 1.17:1 $:5 earned:1 expectations:1 1.18:1 second-quarter:2 board:1 quarterly:2 include:1 edging:1 rise:2 early:1 world:1 1.05:1 --:2 quarter:1 financial:1 estimates:1 past:2 trading:1 3.3:1 year:1 said:2 lead:2 profit:4 projected:1 net:2 across:1 climbs:2 weak:1 reported:3 news:1 strong:2 abroad:1 declining:2 last:1 reports:2 34:4 74:1 products:3 maker:1 adjusted:1 third-quarter:1 rising:1 compared:1 story:1 would:1 positive:1 moderately:1 due:1 rates:2 low:2 spike:2 biggest:2 company:2 favorable:2 analyst:2 posted:1 largest:1 16:1 3.1:1 up:1 devices:3 2007:1 heart:1 cents:3 certain:1 health-care:1 share:4 sales:6 helped:2 currency:2 drug:4 have:1 strength:2 same:1 earnings:3 income:1 higher:3 gaining:2 's:10 most:2 edges:1 72:1 stocks:6 billion:2 charges:1 medical:2 profits:1 consumer:2 medical-device:2 latest:1
stock_ABT r_up	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_ABT r_down	consider:1 less:1 executive:1 manager:1 aggressive:1 its:1 before:1 whose:1 had:1 failed:1 quarterly:1 has:1 momentum:2 hurting:1 appointment:1 which:1 situation:1 possible:2 difficult:1 bringing:1 successor:1 --:1 signal:1 deals:1 banking:1 softness:1 economy:1 collective:1 because:1 financial:1 significantly:1 people:1 energy:1 some:1 concludes:1 out:1 said:2 adds:1 business:1 since:1 closed:1 approach:1 arrival:1 power:1 weak:2 others:1 search:1 threats:1 reports:1 transmission:1 changes:1 first:1 comment:1 named:1 market:3 top:1 next:1 dealmaker:1 500:1 more:2 drugs:1 company:1 but:1 sizable:1 sustained:1 line:1 than:2 he:2 made:1 up:1 value:1 n't:1 values:1 today:1 policies:1 200,000:2 five-month:1 investors:1 health-care:3 proven:1 want:1 rally:1 apparently:1 pay:1 detail:1 earnings:1 sick:1 higher:2 's:5 may:2 after:1 automation:1 fell:1 such:1 stocks:3 acquisitions:1 sectors:1 chief:1 time:1 left:1
stock_ABT r_up	represent:1 less:1 results:2 broader:1 cuts:2 its:5 impact:1 25:1 gamut:1 20:1 $:5 stent:1 had:1 expectations:1 should:2 failed:1 rosy:1 8:1 troubled:1 sent:1 earnings:1 giants:1 worse:1 than:2 get:1 weakness:1 rebound:1 regional:1 bear:1 wave:1 they:1 not:2 major:1 continued:1 bigger:1 like:1 --:4 drop:3 companies:2 yield:1 shields:1 slide:1 40s:1 after-hours:1 branded:1 downside:1 deal:1 30s:1 some:1 back:1 competition:1 115:1 economic:1 trading:1 year:2 provided:1 mid-:1 bullish:1 profit:2 shares:2 7:1 affecting:1 net:4 three:1 across:1 earlier:1 coated:1 million:2 reported:1 key:1 dividend:3 along:1 nosedive:1 arthritis:1 both:1 last:1 could:1 30:1 drug:4 34:9 range:1 fell:2 products:3 analysts:3 drug-coated:2 climb:1 think:1 outlook:2 state-run:1 1.5:1 into:1 nutritional:2 third-quarter:1 down:1 raises:1 throughout:1 market:2 conference:1 given:1 earliest:1 additional:1 would:1 whom:1 question:1 due:1 next:1 indicate:1 much:1 call:1 low:1 strong:3 dozens:1 historically:1 more:2 health-care:1 partly:1 said:1 slumping:1 drugs:2 brings:1 company:2 diversified:1 full-year:1 98:1 valuation:1 second-quarter:7 posted:4 10:2 has:1 15:6 14:1 rival:1 up:1 devices:3 n't:1 patients:1 can:1 were:2 similar:1 industry:1 heart:3 investors:2 cents:2 exceeded:1 share:2 sales:7 high:1 say:1 reports:1 have:2 any:1 posting:1 means:1 treatment:1 details:1 which:2 income:4 interview:1 struggling:1 stock:3 week:2 rise:3 's:9 boosted:1 price:1 felt:1 woes:1 helped:3 levels:1 biologic:1 midsize:1 stocks:1 data:1 charges:1 amid:2 well:1 maker:2 stents:2 '08:2 medical-device:1 components:1 fresh:1 2008:2 profits:1
stock_ABT r_down	relies:1 comparable:1 prescription:1 drugs:1 pays:1 30:3 according:1 private:1 released:1 program:1 does:1 report:1 insurers:1 than:2 more:2
stock_ABT r_up	joints:1 violated:1 sales:1 related:1 destroy:1 parties:1 pain:1 find:1 causes:1 if:1 said:2 justice:1 stent:1 department:1 reimbursements:1 out:1 activities:1 's:3 marketing:1 company:2 arthritis:1 paid:1 quarterly:1 filed:1 report:1 trying:1 appears:1 treating:1 effective:1 third:1 chronic:1 disease:1 patients:1 products:1 can:1 investigating:1 rheumatoid:1
stock_ABT r_down	comment:1 medication:1 version:2 2018:1 into:1 testing:1 condition:1 sales:1 seizure:1 one:1 brought:1 losing:1 2007:1 experts:1 against:1 have:2 approval:1 follow:1 although:1 its:1 headaches:1 seizures:1 blockbuster:1 patent:1 $:1 sodium:1 generic:1 agency:1 generally:1 recommending:1 research:1 favor:1 bipolar:1 concerns:1 safety:1 treatment:2 which:2 basic:1 new:1 1.58:1 moderate:1 company:1 voted:2 treat:2 used:1 's:2 ways:1 big:1 advice:1 arthritis:1 but:1 produce:1 pharma:1 protection:1 liver:1 members:1 despite:1 backed:1 affect:1 years:1 approved:1 after:1 panel:3 billion:1 migraine:1 failed:1 --:1 disorder:1 medical:1 companies:1 according:1 drug:2 until:1 n't:1 person:1 severe:1 protected:1 does:2 handful:1 release:1 obesity:1 panels:1 rheumatoid:1 first:1
stock_ABT r_up	members:1 one:1 against:1 experts:1 recommending:1 approval:1 information:1 based:1 person:1 generic:1 make:1 comments:1 member:1 favor:1 program:1 safety:1 treatment:2 dominate:1 meeting:1 voted:2 treat:1 poor:1 's:2 drugs:1 arthritis:1 liver:1 background:1 despite:1 backed:1 affect:1 now:1 concerns:1 panel:3 moderate:1 countries:1 --:1 many:1 medical:1 drug:1 provide:1 severe:1 rheumatoid:1
stock_ABT r_up	received:1 said:1 's:1 activities:1 marketing:1 over:1 products:1 subpoena:1 stent:1 subsidiary:1
stock_ABT r_up	attorney:1 office:1 over:2 sales:1 probing:2 subsidiary:3 carry:2 throughout:1 open:2 its:2 unit:1 said:3 stents:2 stent:3 make:2 comments:1 makers:1 other:2 disclosed:3 spotlight:1 activities:1 used:2 's:4 marketing:5 company:4 fluid:2 background:1 regulatory:2 article:1 appears:2 received:4 cooperating:1 companies:3 according:2 devices:4 keep:2 matter:2 practices:2 products:2 subpoena:5 published:1 investigating:1 consumer:1 filing:3 medical-device:1 joining:1
stock_ABT r_down	n't:1 multiple:1 cardiologists:1 mix:1 industry:1 suppliers:1 year:1 heavyweight:1 devices:1 next:1 try:1 stents:1 doctors:1 putting:1 but:1 drug-coated:1 hands:1 let:1 appears:1 its:1 latest:1
stock_ABT r_up	issued:1 controversial:1 its:2 death:2 20:2 disclosed:1 cardiologists:1 has:1 risk:2 combination:1 contracts:1 doses:2 suffering:1 putting:1 hands:1 not:1 2:2 day:2 --:1 suppliers:2 try:1 benefit:1 continue:1 cholesterol:1 lends:1 financial:1 heavyweight:1 year:1 said:3 lead:2 investigation:2 receiving:1 recently:1 marketing:1 regulators:2 let:1 regulatory:1 article:1 appears:1 received:1 rare:2 receive:1 industry:1 drug:1 drug-coated:1 published:1 requests:1 cooperating:1 maker:1 heart-rhythm:1 win:1 hospital:1 there:1 next:1 much:1 injury:3 drugs:1 but:1 failure:2 part:1 doctors:1 than:2 professionals:1 devices:1 n't:1 patients:2 can:2 similar:1 taking:3 heart:1 medication:1 health-care:1 sales:1 reports:1 kidney:2 if:1 mix:1 details:1 which:1 higher:2 used:1 multiple:1 alert:2 device:1 medical:1 stents:2 subpoena:1 muscle:3 filing:1 latest:1
stock_ABT r_down	medication:1 heart-rhythm:1 health-care:1 drug:1 controversial:1 doses:1 kidney:1 death:1 20:1 lead:1 day:1 2:2 which:1 injury:2 higher:1 used:1 risk:1 combination:1 published:1 alert:1 failure:1 regulators:1 said:1 article:1 than:1 professionals:1 rare:1 --:1 taking:2 suffering:1 reports:1 receive:1 patients:1 continue:1 can:1 cholesterol:1 muscle:2
stock_ABT r_down	n't:1 multiple:1 cardiologists:1 mix:1 industry:1 suppliers:1 year:1 heavyweight:1 devices:1 next:1 try:1 stents:1 doctors:1 putting:1 but:1 drug-coated:1 hands:1 let:1 appears:1 its:1 latest:1
stock_ABT r_up	heart:1 flawed:1 brought:1 backed:1 against:1 jury:1 relating:1 said:1 monitoring:1 patent:1 stent:1 favor:1 which:1 glucose:1 's:2 business:1 company:1 blood:1 regulatory:1 approval:1 awaiting:1 data:1 ruled:1 case:1 four:1 last:1 analysis:1 discontinued:1 found:1 filing:1 patents:1
stock_ABT r_up	fiscal:1 week:2 major:1 their:1 --:1 issued:1 after:1 results:1 reports:1 next:1 muted:1 drug:1 outlooks:1 earnings:1 retailers:1 begin:1 report:1 cholesterol:1 its:1 second-quarter:1
stock_ABT r_down	heart:1 slipped:1 despite:1 sales:4 competition:2 seen:1 ended:1 held:1 watched:1 first-quarter:1 80:1 throughout:1 its:2 market:2 said:1 just:1 10.7:2 rose:1 guidance:1 below:1 comments:1 late:1 details:1 income:1 defibrillators:1 international:1 net:1 posted:1 implantable:1 11:1 product:1 million:1 's:4 company:1 tally:1 but:1 restructuring:1 nearly:2 closely:1 stabilizing:1 device:2 strong:1 continued:1 analyst:1 $:3 fiscal:1 launch:1 official:1 faced:1 prior:1 benefit:1 costs:1 products:1 drug-coated:2 stent:2 following:1 fresh:2 quarter:2 top:1
stock_ABT r_down	comment:1 1.5:2 all:1 annual:1 force:2 help:1 150:1 within:1 over:2 move:1 reduce:1 sales:1 ninth:1 years:2 four:1 drug-coated:1 newcomers:1 operations:2 battle:1 associated:1 actions:1 its:5 unit:2 complete:1 strategic:1 spokeswoman:1 cut:1 adds:1 $:1 stents:1 stent:1 approved:1 two:1 access:1 next:2 current:1 health:1 fifth:1 fourth:1 between:1 expected:1 save:2 pretax:1 company:2 stock:1 worldwide:1 core:3 global:2 jobs:2 plans:3 business:1 sixth:1 price:1 million:1 overall:1 disclosed:2 diagnostic:1 delivery:1 market:1 said:1 streamline:2 plan:2 background:1 filed:2 manufacturing:2 effort:1 than:1 improve:1 document:2 third:1 could:1 work:2 yield:1 1,000:6 eliminate:1 savings:1 costs:3 brewing:1 diagnostics:2 more:1 care:1 system:1
stock_ABT r_up	1,000:2
stock_ABT r_down	amp:2
stock_ABT r_down	150:1 agency:1 pre-tax:1 deal:1 strengthened:1 labels:1 expects:1 sale:1 four:2 spinal:1 strongest:1 least:1 black-box:2 its:2 risk:2 comments:1 closes:1 said:2 $:6 disease:2 one-time:1 --:2 pharmaceuticals:1 intends:1 expand:1 details:1 more:1 360:3 treat:1 hip:1 added:2 's:6 plans:1 business:3 warnings:2 drugs:2 company:1 million:2 problems:1 arthritis:2 warn:2 regulators:2 gain:2 buying:1 additional:2 treating:1 spine:1 medical:1 infections:2 cash:1 wants:1 item:1 products:1 small:1 serious:2 quarter:1 filing:1
stock_ABT r_up	adjusted:1 dilute:1 ordered:2 deal:2 8-:1 cents:1 infections:2 labels:2 sales:1 ninth:1 disease:2 four:2 spinal:3 through:1 per-share:1 seen:1 its:3 risk:2 impact:2 knees:2 '':1 followed:1 $:9 dilutive:2 add:1 comments:2 3:1 expand:3 fourth:2 9:1 details:1 2010:1 360:5 earnings:1 hip:1 ``:1 arthritis:2 's:9 plans:3 business:7 warnings:2 drugs:2 seventh:1 million:3 problems:3 alert:2 expected:1 neutral:1 background:1 analyst:2 buying:3 treating:3 10:1 13:1 2009:1 stronger:2 cash:3 final:1 patients:2 small:3 serious:2 closing:1 quarter:1 slightly:1 maker:2 hips:2 replacement:2
stock_ABT r_up	helped:1 monitor:1 average:1 published:1 according:1 keep:1 1:3 their:1 levels:2 meters:1 online:1 better:1 adults:1 study:1 than:1 down:1 diabetes:1
stock_ABT r_up	attorney:1 false:1 civil:1 over:1 general:1 four:1 reached:1 settlement:1 $:3 28:1 alleged:1 state:1 has:1 more:1 reporting:1 million:1 prices:1 years:1 than:1 ago:1 regarding:1 charges:1 drug:1
stock_ABT r_up	regarding:1 settlement:1 false:1 $:1 civil:1 over:1 million:1 28:1 alleged:1 drug:1 charges:1 prices:1 reached:1 has:1 reporting:1
stock_ABT r_down	competitors:1 all:1 financial:2 share:4 expectations:2 '':1 its:2 market:2 said:3 adds:1 stent:2 exceeding:2 comments:1 three:1 company:2 gaining:1 ``:1 's:4 price:2 early:2 rapidly:1 chief:2 officer:2 drug-coated:2 following:2 expense:1
stock_ABT r_down	infant:1 financial:1 broader:1 previously:1 nutritional:1 major:1 expectations:1 unit:1 trading:2 unveiled:1 its:3 best:1 pharmaceutical:1 said:1 stent:1 six:1 exceeding:1 trend:1 finally:1 concerns:1 health:1 details:1 formula:1 firms:1 company:1 announced:1 officer:1 week:1 's:4 drug-coated:1 brand:1 took:1 but:1 slides:1 market:1 plan:1 known:1 day:1 early:1 lower:3 third:1 industry:1 months:1 trends:2 banking:1 chief:1 midday:2 pediatric:1 following:1
stock_ABT r_up	skin:1 patient:1 blockbuster:1 its:1 said:1 analyst:1 eighth:1 add:1 more:1 psoriasis:1 's:4 prices:1 beginning:1 than:1 treating:1 reaction:1 effective:1 study:1 disease:1 drug:2 stock:1 experimental:1
stock_ABT r_down	lower:1 climbs:2 series:1 move:1 drug:1 shares:1 slide:2 marginally:1 wake:1 but:3 buyback:2 climb:1 stocks:1 repurchases:1 issues:2 stock:1
stock_ABT r_up	lifted:1 significantly:1 show:1 10,000:1 warning:1 patient:1 quality:1 use:1 adds:1 $:1 also:1 stent:1 shares:1 their:1 progress:1 indicating:1 life:2 's:2 company:1 released:1 letter:1 new:1 approval:1 improve:1 extending:1 corporate:1 study:1 bill:1 n't:2 stents:1 while:1 without:1 toward:1 shaking:1 medical:1
stock_ABT r_up	has:1 votes:2 bill:2 banking:1 tumble:2 provide:1 resolution:1 industry:1 after:2 down:3 crippled:1 bailout:2 voted:1 broader:1 aid:1 following:1 news:1 plunge:1 stocks:3 dives:1 market:1
stock_ABT r_down	sector:1 proposed:1 increasingly:1 domestic:1 dose:1 including:1 plagued:1 prop:1 its:1 industries:2 giant:1 arteries:1 helping:1 stent:1 seems:1 should:1 production:1 cardiologists:1 quarterly:1 has:4 details:1 tonic:2 gains:1 psychiatric:1 early:1 updates:1 glitches:1 did:1 12th:1 companies:2 large:1 lose:1 worries:1 obesity:1 side:2 week:2 set:1 financial:2 weight:1 people:1 trends:1 been:2 devices:1 year:4 makers:1 said:2 federal:2 shrinking:1 research:2 bailout:3 safety:1 new:1 restoring:1 business:1 attention:1 pressure:1 approval:1 beginning:1 halted:1 ate:1 last:1 could:2 reports:1 turn:1 drug-coated:1 signature:1 clogged:1 slightly:2 experimental:3 benefited:2 previously:3 into:1 increased:1 because:1 adopted:1 vote:1 passage:1 open:1 market:2 risk:1 renewal:2 spending:2 legislation:2 tiny:1 quickly:1 rivals:1 clinical:1 rates:2 passed:2 expected:2 ``:2 upcoming:1 drugs:1 share:1 serve:2 took:1 extended:1 hurt:2 tasked:1 demand:1 off:1 those:1 paying:1 rebounding:1 bill:3 up:1 signed:1 n't:4 while:1 following:1 called:1 heart:1 associated:1 certain:1 tax:4 sales:1 '':2 exist:1 drug:6 have:1 seen:1 yet:1 anti-obesity:2 rescue:2 end:2 credit:6 pay:1 also:1 complex:1 earnings:2 which:3 gamble:1 stock:1 development:3 used:1 's:5 boosted:2 price:1 reflect:1 levels:1 device:2 expired:2 shortly:1 effective:3 studies:1 medical:2 stents:1 chief:1 2007:2 trials:1 corporate:2 profits:2 effects:2
stock_ABT r_down	's:4 effective:1 study:1 disease:1 drug:3 according:1 either:1 another:1 alone:1 blockbuster:1 than:1 condition:1 more:1
stock_ABT r_down	because:1 says:1 related:1 including:1 accounting:1 its:1 variety:1 federal:1 make:1 third-quarter:2 next:1 charge:4 take:2 suit:2 earnings:2 week:1 's:1 releases:1 though:1 infringement:1 hefty:3 offset:1 report:1 post:1 payment:1 recent:1 case:1 items:1 sale:1 patent:1 ruling:1 slightly:1 reduced:1
stock_ABT r_down	investments:1 customers:1 plunge:1 's:1 fundamentals:1 health-care:1 find:1 strong:1 opportunities:1 its:1 lows:1 broader:1 sees:1 along:1 stocks:1 multiyear:1 market:1 stock:1
stock_ABT r_up	heart:2 well:1 trade:1 active:1 see:1 session:1 whose:1 additional:2 ways:2 stent:2 two:2 shares:1 longtime:1 which:2 biggest:2 long-time:1 details:1 gaining:2 used:1 's:3 outperformed:2 expected:1 device:4 stocks:2 data:2 combined:2 declining:2 companies:1 according:2 analysis:2 stents:1 drug-coated:2 banks:1 shows:2 studies:3
stock_ABT r_up	clog:1 developed:2 executive:1 focus:2 trade:2 prices:1 manager:1 session:2 through:1 comments:4 years:1 doesn’t:1 year-earlier:2 its:9 ground:2 whose:1 giant:2 arteries:1 $:3 stent:10 should:2 analyst:1 charge:2 program:2 board:1 bypass:2 31:1 weeks:1 has:4 strength:1 details:4 bank:2 updated:2 good:2 co-founders:1 gains:1 weakness:1 safe:2 early:1 18-19:1 updates:1 cautious:1 report:1 artery:1 one:3 continued:3 day:1 volatile:2 common:1 homegrown:2 lost:2 --:4 12th:1 companies:1 fewer:2 large:1 benefit:2 surging:2 authorized:1 quick:2 eye-popping:1 stock:5 16th:1 week:2 financial:1 heart-attack:1 due:1 declines:2 some:2 up:1 past:1 see:1 growth:4 trading:1 year:1 surgery:3 best:2 said:3 profit:2 blue-chip:1 shares:5 forecast:1 bailout:2 health:2 longtime:1 between:1 new:1 ever:1 shows:1 turmoil:2 business:2 sixth:1 million:1 reported:2 restructuring:2 active:1 article:1 strong:1 beginning:2 care:2 quarter:5 last:1 margin:1 study:3 30:6 according:3 reports:1 trial:2 products:1 offsetting:2 drug-coated:5 published:1 clogged:3 undergo:2 safely:2 first:1 comment:1 three:1 down:2 repurchase:1 foreign-exchange:1 another:1 ways:1 market:11 prompted:1 conference:3 use:2 additional:3 would:2 5th:1 third-quarter:3 been:1 eighth:1 start:2 difference:1 call:1 combined:1 expected:2 more:1 rallied:1 cardiology:2 company:4 diversified:2 studies:1 sickest:2 reiterated:1 released:3 lift:2 favorable:1 known:1 than:2 those:1 weighed:2 main:1 calls:1 showed:2 solid:1 dangerous:2 official:1 rate:3 devices:1 bolster:2 placed:1 patients:7 economic:1 following:1 again:1 10th:2 treated:2 could:2 procedure:1 history:1 heart:6 investors:1 share:3 sales:9 helped:2 analysis:2 offense:2 sharp:2 defense:2 sell:1 information:2 compared:1 end:1 make:1 stake:2 detail:2 rally:2 potential:2 5:3 earnings:2 which:3 clots:2 higher:3 status:2 's:9 haven:2 separate:1 boosted:1 price:3 after:2 outperformed:1 effect:1 most:2 involving:1 two:2 device:6 stocks:4 data:3 model:2 recent:2 billion:1 drug-eluting:3 third:5 largely:1 amid:3 conglomerates:1 steady:3 consumer-product:4 stents:5 part:1 so:1 gain:2 2008:1 consumer:1 medical-device:1 left:1
stock_ABT r_down	developed:1 results:1 trade:1 session:1 shares:1 its:9 cardiovascular:1 whose:1 $:5 headline:1 stent:10 should:1 better:1 add:1 treatment:2 has:3 details:1 recipients:1 rebound:1 safe:1 overall:1 suffering:1 updates:1 during:1 years:1 continued:1 bigger:1 eroded:1 lost:1 --:1 1.08:1 51:7 fewer:2 large:1 12th:1 popular:1 rheumatoid:1 financial:1 a.m.:1 companies:1 some:1 used:1 challenges:1 economic:1 year:1 substantially:1 said:1 profit:3 comments:1 forecast:2 looking:1 safety:1 between:1 new:3 net:3 receiving:1 arthritis:1 business:2 continuing:1 reported:4 active:1 strong:4 declining:2 suggested:1 improved:1 getting:1 study:4 uncertainty:1 according:2 drug:2 times:1 trial:1 products:2 due:2 drug-coated:5 published:1 safely:1 ground:1 unexpectedly:1 one:3 raises:2 market:2 often:1 conference:1 pharmaceutical:1 start:1 third-quarter:5 comparing:1 attack:1 clinical:1 call:1 too:1 biggest:2 more:1 head:1 company:1 diversified:1 serve:1 but:1 dangerous:1 posts:2 part:1 competition:1 quick:1 than:3 posted:2 helped:2 showed:1 solid:1 rival:1 launch:1 devices:1 patients:3 growth:1 can:2 clots:1 treated:1 industry:1 streak:1 heart:1 months:1 figure:1 share:3 sales:5 13th:1 reports:1 information:1 rather:1 suggest:1 portion:1 earnings:1 which:2 income:2 performance:1 mid-teens:1 bare-metal:2 brisk:1 higher:3 gaining:2 rise:1 's:7 may:1 price:1 after:2 two:4 coming:1 device:2 such:1 stocks:2 billion:1 off:1 effective:1 studies:1 stents:3 severe:1 healthcare:1 model:1 increase:1 starting:2 profits:2
stock_ABT r_up	senators:1 connections:1 have:1 information:2 group:1 22:1 question:1 two:1 research:2 outside:1 asking:1 income:1 between:1 more:1 physicians:2 university:1 seeking:1 under:1 letter:1 doctors:2 device:1 president:1 come:1 made:1 --:1 medical:1 payments:1 industry:1
stock_ABT r_up	senators:1 one-year:2 they:1 setback:2 known:1 interim:2 its:2 fifth:1 group:1 22:1 stent:4 had:2 outside:1 than:1 stock-market:1 asking:1 under:1 suffered:1 has:2 physicians:2 updated:1 crash:1 forces:1 seeking:1 bear:3 know:2 background:2 --:4 university:1 companies:1 did:1 payments:1 dangerous:1 found:1 hard:1 connections:1 best:1 even:1 comments:1 research:2 behind:2 won:2 between:1 thrive:1 article:1 come:1 protect:1 rare:1 extension:4 attacks:1 industry:1 drug-coated:1 published:1 block:2 into:2 system:2 determine:1 throughout:1 market:3 question:1 two:1 which:2 survive:1 more:2 buy:2 funds:1 clots:2 but:1 delivery:2 part:1 survived:1 doctors:2 prices:1 analyst:1 made:1 rights:2 rival:2 patients:3 can:3 treated:2 study:1 heart:2 have:1 sought:2 technology:2 if:2 information:2 mutual:1 widely:2 income:1 you:2 stock:1 handing:2 used:2 's:1 after:1 blood:1 letter:1 device:1 president:1 stocks:1 response:1 traps:2 medical:2 stents:1 comes:1 serious:1 2008:1 joining:1
stock_ABT r_up	bearing:1 one-year:1 office:1 item:1 '':1 interim:1 our:1 seek:1 its:1 said:1 no:1 patent:1 technology:1 extension:1 system:1 p.m.:1 spokesman:1 behind:1 won:1 widely:1 has:2 ``:1 used:1 's:1 delivery:1 reported:1 name:1 17:1 rights:1 justice:1 ruling:1 stent:1 efforts:1 first:1
stock_ABT r_down	poorest:1 consider:1 painkiller:1 cents:4 declines:1 offset:1 share:3 sales:1 related:2 month:1 certain:1 62:1 businesses:1 aimed:1 year:1 narrowed:1 information:1 prescription-drug:1 compared:1 $:2 driving:1 patent:1 stent:1 assistance:1 people:1 third-quarter:1 charge:1 4:1 year-ago:1 expected:1 net:2 company:1 more:2 requested:1 's:2 form:1 purchase:1 infringement:1 milestone:1 million:2 continuing:1 reported:1 said:2 gain:1 despite:1 payment:2 partially:1 ago:1 loss:3 12:1 programs:1 18:2 record:1 2006:1 drug-coated:1 normally:1 maker:1 medical-device:1
stock_ABT r_down	medication:1 consider:1 give:3 increasingly:4 declines:1 injunction:4 sales:1 competitive:4 month:3 stent-delivery:4 shares:1 article:2 wider:1 narrowed:1 its:5 market:4 amended:4 move:3 needs:1 said:2 end:3 federal:4 stent:5 delays:1 agency:1 system:7 comments:1 start:3 newly:1 has:5 health-care:1 more:1 selling:4 's:3 string:1 opening:3 popular:4 company:6 cholesterol:1 continuing:1 given:1 most:4 putting:4 allowing:1 background:1 review:1 judge:5 approval:1 despite:1 appears:3 buying:1 disadvantage:4 loss:1 great:1 third-quarter:1 using:3 --:5 inexpensive:1 net:1 drug:2 patients:1 products:1 diagnosed:1 drug-coated:5 time:2 blocked:4 become:1 told:1 granted:1 experimental:1 published:2
stock_ABT r_up	infant:1 executive:2 results:3 comments:1 settlement:1 its:6 impact:1 giant:1 overhaul:1 rose:1 guidance:1 surgeons:1 than:1 late:1 disclosed:1 has:2 surprised:1 complaint:2 string:1 continues:2 early:1 reforms:2 sweeping:1 one:1 newly:1 showed:1 lost:1 --:2 deals:1 continue:1 cholesterol:1 soft:1 second:1 expect:1 year:4 said:4 lead:1 jumped:1 review:1 brief:1 legal:1 asthma:3 spokesman:1 formula:1 net:1 told:1 weighing:1 business:1 marketing:1 article:1 last:1 could:1 months:1 according:1 drug:4 infringe:1 trial:2 products:1 due:1 published:1 delays:1 experimental:1 first:1 comment:1 outlook:1 pays:1 treatment:2 catalysts:1 down:1 approval:3 wider:1 apply:1 throughout:1 better:1 given:1 third-quarter:1 next:2 pharmaceuticals:1 way:1 final:1 more:2 firm:1 triggered:1 successful:1 company:4 but:2 stressing:1 volume:1 disruption:1 lowered:1 filed:2 improved:1 analyst:2 replacement-joint:1 rights:1 while:1 future:1 expiration:1 were:1 biotech:1 medication:1 share:1 sales:2 weighed:1 full-year:1 warning:1 ready:1 again:1 needs:1 strength:1 end:1 patent:1 granted:1 agency:1 detail:1 delay:1 details:1 income:1 diagnosed:1 allowing:1 's:3 components:1 forced:1 may:1 price:1 after:2 different:1 two:1 phase:1 recent:1 older:2 alleging:1 spent:1 maker:1 patients:2 time:1 filing:1
stock_ABT r_down	attorney:1 general:1 '':1 recoup:2 makers:1 pharmaceutical:2 overcharging:2 alleged:1 increase:1 state:3 program:3 reimbursements:1 include:1 giants:1 ``:1 sued:2 's:3 allegedly:2 provided:2 drugs:2 prices:1 such:1 13:4 involved:1 losses:2 companies:3 drug:2 patients:2 order:1
stock_ABT r_up	comment:1 heart:1 key:1 angioplasty:2 into:2 move:3 share:3 ``:3 '':3 its:2 market:2 stent-delivery:2 said:2 also:1 patent:1 stent:2 holds:1 help:1 system:3 legal:1 response:1 start:2 other:2 which:1 complaint:1 selling:2 's:2 plans:2 domestic:2 sales:2 delivery:1 arteries:1 fracas:1 doctors:1 prices:1 analyst:1 improve:2 11:1 12:1 15:1 thread:1 could:2 allows:1 stents:1 without:1 products:2 drug-coated:2 popular:2 fresh:1
stock_ABT r_up	see:1 have:1 meltdown:1 your:2 market:1 now:3 wealth:2 late:1 too:1 probably:1 you:3 company:1 selling:1 's:2 hazardous:2 plenty:1 coming:1 stocks:2 did:1 could:2 n't:1 're:1
stock_ABT r_up	associated:1 letter:1 process:1 '':1 identify:1 committee:1 any:1 information:1 given:1 said:3 field:1 their:1 other:1 has:1 disclose:1 ``:1 nature:1 company:2 psychiatric:1 but:2 they:1 authorities:1 received:1 benefits:1 did:2 n't:2 payments:2 professional:1 filing:1 otherwise:1
stock_ABT r_down	emerging:1 slow:1 targeting:1 like:1 sales:1 markets:1 makers:1
stock_ABT r_up	heart:1 official:1 end:1 company:1 continues:1 drug:1 said:1 expect:1 year:1 approve:1 its:1 experimental:1 before:1
stock_ABT r_up	heart:1 share:2 results:1 product:1 throughout:1 its:1 market:1 ground:1 additional:1 expectations:1 comments:2 second-quarter:2 rivals:1 other:1 details:1 income:1 new:1 net:1 company:1 gave:1 updated:1 's:1 some:1 price:1 sales:1 fell:1 key:1 analyst:1 areas:1 fiscal:2 short:1 14:3 lost:1 charges:1 amid:1 up:1 devices:1 products:1 analysts:1 came:1
stock_ABT r_up	litigation:1 monopoly:1 $:1 created:1 pay:1 agreed:1 million:1 allegations:1 drug:1 its:1 settle:1 over:1
stock_ABT r_up	'':1 infant:1 said:1 trace:1 very:1 positive:1 melamine:1 containing:1 one:1 sample:1 levels:1 low:1 formula:1 found:1 ``:1
stock_ABT r_up	saying:1 melamine:1 trace:1 do:1 pose:1 infant:1 tiny:1 n't:1 levels:1 health:1 allow:1 formula:1 concerns:1
stock_ABT r_down	largely:1 agreed:1 related:1 according:1 brought:1 ended:1 reached:1 settlement:2 its:1 levels:1 improperly:2 litigation:3 said:2 court:1 $:6 federal:1 pay:2 lawsuits:1 class-action:1 had:1 least:1 hitting:1 risk:1 details:1 which:1 cardiovascular:1 has:1 over:1 pending:1 used:1 tried:1 started:1 million:2 stop:1 cut:1 throughout:1 trying:1 those:1 10:1 resolve:2 monopoly:1 whether:1 involved:1 versions:1 sale:1 drug:2 filing:1 trial:1 portion:1 maintain:1 cholesterol:2 disease:1 claims:3 plaintiffs:1 maker:1 generic:1
stock_ABT r_up	infant:3 industrial:1 consume:1 backing:1 issued:1 advisors:1 one:1 medical:1 per:1 determine:1 table:1 selected:1 drug:1 2.5:1 if:1 pharmaceutical:1 said:3 trace:1 would:1 patent:1 there:1 below:1 least:1 chemical:1 contained:1 parts:1 listed:2 time:1 finding:1 formula:4 assessment:1 sold:1 drink:1 treatment:1 week:1 melamine:3 safe:2 partly:1 stance:1 received:1 food:1 approvals:1 brand:1 after:1 arthritis:1 released:1 were:1 new:2 article:1 reverses:1 present:1 drugmaker:1 million:1 exception:1 level:1 --:2 could:2 companies:2 's:2 n't:1 amount:1 determined:1 medical-device:1 allow:1 published:1 following:1 biotechnology:1 rheumatoid:1 order:1 patents:1
stock_ABT r_up	infant:6 group:1 ads:1 28:1 concerns:1 health:1 has:1 do:1 tests:1 combination:1 food:1 safe:2 they:1 new:1 not:2 level:2 --:2 standards:1 item:1 contain:1 because:1 related:2 decided:1 devices:1 2.5:1 said:4 federal:1 per:1 p.m.:1 contained:1 does:1 safety:1 formula:8 ever:1 public:1 drink:1 stance:1 sold:2 million:1 additional:1 both:1 could:2 parts:1 against:1 amount:2 industrial:2 consume:1 one:2 determine:1 establish:1 raise:1 would:2 there:1 least:2 assessment:1 melamine:6 partly:1 brand:2 chemicals:2 reverses:1 present:2 exception:1 advocacy:1 n't:4 below:1 determined:1 can:1 10th:1 ran:1 disclosures:1 if:1 information:1 violate:1 chemical:2 rules:1 setting:1 finding:2 used:1 trace:2 warnings:1 after:2 medical:1 implied:1 allow:2 time:1 claims:1
stock_ABT r_down	comment:1 setback:1 submit:1 year:1 its:2 plans:1 information:1 said:1 based:1 additional:1 least:1 next:1 delay:1 other:1 animal:1 new:2 suffered:1 which:1 arthritis:1 most:1 background:1 data:1 analyst:1 third:1 launch:1 --:1 18:1 months:1 drug:2 trial:1 severe:1 promising:1 quarter:1 rheumatoid:1 asked:1
stock_ABT r_up	competition:1 blockbuster:1 its:1 giving:1 won:1 treatment:1 new:1 gives:1 used:1 's:3 combination:1 company:2 faces:1 victory:1 key:1 approval:2 received:1 statins:1 drug:2 generic:1 can:1 threat:1 cholesterol:1
stock_ABT r_up	heart:1 '':1 its:1 pharmaceutical:1 management:1 alleged:1 chemical:1 charge:1 treatment:1 babies:1 ``:1 used:1 's:2 company:2 prices:1 10:2 monopoly:1 --:1 rival:1 drug:2 cholesterol:1 clearance:1 maker:1 acquisition:1
stock_ABT r_down	trade:1 6.6:1 see:1 session:1 subsidiary:1 175:1 its:2 developer:1 $:3 rose:1 stake:1 shares:2 their:1 expected:1 remaining:1 gaining:2 million:1 's:2 option:1 after:1 diagnostic:1 biggest:2 active:1 during:1 stocks:2 declining:2 purchase:1 --:1 companies:1 pay:1
stock_ABT r_up	psoriasis:1 saying:1 's:1 scientific:1 --:1 warned:1 company:1 supported:1 drug:1 evidence:1 regulators:1 misleading:1 not:1 claims:1 makes:1 over:1
stock_ABT r_down	bankruptcies:1 since:1 financial:1 defensive:1 less:1 money:3 combining:1 bring:1 dig:1 economic:1 economy:1 year:2 foreclosures:1 portfolio:1 face:1 its:1 out:1 debt:1 end:1 position:1 ways:1 make:2 there:2 administration:1 ideas:2 investment:2 printing:1 rates:1 low:1 interest:1 you:2 save:1 markets:1 more:1 cutbacks:1 do:1 we:1 10:1 stimulate:1 next:1 reason:1 train:1 worst:1 they:1 coming:1 losing:1 funding:1 believe:1 projects:1 your:1 ago:1 faith:1 keeping:1 12:1 incoming:1 contracting:1 --:4 light:1 losses:1 companies:1 job:1 times:1 try:1 tunnel:1 part:1 can:2 truth:1 strategies:1 2009:4 spend:1
stock_ABT r_up	product:1 court:1 federal:1 patent-infringement:1 's:1 against:1 drug:1 which:1 filed:1 autoimmune:1 relating:1 lawsuit:1
stock_ABT r_down	treating:1 heart:1 major:1 arteries:1 necessary:1 deal:1 milder:1 drugs:1 issued:1 medical:1 were:2 disease:1 n't:2 patients:2 said:1 treated:1 criteria:1 symptoms:1 new:1 clogged:1 procedures:1
stock_ABT r_down	because:1 statements:1 being:1 past:1 us:1 another:1 year:1 portfolio:1 calendar:1 closes:1 torn:1 had:1 better:1 few:1 book:1 beating:2 unprecedented:1 hope:1 stock:2 funds:2 truly:1 endure:1 tossed:1 pages:1 uncertain:2 like:1 brutal:2 face:2 tale:1 can:1 2008:3 2009:2
stock_ABT r_down	gloomy:1 background:1 agreed:3 focus:2 four:1 bright:1 including:2 during:2 appetite:1 agrees:1 decade:1 announcement:1 certainly:1 21:1 tight:2 merger:2 bell:1 only:1 other:1 has:5 hope:1 earnings:4 premium:2 get:1 far:1 fat:1 results:1 ones:1 nearly:2 they:1 21.50:1 continued:1 easily:1 awaited:1 eye-care:1 --:1 companies:2 eve:1 traders:1 activity:1 mergers:1 chew:1 smaller:1 weight:1 energy:1 some:1 past:1 2.8:6 slumped:2 comments:1 its:2 sixth:1 new:1 allowing:1 price:2 shows:1 business:3 hefty:1 sparked:1 seventh:1 agreement:1 willing:1 bite:1 along:1 debt:2 beginning:1 $:21 reaction:1 subdued:1 discount:3 could:1 double-digit:1 times:1 range:2 plus:1 analysts:1 pick:1 traded:1 maker:2 otherwise:1 fourth-quarter:1 own:1 point:1 into:3 marked:1 offerings:1 another:1 throughout:1 market:3 decline:1 shareholders:1 cheered:1 deal:4 their:1 spending:1 binge:1 there:1 start:1 2:1 doubling:1 more:2 eyes:1 sessions:1 season:2 acquire:5 dreary:1 but:3 stick:1 demand:1 prices:1 effort:1 than:2 buying:1 exposes:2 launches:2 up:1 recession:2 near:2 economic:1 can:1 were:1 cards:1 meet:1 closing:2 acquisition:4 1.4:1 futures:4 hoping:1 investors:3 something:1 have:2 close:1 again:1 rather:1 offer:1 eye-health:3 also:2 concerns:1 details:1 1.36:8 stock:8 's:11 may:1 dive:1 after:1 spot:1 fell:1 sooner:1 services:1 stocks:1 eighth:1 expand:1 billion:10 purchase:1 meander:2 off:1 third:1 updates:1 later:1 2000:1 materials:1 so:1 healthcare:1 overseas:1 executives:1 expands:1 playing:1 medical-device:2 once:1
stock_ABT r_up	proposed:1 cheap:1 bright:1 through:1 still:1 its:1 announcement:1 $:1 merger:2 environment:1 pretty:1 announce:1 hope:1 premium:1 sitting:1 very:1 sooner:1 --:1 companies:3 morning:1 deals:1 slide:2 activity:1 quarter:1 vision:1 brave:1 some:1 up:1 likely:1 investment:1 declined:1 really:1 said:2 appear:1 current:1 strategist:1 red:1 business:1 hefty:1 sparked:1 agreement:1 although:2 path:1 article:1 could:1 credit:1 pick:1 otherwise:1 major:1 awaited:1 set:1 news:2 market:1 given:1 would:1 doubt:1 historically:1 more:1 ``:1 dreary:1 prices:1 than:1 buying:1 cash:1 record:1 toward:1 torrent:1 acquisition:3 1.4:1 investors:3 '':1 have:2 ink:1 relatively:1 rather:1 eye-health:1 tight:1 earnings:3 fourth:1 brace:2 stock:1 's:3 may:3 published:1 spot:1 levels:1 stocks:1 billion:1 especially:1 later:1 2008:1 800:2
stock_ABT r_down	even:1 fourth-quarter:1 's:2 announces:1 barely:1 results:1 expect:1 broke:1 report:1
stock_ABT r_up	amp:2
stock_ABT r_down	sector:1 homes:1 show:1 issued:2 focus:2 trade:1 session:1 shares:1 cuts:2 its:3 whose:1 giant:2 expectations:2 add:1 black:1 quarterly:1 main:1 earnings:3 gains:2 unsold:1 results:1 updates:2 background:2 report:1 years:1 investor:1 --:1 companies:2 stock:2 worldwide:1 higher:1 declines:2 sign:1 see:1 cost:2 's:2 profit:2 comments:1 forecast:2 increase:2 toll:1 resilient:1 new:1 continuing:1 reported:2 focused:1 offset:2 active:1 article:1 beginning:1 reaction:1 quarter:1 taking:1 reports:1 products:2 published:1 makes:2 first:2 fourth-quarter:2 revenue:1 into:1 marked:2 foreclosures:1 throughout:1 market:1 decline:2 remains:1 5th:1 people:1 one-time:2 next:2 pharmaceuticals:2 expected:2 500:1 more:1 gear:1 season:1 construction:1 kicks:1 slowdown:2 former:1 those:1 10:1 14:6 devices:2 recession:1 economic:1 investors:1 health-care:2 sales:4 helped:2 home:1 also:2 details:2 which:2 becomes:1 economy:1 week:2 pain:2 price:2 after:1 76:1 fell:2 president:1 short:2 medical:2 well:2 sale:1 '09:4 2009:2 consumer:2
stock_ABT r_up	sector:2 saying:1 shield:1 global:1 quarters:1 helped:3 businesses:1 unfavorable:1 prop:1 its:4 arteries:1 $:5 stent:3 guidance:1 swoon:1 28:9 expectations:2 than:1 advisories:2 quarterly:1 rose:1 continues:1 overall:1 sidestepping:1 updates:1 despite:2 amp:2 posts:2 doubled:1 facing:1 banking:1 410:1 claw:1 economy:2 says:1 companies:1 some:1 back:1 challenges:1 rate:1 growth:2 lead:1 profit:4 jumped:1 patients:1 comments:1 forecast:1 new:3 net:2 million:1 reaching:1 maintains:1 continuing:2 27:3 respite:1 strong:4 beginning:1 arthritis:2 roundup:1 reaction:1 last:1 climbed:1 36:2 drug:3 range:1 a.m.:2 drug-coated:1 surprises:2 slightly:1 fourth-quarter:3 open:1 market:2 spending:1 faltering:1 long:1 start:1 rates:1 more:1 cutbacks:1 ``:1 plunge:1 offering:1 slumping:1 company:1 but:1 reiterates:1 analyst:1 posted:2 jump:2 recession:1 while:1 future:1 were:1 spotlight:2 published:1 heart:1 figure:1 health-care:1 sales:6 '':2 reports:1 hospitals:1 incorrect:1 damaged:1 suggest:1 earnings:2 which:1 income:2 performance:1 stock:2 used:1 's:2 may:1 price:1 after:2 rise:2 device:2 125:2 short:1 shortly:1 3rd:1 amid:1 futures:1 well:1 stents:3 broad:1 2009:2 corporate:1 latest:1
stock_ABT r_up	sector:1 major:1 financial:1 one:1 trading:1 rally:2 its:1 rundown:1 gainers:1 rose:1 rebounded:1 shares:2 earnings:2 biggest:3 ever:1 stock:1 gaining:2 's:3 after:1 stocks:3 declining:2 decliners:1 drops:1
stock_ABT r_down	heart:1 all:1 tough:1 deal:1 strategic:1 looks:1 its:1 said:1 stent:1 workers:1 environment:1 which:1 has:1 may:1 company:1 but:1 lay:1 financing:1 novel:1 off:1 medical:1 up:1 while:1 works:1 caught:1 nearly:1
stock_ABT r_up	heart:1 all:2 says:1 deal:2 among:1 hard:1 workers:2 strategic:2 looks:2 tough:1 struggles:1 its:2 expensive:1 said:2 prove:1 stent:1 caught:1 off:2 find:1 environment:1 needed:1 which:1 technology:1 has:2 conclusion:1 's:1 may:2 familiar:1 company:1 but:2 lay:2 become:1 device:1 article:1 financing:2 novel:1 natural:1 ranks:1 industry:1 companies:1 up:1 while:2 mature:1 published:1 biotechnology:1 works:2 studies:1 medical:2 nearly:2
stock_ABT r_up	repair:2 all:2 limited:1 agreed:3 related:2 three:4 involve:1 litigation:2 patent:3 lawsuits:3 two:3 comments:1 only:1 2:4 agreements:1 between:2 stock:1 cardiology:2 quote:1 updates:1 others:3 not:4 cases:1 ending:2 pursue:4 companies:2 time:1 settled:3
stock_ABT r_up	over:3 years:2 15,000:2 its:7 cut:4 $:7 expectations:2 should:2 charge:1 program:2 2013:2 details:1 co-founders:1 involuntary:1 continues:1 overall:2 criticized:2 five:2 background:1 drugmaker:2 loss:2 resolve:1 --:4 write-down:2 noted:1 deal:2 estimates:2 related:2 widened:2 likely:1 cost:2 projections:1 year:2 further:2 2.7:1 2.5:2 said:2 adds:1 profit:2 projected:2 per:2 forecast:2 current:2 above:2 net:4 announced:2 cost-cutting:2 jobs:4 deliver:2 efficiency:2 estimate:2 maker:1 comment:1 fourth-quarter:5 adjusted:2 revenue:2 one:2 total:2 decline:2 long:2 overpaid:2 flat:2 posting:2 analyst:1 2.9:2 1/28:2 while:2 acquisition:2 1.4:2 downplayed:1 share:2 sales:3 warning:1 numbers:1 unveiled:2 moves:2 detail:1 other:2 earnings:2 which:2 stock:1 worldwide:2 's:2 plans:2 though:2 market-share:1 letter:1 billion:7 well:2 savings:2 2006:3 medical-device:1 2008:2 2009:8 talk:1
stock_ABT r_up	comment:1 because:3 letter:3 promotional:2 warning:2 have:2 information:2 suggest:1 fourth:1 sent:2 's:3 risk:2 company:3 material:2 regulators:2 important:2 they:1 safer:1 than:1 --:2 according:1 drug:3 misleading:3 omits:2
stock_ABT r_up	6,000:2
stock_ABT r_down	acquisitions:1 picture:1 emerging:1 's:2 lead:1 huge:1 sit:1 companies:1 clearer:1 drug:1 which:2 pursuing:1 follow:1 major:1 sidelines:1 might:2
stock_ABT r_up	heart:2 medication:1 represent:1 domestic:1 tiny:1 fight:1 open:1 market:1 huge:2 use:1 said:2 end:1 $:1 stent:2 hospital:2 purchasing:2 prop:1 2:1 agreements:2 fourth:1 new:2 has:2 stock:1 arteries:1 background:1 prices:1 group:2 billion:1 signed:2 roughly:1 devices:3 drug-coated:2 clogged:1
stock_ABT r_down	tap:1 ending:2 offerings:1 market:1 again:1 $:1 initial:1 long:1 public:1 drink:1 stock:1 week:1 million:1 's:2 spell:3 dry:3 four:1 debut:3 well:1 maker:3 deals:1 680:1 once:1
stock_ABT r_down	among:1 stretches:1 tap:1 final:1 defibrillators:1 share:1 begin:1 crop:1 offerings:1 evening:1 trading:1 have:1 tumultuous:1 tone:1 spin-off:1 its:1 market:2 24:1 again:1 spell:1 said:1 $:2 generic:1 leading:1 initial:1 long:2 prognosis:1 version:1 holding:1 largest:1 expected:1 has:1 markets:1 public:1 stock:1 week:1 generating:1 million:1 's:4 offering:1 received:1 drink:1 priced:1 most:1 cardiac:1 approval:1 stocks:1 appears:1 after:1 dry:1 four:1 keeping:1 stabilized:1 name:1 skittish:1 --:4 debut:1 well:2 up:1 maker:2 deals:1 stents:1 products:1 buzz:1 tablets:1 680:1 medical-device:1 once:1
stock_ABT r_up	13:1 welcome:1 $:1 million:1 initial:1 since:2 shares:1 driving:1 debut:1 public:1 much:1 offering:1 higher:1 720:1 rallies:2 stock:1 maker:1 first:2
stock_ABT r_down	heart:1 competition:1 '':1 questions:1 year:1 its:2 market:1 stent:1 grow:1 ``:1 company:1 after:1 here:1 device:1 hold:1 appears:1 heightened:1 whether:1 amid:1 can:1 drug-coated:1 position:1 launched:1
stock_ABT r_down	sector:1 being:1 implants:1 results:2 participate:1 year-earlier:1 its:4 fifth:1 giant:1 busy:1 ease:2 shingles:1 concerns:2 under:1 has:1 division:1 good:2 risk:1 overall:2 fallout:1 despite:1 defibrillator:1 multiple:1 --:2 leave:1 rheumatoid:1 trading:1 year:1 further:1 jumped:1 marketed:1 patients:1 comments:1 enough:2 above:2 defibrillators:1 new:1 net:3 appeal:1 dental:1 heart-device:1 core:1 business:1 implantable:1 fronts:1 pressure:1 key:2 article:1 beginning:1 prospects:1 prior-year:2 study:1 according:1 drug:1 maker:2 appeared:2 increased:1 down:2 spinal:1 unit:1 shareholders:1 top:1 third-quarter:2 been:1 touting:1 rivals:1 treat:1 expected:1 markets:3 midday:1 psoriasis:1 acquisitions:1 tally:2 released:1 reflecting:1 analyst:1 posted:2 developing:1 recall:1 healthy:1 while:2 were:1 treated:1 could:1 share:2 weighed:2 have:1 technology:1 diseases:1 medical-devices:1 lately:1 other:1 details:1 income:2 stock:1 product:3 's:6 may:1 price:1 arthritis:2 problems:2 fell:1 approved:1 soared:2 fiscal:2 off:1 charges:3 amid:1 medical:1 disease:1 2007:1
stock_ABT r_up	sector:1 participate:1 implants:1 price:1 n't:1 year:1 technology:1 current:1 story:1 busy:1 would:1 seek:1 worth:1 access:1 authorized:1 capital:1 expected:1 appeal:1 company:1 week:1 exactly:1 's:3 around:1 permission:1 share:2 dental:1 million:1 shareholders:2 said:2 acquisitions:1 has:1 last:1 --:1 could:1 cash:1 maker:1 leave:1 published:1 medical:1
stock_ABT r_down	fourth-quarter:2 boosted:1 drop:1 revenue:1 cents:1 correction:1 industrywide:1 results:1 month:1 services:1 been:1 drug:1 have:1 such:1 slumped:1 margins:1 swung:1 its:3 announcement:1 profit:1 rose:1 28:1 40:1 increase:2 numerous:1 income:1 quarterly:1 consecutive:1 net:1 save:1 boost:1 announced:1 higher:1 's:2 though:1 drugs:1 dividends:1 company:1 capital:1 sales:1 released:1 cutting:1 new:1 device:1 dividend:3 strong:2 procedures:1 11:3 demand:1 last:1 reported:1 follows:1 medical:1 annual:1 companies:1 devices:1 laser:1 stent:1 maker:1 comes:1 cataract:1
stock_ABT r_down	buy:1 --:1 company:1 devices:1 optical:1 products:1 health:1 surgery:1 cleared:1 maker:1
stock_ABT r_up	'':2 amp:4 ``:2
stock_ABT r_down	facility:2 nutritional:2 capping:1 open:2 investment:1 manufacturing:1 $:3 there:1 research:1 largest:1 biggest:1 markets:1 announced:1 plant:1 's:1 plans:1 300:1 company:2 million:1 its:1 foothold:1 opened:1 project:1 products:1 seeks:1 makes:1
stock_ABT r_down	operations:2 among:2 investors:3 into:2 payroll:2 existing:1 10-year:2 paper:2 including:2 rent:2 borrowings:2 years:1 appetite:2 everyday:2 short-term:4 maturing:1 needs:2 investment-grade:2 adds:1 $:5 would:2 top:1 detail:1 comments:1 their:2 3:1 5:2 take:2 8:2 size:1 issue:1 sold:1 recasts:1 more:1 used:2 's:2 advantage:2 bonds:5 marketing:4 refinance:4 commercial:2 new:2 fund:4 part:2 they:4 demand:2 five-:2 debt:7 investor:2 billion:5 10:1 last:1 like:2 auction:1 notes:2 30:1 companies:2 sale:1 deal:2 deals:2 --:4 three:2 time:1 long-term:2 launched:1 bond:2
stock_ABT r_down	sector:2 raised:1 trillion:2 seeks:2 less:2 cuts:1 50:1 high:1 healthcare:1 3.2:1 drug:2 budget:2 dividend:3 1990s:1 3.6:2 hospitals:2 any:1 market:3 if:1 index:1 cut:2 based:1 $:5 spending:1 much:1 since:1 bulk:1 its:2 sent:2 their:1 offers:1 decade:1 under:1 finding:1 pay:2 percentage:1 proposal:2 apply:2 price:1 500:1 stock:2 billion:1 buy:1 's:6 health-care:1 10:3 dividends:1 company:1 published:1 stay:1 early:1 pressure:2 step:1 nearly:1 they:1 coming:1 prices:4 article:1 stocks:2 than:2 after:3 2:1 past:1 essentially:1 insurers:2 off:1 prescription:2 ahead:1 --:1 average:1 annual:1 companies:1 richer:1 yield:1 across:2 more:1 patients:2 yields:1 can:1 time:1 payments:2 2007:1 sank:2 bond:1
stock_ABT r_down	dissecting:1 forecasting:1 financial:1 have:2 surviving:2 among:1 determine:1 sharp:1 statements:1 species:1 market:2 would:1 adapt:1 which:1 might:1 stock:1 pioneering:1 buy:1 ability:1 models:1 stocks:3 analyst:1 made:1 hostile:1 unusually:1 corporate:1 fittest:2
stock_ABT r_down	consider:1 through:1 expect:1 have:1 follow:1 investment:1 market:1 delay:2 stocks:4 negative:1 been:1 lately:1 better:1 state:1 lured:1 low:1 tumbles:2 across:1 economy:1 styles:1 retrench:2 they:2 prices:1 broader:1 hold:1 buying:1 reaction:1 companies:1 up:1 drug:2 recession:1 testimony:1 trading:1 south:1
stock_ABT r_down	tap:1 deal:1 less:1 agreed:1 reliant:1 buy:1 have:1 year:1 research:1 pharmaceutical:1 $:3 create:1 41:2 take:1 year-ago:1 9:1 markets:1 capital:1 more:1 surges:2 company:1 pushing:1 levels:1 issuance:3 they:1 spree:1 aiming:1 billion:1 diversified:1 companies:1 up:1 drug:3 times:1 traditional:1 part:1 healthcare:1 latest:1 acquisition:1 bond:3
stock_ABT r_up	47:2 $:2
stock_ABT r_down	pharmaceutical:1 epilepsy:1 central:1 expirations:1 business:1 patent:1 nervous:1 company:1 allergy:1 focus:1 drug:2 system:1 drugs:1 shifting:1 offset:1 blockbuster:1 its:1 seeks:1 like:1
stock_ABT r_up	sell:1 received:1 said:1 's:2 tentative:1 --:1 generic:1 tablets:1 approval:1 has:1
stock_ABT r_up	global:1 back:1 8217:2 128:1 have:1 total:1 market:1 pharma:1 shocked:1 has:1 announced:1 more:1 life:1 date:1 than:1 $:1 billion:1 third:1 companies:1 deals:2 s:2 2009:1
stock_ABT r_up	sector:3 sharply:2 move:2 comments:2 its:2 $:3 stent:8 winning:1 4:3 has:2 gains:1 rise:2 early:1 four-session:1 amp:2 advanced:1 drop:2 stock:2 thanks:2 bets:3 back:3 year:1 edged:1 plays:2 muted:3 cancels:3 pioneer:2 new:3 prospects:3 last:1 broad-based:2 could:1 outpace:1 called:2 rose:1 action:1 vault:3 drugmakers:1 makes:1 biotech:2 into:2 market:3 positive:2 placing:3 tiny:3 their:2 territory:2 more:3 company:5 but:2 wake:1 newer:2 hopes:3 made:3 16:1 up:1 devices:5 recession:1 while:4 nine:1 study:1 streak:1 heart:3 1.2:1 0.3:1 0.7:1 seen:2 different:3 end:1 shares:1 details:1 fourth:1 atop:3 higher:2 gaining:1 's:4 plans:3 price:2 extending:1 modest:1 remarks:2 stocks:2 billion:3 off:2 especially:2 later:1 chief:3 week:1 position:2 paced:1
stock_ABT r_up	streak:1 1.5:1 0.2:1 moved:1 0.4:1 trading:1 year:1 end:1 $:2 rose:1 chief:1 comments:1 winning:1 3:2 500:2 higher:1 week:1 edged:1 gains:2 early:1 extending:1 four-session:1 wake:1 stocks:1 sides:1 advanced:1 both:1 made:2 last:1 could:1 later:1 up:1 recession:1 while:1
stock_ABT r_down	heart:1 layoffs:1 garner:1 regulatory:1 still:1 its:1 sell:1 needs:1 stent:1 secured:1 stave:1 start:1 has:2 selling:1 company:1 key:1 milestone:1 device:1 approval:1 financing:1 novel:1 off:1 --:1 cash:1 severe:1 small:1
stock_ABT r_down	operations:1 heart:1 annual:1 force:1 non-core:1 into:1 $:1 high:1 growth:1 businesses:1 research:1 technology:1 its:1 market:1 belief:1 management:1 targeting:1 additional:1 multibillion-dollar:1 effort:1 workers:1 had:1 comments:1 next:1 details:1 which:1 launching:1 more:1 cost-cutting:1 eventually:1 's:1 plans:1 140:1 leg:1 evaluate:1 company:2 million:1 efficiency:1 completely:1 cut:1 streamline:1 plan:1 background:1 device:1 spur:1 than:1 improve:1 10:3 31:1 work:1 leading:1 savings:1 cost:1 stent:1 become:1 could:1 blood:1
stock_ABT r_up	all:1 institutional:1 money:1 meetings:1 move:1 surgical:1 experiments:1 high-profile:1 its:1 developer:1 one:1 much:1 workers:1 crew:1 brighter:2 cardiologists:2 under:1 save:1 oversight:1 worth:2 far:1 scaling:1 nearly:1 during:1 hearing:2 --:1 large:2 small:1 heavy:1 set:1 financial:1 deal:1 people:2 humans:1 sign:1 past:1 cost:2 year:1 review:2 comments:1 research:1 laid:1 safety:1 between:1 issue:1 heart-device:1 recently:1 regulators:1 key:1 article:1 beginning:2 shine:2 boards:3 oversee:1 could:1 annual:1 drug:1 trial:1 products:2 planned:1 published:1 studies:1 strategic:1 down:1 fake:3 few:1 been:1 their:3 clinical:2 meeting:3 more:1 fire:1 company:1 needle:1 failure:1 properly:1 whether:2 up:1 devices:1 successes:1 officials:1 spotlight:2 detailed:1 heart:2 certain:2 sales:1 have:1 relatively:1 compared:1 trials:1 discussion:2 drugs:1 other:1 pursues:1 week:1 used:1 's:2 treatments:2 involving:1 coming:3 remarks:1 off:1 light:1 medical:3 industry:1 disease:2 senior:1 charged:1
stock_ABT r_up	heart:1 sales:1 billions:1 see:1 if:1 asthma:1 would:1 federal:1 better:1 other:1 treat:1 under:1 new:1 conditions:1 government:1 drugs:1 arthritis:1 they:1 than:1 dollars:1 register:1 proposals:1 up:1 're:1 options:1
stock_ABT r_up	sector:1 all:1 over:1 move:1 years:1 cardiologist:1 broader:1 amp:2 chair:1 still:1 cardiovascular:1 setbacks:1 now:1 $:1 better:1 include:2 eventually:1 them:1 good:2 hit:1 familiar:1 break:2 during:1 8216:4 --:1 yield:1 shots:1 cholesterol:2 downward:2 development:1 financial:1 people:1 trend:3 said:1 away:1 shares:1 looking:1 medicine:1 new:1 approach:1 told:1 filings:1 key:1 regulatory:1 news:1 hearing:1 advance:1 search:1 acquiring:1 ahead:1 could:2 drug:4 s:2 products:1 published:1 drugmakers:2 maker:1 experimental:1 major:1 8217:6 one:1 backed:1 promise:1 article:1 says:1 crisis:1 market:1 bankruptcy:1 conference:1 raise:1 leading:1 there:2 hammered:1 been:1 their:1 much:1 acquisitions:1 ``:1 cardiology:1 drugs:1 funds:1 but:2 raising:1 has:2 15:1 matter:1 were:1 industry:1 heart:1 seven:1 '':1 say:1 have:2 respective:1 goal:1 concerns:1 auto:1 developers:1 higher:1 gaining:1 's:1 price:1 fell:1 plan:1 coming:1 stocks:2 diabetes:1 billion:1 considered:1 amid:1 disease:1 so:1
stock_ABT r_down	seeing:1 major:1 deal:1 people:1 over:1 global:1 cheap:3 trade:1 held:1 decided:1 discussions:1 issues:1 whose:1 funding:1 make:1 shares:1 access:1 their:1 splash:1 biggest:2 price:1 gaining:2 's:5 advantage:2 familiar:1 company:1 but:1 reason:1 preliminary:1 not:1 stocks:2 active:1 concerns:1 declining:2 acquisitions:1 financing:2 acquiring:1 pursue:1 companies:2 according:1 matter:1 session:1 starting:1 other:1 mergers:1
stock_ABT r_down	s:2 8217:2
stock_ABT r_down	deal:1 6.6:1 session:1 moves:1 seek:1 its:1 whose:1 buyers:1 $:1 shares:1 much:1 biggest:2 include:1 gaining:2 division:1 's:2 plans:1 pharmaceutical:1 big:1 conglomerate:1 stocks:2 declining:2 billion:1 valued:1 could:1 making:1
stock_ABT r_up	weighs:1 alliance:1 investors:1 over:1 trading:1 broader:3 market:3 bankruptcy:1 busy:1 consumers:1 while:1 earnings:1 pitching:1 specialist:1 shopping:1 upcoming:1 forming:1 early:1 gain:2 they:1 stocks:3 fret:1 slides:2 industry:1 drug:1 banking:1 jitters:2 're:1 products:1
stock_ABT r_up	financial:1 trend:1 health-care:2 reaffirms:2 sales:1 heavyweight:1 broader:1 reaffirmed:1 its:1 giant:2 shares:2 forecast:3 expected:1 posting:1 than:1 market’s:1 after:3 despite:1 downward:1 buck:1 lower:1 quarter:1 industry:1 climb:2 2009:1 slightly:1 first:1
stock_ABT r_down	saying:1 move:3 focus:4 quarters:1 session:2 signs:1 its:2 ground:3 whose:1 $:1 surprises:2 expectations:1 advisories:2 has:1 rose:1 overall:1 early:1 amp:2 trade:1 retreat:1 companies:2 53:3 continue:1 activity:1 quarter:1 added:1 smaller:1 significantly:1 see:1 economic:1 's:4 declined:1 said:1 giving:1 shares:6 forecast:4 re:2 closed:1 new:1 net:1 ammunition:1 sinks:2 conglomerate:1 sink:1 active:1 100:1 declining:2 roundup:1 cautious:1 losses:1 haunts:4 drug:3 turn:1 afternoon:1 drug-coated:1 stent:1 slightly:1 outlook:1 revenue:1 appeared:1 number:1 8217:4 8216:2 story:1 bears:1 negative:1 going:1 stock:1 biggest:2 territory:1 more:1 concentrated:1 sessions:1 but:1 expected:1 demand:1 surged:1 than:1 he:1 include:1 15:1 straight:1 future:1 were:1 investors:1 health-care:1 sales:3 bias:1 reports:2 further:1 any:2 also:1 earnings:3 income:1 bare-metal:1 higher:5 gaining:2 towards:1 first-quarter:2 after:2 includes:1 moving:1 two:1 midsize:1 stocks:5 lower:1 short:1 corporate:1 clear:1 futures:1 stents:1 points:1 starting:1 latest:1
stock_ABT r_up	advance:1 first-quarter:1 climbs:2 positive:1 health-care:1 shares:1 trade:1 conglomerate:1 report:3 products:1 earnings:3 mixed:3 wake:1 stocks:3
stock_ABT r_up	loss:1 lower:1 2009:1 first-quarter:1 patent:1 rulings:1 its:1 prediction:1 earnings:1 led:1 swung:1 maker:1 medical-device:1
stock_ABT r_down	votes:1 after:1 results:1 n't:2 released:1 vote:1 similar:1 day:1 comes:1
stock_ABT r_up	's:1 heavily:1 company:1 lean:1 sales:1 force:1 more:1
stock_ABT r_up	sector:3 rest:1 largely:1 trades:1 shares:1 slides:2 but:2 climb:2 drugmakers:3 red:1 gain:1
stock_ABT r_down	billion:1 mutual:1 1.7:1 $:1 means:1 amid:1 screen:1 stocks:1 fund:1 economic:1 pool:1 rigorous:1 downturn:1 has:1 declining:1 choose:1
stock_ABT r_down	jobs:1 their:1 giving:1 company:1 insurance:1 drugs:1 patients:1 health:1 lose:1 away:1
stock_ABT r_down	help:1 people:1 expanding:1 health-care:1 burger:1 makers:1 giant:1 overhaul:1 $:1 system:1 shares:1 8:1 's:4 afford:1 sold:1 million:1 programs:1 amid:1 medicines:1 prolonged:1 recession:1 efforts:1
stock_ABT r_down	compared:1 's:2 stent:1 study:1 against:1 released:1 made:1 preliminary:1 device:1 data:1 its:1
stock_ABT r_up	's:2 holdings:1 companies:1 well:1 hedge-fund:1 including:1 stock:1 divest:1 themselves:1 several:1 must:1
stock_ABT r_down	roundup:1 conference:1 's:1 cancer:2 findings:1 drugs:1 big:1 some:1 two:1 against:1 early:1 promise:1 breast:1 new:1 weekend:1 class:1 types:1 shows:1
stock_ABT r_down	low:1 combination:1 business:1 --:1 compound:1 two:1 submitted:1 high:2 investigational:1 including:1 treatment:1 healthcare:1 mixed:1 international:1 cholesterol:1 has:1 announced:1 more:1
stock_ABT r_down	heart:4 deaths:2 certain:2 among:3 against:2 devices:2 such:1 surgery:1 reducing:2 makers:1 conference:1 again:2 compared:2 no:2 stent:2 question:2 debated:1 better:2 combined:2 drug:2 formally:1 drugs:2 released:3 therapy:2 alone:2 article:1 diabetes:2 showed:2 --:2 study:3 leading:1 value:2 attacks:2 patients:2 stents:1 published:2 did:2
stock_ABT r_down	heart:1 medication:1 sees:1 heavyweight:1 opportunities:1 long:1 still:1 its:1 market:1 little:1 arteries:1 $:1 pace:1 anti-clotting:1 tiny:1 pills:1 4:1 new:1 more:1 do:1 drugs:1 use:1 possible:1 but:1 quest:1 courses:1 dividend:1 aiming:1 than:1 must:1 billion:1 stocks:1 --:1 require:1 guru:1 keep:2 n't:1 stents:2 maintain:1 munis:1 push:1 position:1
stock_ABT r_down	acquisitions:1 said:1 's:1 pursue:1 company:1 health-care:1 but:1 n't:1 chief:1 interested:1 products:1 instead:1 mergers:1 more:1
stock_ABT r_down	firm:1 coverage:1 initiated:1 cardiovascular:1
stock_ABT r_down	updated:1 asthma:1 --:1 delays:1 see:1 recommending:1 label:1 recommended:1 warning:1 drug:2 further:1 if:1 children:1 causes:1 staff:2
stock_ABT r_up	down:1 may:3 signal:3 days:1 downtrend:3 new:3 markets:1 day:2 recent:1
stock_ABT r_up	billion:1 violating:1 ordered:1 $:3 federal:1 pay:1 arthritis:1 one:1 1.67:3 patent:1 treatment:1 largest:1 infringement:1 jury:1 unit:1
stock_ABT r_down	advisory:1 pointing:3 show:1 issued:1 session:1 signs:4 portfolio:1 its:1 24:2 whose:1 $:1 rose:6 bell:1 should:2 window:1 board:1 dressing:1 8:3 has:1 do:1 bid:1 early:1 they:1 half:3 report:1 during:3 one:1 day:1 --:7 always:1 medicines:1 companies:1 soar:3 right:1 penalties:1 related:1 second:4 actively:1 trading:2 picked:1 year:3 close:4 thinks:1 declined:1 shown:1 funding:1 federal:1 lean:2 shares:2 looking:1 health:1 closed:3 ever:1 available:2 ends:3 experimental:1 jury:1 opening:1 news:1 100:5 strong:4 come:1 vaccine:1 quarter:8 benefits:1 ahead:3 influential:1 funded:1 according:1 1.67:1 3.5:2 afternoon:1 traded:1 comes:1 among:1 managers:1 point:2 1.6:1 awaited:1 highly:1 market:1 1.2:1 comparing:1 priority:1 start:4 stock:6 final:1 500:8 low:3 flat:1 released:1 part:1 prices:2 90:3 buying:1 case:1 13:1 14:1 science:1 clients:1 flu:1 up:13 n't:1 receive:1 while:1 economic:4 were:5 history:1 1.4:1 0.8:2 slid:1 ordered:1 investors:4 1.3:1 predict:1 topics:1 1.8:1 have:1 moves:1 their:1 5.2:2 recovery:3 patent:1 pay:1 traders:1 also:1 winners:1 5:3 damages:1 animal:1 largest:2 higher:10 added:2 's:2 after:1 flurry:1 fell:1 stocks:8 data:1 billion:1 lower:1 effective:1 fund:1 studies:2 futures:16 looked:3 points:20 patents:1 volumes:3 came:3 latest:2
stock_ABT r_down	advisory:1 help:1 lack:1 session:1 including:1 still:1 injuries:1 over-the-counter:1 should:1 potential:1 employee:1 include:1 pill:1 ingredient:2 do:1 sapped:1 get:1 banned:1 they:1 affect:1 buyout:1 --:2 follows:1 medicines:1 companies:1 common:1 contain:1 quarter:1 reduced:1 reduce:2 second:1 doses:1 pain:3 federal:1 comments:1 closed:1 new:1 boost:1 sliding:1 told:1 taxing:1 prescribe:1 confidence:1 host:2 key:2 pharmacists:1 cough:1 beginning:1 panel:6 restrictions:2 prescription:2 limits:1 could:2 30:1 drug:2 range:1 products:2 options:1 first:1 market:1 headaches:1 use:1 additional:1 would:2 treat:1 injury:1 meeting:1 combined:1 recommends:3 drugs:1 but:2 liver:2 doctors:2 eliminated:1 than:1 has:1 developing:1 alter:1 n't:1 patients:1 limit:1 ruling:1 associated:1 painkiller:2 recommendation:2 single:1 experts:3 dropped:1 painkillers:2 information:2 strength:1 ingredients:1 able:1 recommended:2 other:1 earnings:1 acetaminophen:5 's:4 advice:1 after:1 most:1 stocks:1 approved:1 longer:1 medical:1 no:1 severe:1 order:1 researchers:1
stock_ABT r_down	received:1 raised:1 killer:1 pain:1 ability:1 --:1 company:1 after:1 fell:1 concerns:1 letter:1 partner:1 its:1
stock_ABT r_down	prospect:1 major:1 weaker:1 decides:1 woes:1 caused:1 health-care:1 some:1 sales:1 competition:1 years:1 prices:1 economic:1 result:1 year:1 expects:1 market:2 pharmaceutical:1 consumers:1 also:1 generic:1 things:1 due:1 should:1 contract:1 stock:1 acetaminophen:1 expected:1 new:1 more:1 cutbacks:1 than:1 manufacturers:1 drugs:1 company:1 under:1 continuing:1 here:1 results:1 pressure:2 because:1 know:1 not:1 post:1 bringing:1 second-quarter:1 surprising:1 difficulty:1 uncertainty:1 companies:1 50:1 drug:2 limit:1 time:1 popular:1 first:1 reform:1 pricing:1
stock_ABT r_down	biologics:1 named:4 invests:1 decides:1 succeeds:1 previously:1 over:1 health-care:2 some:1 outgoing:1 years:1 arm:1 not:1 unit:3 drug:1 limit:1 exclusivity:1 should:1 its:2 market:1 before:1 move:1 pharmaceutical:5 said:3 takes:1 consumers:1 generic:1 beginning:1 chief:1 comments:1 investment:1 1:1 pharmaceuticals:2 role:1 stock:1 acetaminophen:1 new:4 proposal:1 company:2 early-stage:1 more:1 division:1 head:2 executive:2 drugs:1 price:1 reach:1 here:1 sales:1 break:1 4th:1 biologic:1 updates:1 vice:3 regulatory:2 president:4 opportunity:1 than:1 12:1 surprising:1 effective:2 versions:1 --:1 brand-name:1 companies:1 submitted:1 while:1 products:4 can:1 things:1 popular:1 international:1 senior:1 gives:1 filing:2 know:1
stock_ABT r_up	comment:2 biologics:1 bill:1 could:1 proposed:1 give:1 results:1 month:3 '':1 interim:1 analysis:1 committee:1 years:2 exclusivity:1 complex:1 blinded:1 market:2 before:2 begin:1 terminated:3 generic:1 based:1 would:1 their:1 notice:1 opportunity:1 due:1 least:1 analyst:1 makers:1 comparing:3 add:1 clinical:3 safety:1 expensive:1 generics:1 living:1 --:1 proposal:1 congressional:1 gives:1 independent:1 ``:1 selling:1 submitted:1 than:1 pharmaceutical:1 drugs:2 sixth:1 reach:1 but:1 cheaper:1 break:1 12:2 biologic:1 not:1 aide:1 beginning:1 steering:1 posted:1 reaction:1 made:1 last:3 third:1 versions:2 concerns:1 medicines:1 brand-name:2 companies:1 according:1 drug:3 trial:4 competitors:1 stopped:1 can:1 cholesterol:3 senior:1 more:1 similar:1 cells:1
stock_ABT r_down	raised:1 unclear:1 885:1 dollar:1 actively:1 rising:1 declined:1 if:1 whose:1 marketed:1 shares:1 clinical:1 session:1 6:1 500:1 after:1 jointly:1 halted:1 although:1 fresh:1 stocks:1 concerns:2 gained:1 12:1 18:1 climbed:2 companies:1 drug:2 trial:1 while:1 points:3 were:2 trading:1 cholesterol:1
stock_ABT r_down	among:1 raised:1 unclear:1 background:1 nominee:1 show:1 some:1 results:2 13th:1 prices:1 economic:1 trading:1 concerns:1 throughout:1 declined:1 if:1 whose:1 4.7:1 5.3:1 adds:1 although:1 shares:1 next:2 firm:1 their:1 3:1 clinical:1 session:1 closed:1 largest:1 expected:1 tech:1 company:1 500:1 stock:1 giants:1 gained:1 after:1 's:1 drugs:1 turned:1 bellwethers:1 reporting:1 seventh:1 nation:1 halted:1 worries:1 increases:1 inflation:1 updates:1 former:1 fresh:1 report:1 such:1 stocks:1 second-quarter:2 begins:1 reaction:1 hearings:1 --:1 wholesale:1 climbed:2 companies:2 up:1 reports:1 trial:1 while:1 points:3 week:2 after-hours:1 banks:2 cardiologist:1 cholesterol:1 consumer:1 remains:1
stock_ABT r_up	cancer:2 into:1 lung:2 aimed:1 said:2 develop:1 variety:1 cell:2 other:1 disclosed:1 test:1 entered:1 molecular:1 screening:1 normal:1 company:1 agreement:1 but:1 diagnostic:1 automated:1 not:1 wide:1 has:1 tumors:1 n't:1 cancers:1 were:1 cells:1
stock_ABT r_up	investors:1 turned:1 sales:3 competition:3 two:1 3.6:3 currency:2 cost:1 higher:1 cuts:1 unfavorable:2 its:2 declined:1 out:1 would:1 profit:3 moderately:1 due:1 than:1 better:1 rates:2 earnings:1 expected:1 net:1 4:1 's:2 increased:1 drugs:2 some:1 knew:1 results:1 but:1 hurt:2 fell:1 nearly:1 demand:1 second-quarter:2 tighter:2 helped:1 lower:3 quarter:1 prescription:2 largely:1 posts:2 reports:1 spending:2 generic:3 products:2 difficult:1 consumer:3 maker:1
stock_ABT r_down	heavily:1 arthritis:1 dollar:1 focus:4 years:1 prices:2 session:5 shares:7 unfavorable:1 its:5 issues:3 whose:5 20:1 $:2 rose:6 presence:1 had:1 expectations:3 than:1 premarket:2 gave:2 increased:5 government:1 food:1 anticipated:1 early:1 effects:1 background:1 formula:1 press:2 trade:1 continued:1 maintaining:1 --:3 companies:8 morning:1 slide:1 25:1 after-hours:1 quarter:3 out:2 925:1 available:1 set:3 financial:1 due:2 energy:1 estimates:1 competition:1 up:3 2.9:1 actively:4 trading:4 3.1:1 82:3 our:3 2.1:1 2.7:2 2.6:9 2.5:1 2.4:1 said:3 profit:4 jumped:2 spokesman:1 outpacing:1 comments:1 forecast:5 current:2 3:1 nudge:2 new:1 911:1 across:2 participation:3 told:3 cost-cutting:1 core:1 we:1 earlier:3 business:3 excludes:1 night:1 points:9 costs:3 reported:1 restructuring:2 snapped:2 article:4 100:3 strong:1 after:2 stage:1 gained:5 cautious:2 carried:2 climbed:4 reports:2 late-day:1 74:1 figures:1 analysts:2 stent:1 action:1 retail:2 traded:4 maker:2 patents:1 8500:1 major:1 benefited:1 revenue:2 year:1 steady:1 one:3 down:1 active:1 throughout:1 market:3 conference:2 rivals:1 best-selling:3 third-quarter:1 pharmaceuticals:3 much:2 call:2 stock:4 interest:5 expected:1 rates:1 9.6:1 globe:2 500:7 more:2 concentrated:1 ``:3 0.2:1 growth:2 releases:1 drugs:5 company:6 diversified:1 but:1 hurt:2 gain:3 bidding:1 upbeat:3 baby:1 second-quarter:4 globally:1 grew:1 second:1 devices:2 n't:3 while:3 3.5:1 expiration:1 were:1 already:1 acquisition:3 stronger-than-forecast:3 1.6:1 1.7:1 impacts:1 0.1:1 expanding:3 partnership:3 sag:1 sales:3 0.7:1 '':3 currency:3 drug:4 have:7 2.2:3 moves:1 technology:2 denying:2 gains:2 compared:1 end:1 no:3 generic:1 86:1 generally:1 11.1:2 matching:1 traders:2 also:1 report:2 interested:2 details:1 which:6 outlook:1 decelerating:1 higher:6 high-priced:1 product:1 added:1 's:21 slightly:1 see:1 earnings:4 reporting:2 falls:3 helping:1 helped:2 fell:6 biologic:1 two:3 such:1 stocks:7 recent:1 ago:1 lower:1 short:2 charges:2 amid:1 medical:2 futures:8 stronger:1 implied:2 push:1 lineup:1 consumer:1 latest:1
stock_ABT r_down	biotech:1 raised:1 help:1 saying:1 estimates:1 quarters:1 pharmaceutical:1 said:1 based:1 charges:1 generic:1 surprises:2 avoid:1 due:1 advisories:2 earnings:4 acetaminophen:1 taken:1 ingredient:1 concentrated:1 product:1 company:1 restructuring:1 part:1 key:1 second-quarter:1 recent:1 roundup:1 lower:1 --:1 companies:1 reports:2 recalling:1 patients:1 future:1 weigh:2 drops:1 corporate:1 acquisition:1 latest:1
stock_ABT r_up	decline:1 abroad:1 's:3 reported:1 charges:1 rose:1 company:1 stronger:1 sales:1 fewer:1 than:1 61:3 earnings:1 offset:1 second-quarter:1 more:1
stock_ABT r_up	operations:1 heart:1 one-year:1 have:1 just:1 over:1 sequential:1 sales:5 quarters:1 helped:2 report:2 cost:2 periods:1 launch:1 cuts:2 7th:1 partner:2 year-earlier:1 investment:1 those:1 faces:1 category:1 management:1 cardiac:1 appear:1 stents:1 profit:5 graph:2 not:1 anniversary:1 comments:1 analyst:1 grown:1 outside:1 potential:1 device:2 earnings:2 rhythm:1 quarterly:2 new:1 challenges:1 has:1 compare:1 final:1 indicating:1 stock:1 do:1 's:7 passed:1 both:1 big:1 company:1 growth:2 here:1 includes:1 its:1 fell:2 strong:1 basis:1 prices:1 rises:3 second-quarter:3 vaccine:2 reaction:1 lower:2 12:2 explosive:1 61:2 6th:1 medical:1 double-digit:1 posts:1 days:1 merger:4 while:2 costs:2 products:1 drug-coated:1 stent:3 recently:1 higher:2 consumer:1 maker:1
stock_ABT r_down	prospective:1 because:1 full-year:1 defer:1 maintained:1 executive:1 year:1 results:1 promotional:1 '':1 slowed:1 economic:1 7.5:3 market-share:1 star:1 surgery:1 throughout:1 linked:1 market:2 knees:1 basketball:1 $:1 touts:1 pattern:1 guidance:1 slide:1 comments:1 downgraded:1 behind:1 continue:1 details:1 which:1 misleading:1 downturn:1 has:2 patients:1 earnings:2 billion:1 ``:1 global:1 's:2 said:1 efficacy:1 overstated:1 signs:1 company:2 overall:1 expansion:1 sales:2 fell:1 but:1 risks:1 continued:1 second-quarter:1 11:1 stabilized:1 losses:1 forecast:1 drug:3 regulator:1 chief:1 growth:1 procedure:1 softness:1 its:3 hips:1 replacement:1
stock_ABT r_up	strengthened:1 mandate:1 's:3 advisers:1 pharmaceuticals:1 positions:1 top:1 after:1 landing:1 multibillion-dollar:1 their:2 have:1 year:2 industry:1 fourth:1
stock_ABT r_up	heart:1 all:1 fields:1 agreed:1 fights:1 expects:1 related:1 prevents:1 each:1 report:1 least:1 suing:1 first-quarter:1 settlement:4 stent-delivery:3 whose:1 $:8 patent:1 pay:4 42:1 legal:2 also:1 charge:1 other:2 details:1 which:1 400:3 has:1 systems:3 's:1 company:1 million:4 part:2 nearly:1 background:1 device:1 such:1 cases:1 years:1 effort:1 between:1 fiscal:1 10:1 regarding:1 resolve:1 rival:3 clear:1 companies:2 air:1 deals:1 stents:3 settle:1 stent:2 completing:1 patents:1
stock_ABT r_up	operations:1 heart:1 all:1 financial:1 deal:1 half:1 fights:1 second:1 battle:1 close:1 its:2 sell:1 said:3 end:1 $:3 patent:1 pay:1 seems:1 details:1 statement:2 400:3 expected:1 --:1 war:1 nutrition:2 provide:1 's:2 business:1 big:1 company:1 million:1 but:1 includes:1 nearly:1 coming:1 brands:1 such:1 cases:1 effort:1 between:1 regarding:1 these:1 rival:1 clear:2 companies:1 sale:1 air:1 n't:1 stents:1 settle:1 healthcare:1 did:1 2009:1 completing:1
stock_ABT r_down	agency:1 associated:2 cancer:1 stronger:1 warns:1 already:1 second:1 warning:4 adding:1 children:3 risk:4 information:1 use:2 said:3 group:1 additional:1 best-selling:1 there:2 increase:1 other:2 which:2 factor:1 new:1 fatal:1 added:1 's:5 increased:2 warnings:2 drugs:5 arthritis:1 boxed:1 blockers:1 regulators:1 because:1 they:1 known:1 lymphoma:2 class:1 like:2 developing:1 --:2 adolescents:3 medicines:1 infections:1 strongest:1 drug:1 tumor:1 cancers:2 can:2 popular:1 serious:1 starting:1 latest:1
stock_ABT r_down	recently:1 reporting:1 outperformed:1 halted:1 trial:1 analysts:1
stock_ABT r_up	comment:1 required:1 investors:1 extra:1 executive:1 share:1 '':1 talks:1 establish:1 any:1 if:1 sell:1 said:2 asthma:1 seek:1 able:1 detail:1 its:1 few:1 version:1 treatment:1 fourth:1 tell:1 has:1 meeting:1 company:1 told:1 ``:1 within:1 complete:1 price:1 hopes:1 approval:2 analyst:1 weeks:1 shortly:1 submission:1 --:1 follows:1 work:1 submitted:1 correct:1 2007:1 following:1 meet:1 asked:1
stock_ABT r_down	still:1 help:1 deal:1 core:3 sales:1 settlements:2 results:1 weighed:3 improving:1 full-year:1 comments:1 legal:3 first-quarter:4 calendar:1 throughout:1 its:2 hit:1 size:1 litigation:3 '':1 said:2 recently:1 slipped:1 million:1 profit:5 guidance:1 extra:1 medical-devices:3 expectations:3 one-time:1 appears:1 revenue:1 cents:1 details:1 income:1 performance:1 net:1 360:1 earnings:4 tumbled:2 ``:1 after:1 's:9 though:2 beat:3 big:2 company:2 were:1 corrected:1 story:1 but:1 falls:2 early:1 fell:2 despite:1 not:1 below:1 analyst:1 recent:1 fiscal:3 down:4 39:1 38:10 charges:6 drop:1 37:1 $:2 connection:1 a.m.:1 time:1 maker:3 published:1
stock_ABT r_up	heart:1 alleging:1 court:1 infringed:1 succeeded:1 doctor:1 federal:1 upon:1 over:1 suit:1 patent-infringement:1 stent:1 against:2 patent:1 stents:1 his:1 filed:1 battle:1 also:1 has:2
stock_ABT r_up	``:1 follows:1 corrected:1 drug:1 p.m.:1 '':1 version:1 treat:1 published:1 approved:1 short-term:1
stock_ABT r_down	comment:2 required:2 likely:1 unlikely:2 another:1 year:1 further:2 its:5 might:2 said:3 asthma:3 second:2 detail:1 research:3 treatment:3 before:3 2011:8 approves:2 more:3 marketing:2 company:5 after:3 delayed:1 regulators:3 letter:4 half:2 approval:2 approved:2 suggested:2 received:2 submission:2 launch:1 --:3 warned:2 work:2 sale:2 until:1 receive:2 time:2 following:2 asked:1
stock_ABT r_down	show:1 agreed:1 focus:2 held:1 likely:1 trading:1 privately:1 technology:1 its:1 said:1 $:3 pay:1 400:1 into:1 movement:1 million:1 's:1 business:1 continues:1 significant:1 push:1 maker:1
stock_ABT r_up	less:1 soon:1 held:1 exclusivity:1 its:2 merger:1 rose:4 workers:1 revenue:1 29:1 contractor:1 late:1 finally:1 bond:1 drugmaker:1 gains:1 familiar:1 bid:1 results:2 report:1 bit:1 continued:1 day:1 endless:1 --:2 drop:1 morning:1 lasting:1 people:1 defense:1 home:1 7.8:1 out:1 medications:2 shares:4 3:1 market:2 new:1 falling:1 earlier:1 jobs:1 struggle:2 losing:1 news:1 100:1 come:1 rut:1 both:1 benefits:1 could:1 economics:1 days:1 biologics:1 34:1 retreating:1 trickle:1 slightly:1 yearly:1 outlook:1 point:1 forecaster:1 number:1 one:1 total:1 unit:1 pharmaceutical:1 jobless:1 their:1 leading:1 two:1 confident:1 pared:1 expected:2 markets:1 500:2 more:2 posting:1 forward:1 shortfall:1 gain:1 quarterly:1 last:1 than:2 versions:2 up:2 while:3 growing:1 situation:1 industry:1 biotech:1 tap:1 according:1 disappointing:1 moves:1 if:1 end:1 4.3:1 generic:1 buoyant:1 backs:1 1:1 fourth:1 stock:2 week:2 junk:1 added:1 's:1 plans:1 after:5 fell:1 biologic:2 coming:2 stocks:1 recent:1 lower:1 kept:1 fund:1 builder:1 futures:4 points:5 allow:1 claims:2 filing:1
stock_ABT r_up	sector:1 help:2 companies:2 health-care:2 second:1 through:1 per:2 tab:2 year:2 fifth:1 group:1 $:4 reform:2 medical-devices:2 comments:1 4:2 proposal:2 include:1 contribute:2 billion:2 12th:1 could:2 cover:2 according:2 heavyweights:1 10th:1 asked:2
stock_ABT r_up	sector:2 emerging:1 among:1 increasingly:1 agreed:1 all:1 not:1 its:2 note:1 $:1 favor:1 outperformance:1 much:1 improvement:1 environment:1 attractive:1 turnaround:1 volatility:1 between:1 report:1 structural:1 --:2 eased:1 companies:1 yields:1 view:1 picker:1 creation:1 some:1 surrounding:1 expect:1 our:2 out:1 category:1 reform:1 research:2 discounts:1 3:1 safety:1 health:2 provides:1 paradise:1 new:1 410:1 we:3 recently:1 business:1 reach:1 million:1 operating:1 key:2 dividend:1 strong:1 change:1 care:2 improved:1 positioning:1 analysts:2 flocking:1 think:1 upgraded:1 repair:1 due:1 spotting:1 names:1 another:1 market:3 broadening:1 rated:2 leading:1 create:1 three:1 their:1 2:1 call:1 today:1 more:1 ``:2 buy:1 favorable:1 has:2 pickers:1 up:1 value:1 remain:2 stories:1 can:1 margin:1 heart:1 investors:1 share:1 rancor:1 '':2 single:1 acceleration:1 lie:1 anymore:1 make:1 1:1 other:1 performance:1 you:1 stock:4 's:5 models:1 correlation:1 driver:1 driven:1 shareholder:1 favorites:1 stocks:2 intrinsic:1 recent:1 values:1 factors:1 together:1 maker:1 so:1 healthcare:1
stock_ABT r_down	emerging:1 valve:1 show:1 agreed:1 move:1 dollar:4 focus:2 injects:1 stability:1 held:2 still:1 its:2 fifth:2 $:6 23:1 rose:6 add:1 other:1 equity:1 stable:1 might:1 versus:1 hit:3 risk:1 without:1 big:1 rise:3 overall:1 inflation:1 new:1 continued:1 410:2 succession:2 crude-oil:1 side:1 added:4 energy:2 used:1 economic:4 chambers:1 80:1 index:1 said:1 adds:1 driving:1 since:1 near:1 does:1 provider:1 import:1 strategist:1 available:2 we:2 deflation:1 million:2 notable:1 reported:1 key:1 100:3 hits:1 potentially:1 climbed:1 develops:1 plus:1 mixed:1 argue:1 makes:1 repair:2 major:1 point:2 into:1 one:1 privately:1 throughout:1 half-point:1 market:2 broadening:1 positive:5 their:1 2:1 stock:6 raft:4 territory:1 500:3 more:1 ``:1 buy:1 factor:1 but:1 properly:1 lows:5 prices:4 than:1 11:1 10:1 12:1 announcing:1 up:2 n't:1 record:1 while:2 can:1 were:1 growing:4 problem:1 acquisition:1 streak:1 heart:3 1.7:1 1.3:1 turned:1 '':1 currency:1 have:1 sense:4 close:1 moves:1 technology:1 surgery:2 5.2:1 recovery:4 fixing:1 make:1 edge:1 grew:1 details:1 which:2 inch:3 higher:6 worldwide:4 product:1 currencies:1 's:1 plans:1 price:2 after:7 reach:1 fast-growing:1 fell:1 cardiac:1 frequently:1 stocks:4 data:8 recent:1 futures:12 face:1 points:6 basket:1 fresh:4 valves:1 consumer:1 spend:1 latest:2
stock_ABT r_up	artery:2 fourth-quarter:1 all:1 deaths:1 ai:1 sigh:1 into:1 each:1 year:1 number:1 trade:1 four:1 actively:1 another:2 such:1 annually:1 its:3 best:1 sell:2 pharmaceutical:1 most:1 statistics:1 20:3 $:2 stent:4 opening:2 backers:1 treatment:2 shares:1 than:1 causing:1 according:1 market:2 forces:1 innovation:1 units:1 150,000:1 planned:1 breathe:1 product:2 buy:1 's:4 drug-coated:2 business:1 whose:1 after:2 expected:1 restructuring:1 nearly:1 half:1 device:1 world:2 approval:2 procedures:1 why:1 roundup:1 received:2 disease:2 join:1 standalone:1 country:1 medical:1 launch:1 companies:1 fast-growing:2 drug:1 morning:1 n't:1 more:1 patients:1 session:1 2006:1 relief:1 venture:1 -2:2 growing:1 undergo:1 maker:2 procedure:1
stock_ABT r_down	acquisitions:1 brightened:1 return:1 like:1 --:1 boosted:1 straight:1 enough:1 its:1 environment:1 strategy:1 second:1 economic:1 through:1 looks:1 growing:1 has:1 company:1 day:1
stock_ABT r_down	body:1 because:1 accurate:1 unsafe:1 up:1 diabetics:1 determine:1 toughen:1 medication:1 monitors:1 use:1 monitoring:1 agency:1 its:1 current:1 their:1 too:1 international:1 has:1 accuracy:1 wants:1 commissioner:1 used:1 standard:1 levels:1 lax:1 requirements:1 20:1 --:1 require:1 allows:1 according:1 devices:3 believes:1 whether:1 more:1 asked:1
stock_ABT r_down	yearly:1 heart:1 major:1 agency:1 examines:1 they:1 accurate:1 unsafe:1 up:1 growth:1 promise:1 determine:1 says:1 surgery:1 toughen:1 medication:1 targets:1 levels:1 conference:1 provided:1 use:1 monitoring:1 their:1 six:1 long:1 next:1 current:1 whether:1 potential:1 wants:1 too:1 acquirers:1 international:1 has:2 final:1 more:2 week:1 do:1 commissioner:1 used:1 cardiology:1 big:1 monitors:1 body:1 possible:1 but:1 standard:1 believes:1 shifting:1 newer:1 coming:1 requirements:1 hold:1 because:1 comment:1 stage:1 20:1 --:1 require:2 allows:1 according:1 devices:4 asked:1 n't:1 stents:1 diabetics:1 lax:1 accuracy:1 its:1 spotlight:1 valves:1
stock_ABT r_up	comment:1 heart:4 said:3 helping:4 older:4 studies:4 avoid:4 outperformed:4 two:4 devices:4 3:4 better:4 prices:2 patients:4 three-year:4 updates:1 device:4 serious:4 share:2 data:4 events:4
stock_ABT r_down	heart:1 deal:1 showdown:2 evidence:1 helped:1 adding:1 unit:2 pharmaceutical:2 competitor:2 stent:1 make:1 setting:2 rates:1 market:1 has:3 events:1 's:1 again:1 outperformed:1 conglomerate:2 device:2 strong:2 data:1 potential:1 billion:2 purchase:2 lower:1 valued:1 showed:1 older:1 rival:2 could:1 up:2 leader:1 large:1 leading:1 serious:1 bidder:2 study:1
stock_ABT r_up	help:2 money:1 years:2 adding:3 cut:2 stent:10 writes:1 has:3 might:1 around:2 emergency:1 big:2 putting:1 using:2 fewer:1 some:1 measure:2 wire:1 blue-chip:1 between:1 sensor:1 leader:4 scientific:1 pressure:3 arteries:1 imaging:2 article:2 safer:1 both:3 attacks:2 study:4 products:1 drug-coated:1 published:2 studies:4 first:1 comment:1 examining:2 appeared:1 year:1 accounts:1 tools:1 market:4 conference:1 '':1 leading:3 two:5 2:6 rates:3 interest:1 ``:1 offering:1 cardiology:1 tool:2 took:1 released:1 newer:3 involve:1 made:2 15:1 14:1 showed:6 versions:3 these:1 rival:1 cash:1 devices:7 patients:1 heart:7 measurement:1 evidence:3 helped:3 death:2 sense:1 compared:2 drubbing:1 make:5 narrowing:1 details:1 which:1 place:2 several:1 events:4 's:4 after:2 outperformed:3 stocks:1 data:3 lower:3 older:3 odds:2 flow:1 traditional:2 stents:1 serious:4 reserve:1
stock_ABT r_up	people:1 into:1 '':1 held:1 close:1 settlement:1 its:1 unit:1 considering:1 pharmaceutical:1 said:2 $:4 headline:1 pay:1 initial:1 p.m.:1 entered:1 increasing:1 litigation:1 ``:1 's:1 offer:1 familiar:1 million:1 agreement:1 27:1 regulatory:1 billion:1 name:1 --:2 drug:1 filing:1 patent:1 published:1 situation:1 maker:1
stock_ABT r_up	stock:10 comment:2 emerging:1 background:1 reinvent:1 money:3 over:7 executive:2 results:1 unlikely:1 6.6:2 6.5:1 underlying:1 businesses:6 rooms:1 talks:1 still:1 its:19 before:1 whose:3 26:1 busy:1 20:1 $:6 million:1 euros:2 front:3 rose:3 segments:1 point:1 had:2 state:1 2.5:1 94:1 add:2 causing:1 certain:1 those:1 pretty:2 cash:6 pay:3 weeks:1 has:3 2011:1 2013:1 details:1 ...:2 them:1 global:1 gains:1 advantage:4 big:1 continues:1 consolidation:4 wave:1 124:1 private:1 portfolios:1 milestone:1 buyer:1 world:2 0.5:1 tick:1 flee:1 day:1 bank:2 cool:1 amid:1 like:2 course:1 --:8 edge:2 performers:1 companies:3 morning:1 deals:6 banking:2 good:1 session:3 payments:1 18:1 done:1 advised:1 economy:1 mergers:4 looks:1 system:2 bets:1 clients:1 financial:1 leaders:1 deal:4 burst:1 globe:1 some:8 related:1 scenes:1 tires:1 actively:3 trading:8 signed:1 competitors:1 year:1 further:1 operation:1 activities:6 makers:1 best:2 out:3 investor:1 weekend’s:1 said:1 lead:2 roughly:1 investing:1 since:1 4:1 shares:4 week:1 vaccines:1 outside:1 gathers:1 market:1 7:4 capital:1 new:2 fall:1 increasing:3 across:1 announced:3 available:2 jitters:1 adding:1 arthritis:1 raising:4 business:3 lay:2 got:1 activity:4 focus:2 agreement:1 hours:3 kicking:1 host:1 if:1 others:1 active:1 news:1 100:3 closing:1 pharma:2 conglomerate:5 acquire:1 drops:2 last:2 cow:1 met:1 broad-based:1 industry:5 firing:1 drug:14 suggests:1 plus:1 disappointment:5 testimony:1 climb:1 struck:1 slightly:2 maker:1 south:1 otherwise:1 prices:2 business-friendly:1 presence:1 feel:1 into:1 offset:3 pick-up:1 billions:1 one:1 price:2 flat:1 world’s:1 rising:3 been:1 another:2 upgrades:1 detail:1 total:1 between:1 unit:5 logic:1 rival:5 pharmaceutical:9 industrials:1 publicly:1 district:1 all:1 stretch:1 top:3 placing:1 two:1 least:1 pharmaceuticals:2 increase:1 much:1 growth:2 wobbly:1 way:1 wildly:1 biggest:2 markets:2 500:6 board:1 firm:1 acquisitions:3 plunge:1 valuations:3 successful:2 turned:1 company:7 equity:1 milestones:1 but:1 failure:2 chemicals:7 lift:2 wake:1 announce:1 plastics:7 despite:1 potential:1 buying:1 1998:1 shoot:1 high:1 financing:1 15:1 14:1 announcing:1 rights:1 proceeds:2 gotten:1 pretend:1 flu:1 up:15 value:2 while:5 future:1 can:3 were:10 making:4 selling:6 plunges:2 leaves:1 acquisition:1 something:1 0.9:1 biotech:1 barely:1 1.1:1 investors:1 give:1 meeting:4 election:3 engaged:1 evidence:1 '':1 player:1 say:1 buy:3 dropped:1 have:1 bankruptcies:1 rally:1 riskiest:1 work:1 their:2 comments:2 utility:1 confirmed:6 mostly:1 pure:1 rather:1 47:1 began:1 4.8:1 any:1 chemical:1 also:1 reputation:1 5:1 3.8:2 which:1 largest:1 announcements:1 several:1 operators:1 higher:8 gaining:3 product:1 diversified:1 's:21 economies:2 weaker:1 after:8 analyst:3 flurry:1 reforms:2 driven:1 bolsters:1 share:2 stocks:10 weekend:4 concerns:3 expand:7 billion:14 purchase:1 today:1 off:1 takes:4 quarter:1 moved:1 futures:9 itself:1 sale:2 greet:1 wants:1 46:1 chief:2 points:17 status:1 2007:1 enterprise:1 push:4 looking:1 updates:1 latest:2
stock_ABT r_up	7.2:1 not:2 manager:1 6.4:6 through:1 shares:1 broader:3 signs:1 portfolio:1 aggressive:1 its:1 fifth:1 whose:1 renewed:5 $:8 cliff:1 euros:1 rose:1 window:1 revenue:1 outside:1 only:2 potential:1 candidates:1 questioned:1 dressing:1 has:1 might:1 surprised:1 them:1 good:6 gains:1 acquisition:1 government:1 market’s:1 big:1 bid:4 continues:1 consolidation:3 difficult:1 report:2 during:1 day:1 trigger:1 like:1 megadeals:1 ended:1 --:2 companies:2 50:1 benefit:1 session:1 yields:1 activity:6 become:1 higher:5 round:1 mergers:3 suitors:3 deal:3 burst:4 energy:1 some:4 up:3 see:1 growth:3 trading:1 goes:1 home:2 appetite:2 best:1 out:2 even:4 recession:1 said:5 actively:1 barrier:1 lead:1 short-lived:4 managers:3 viability:1 materials:1 vaccines:1 looking:1 500:3 safety:1 unit:2 generics:1 buying:1 got:1 firms:1 strategist:3 announced:2 can:4 available:1 weighing:1 business:2 seventh:1 quarter-end:1 after-hours:1 points:3 acquisitions:2 pharma:1 busy:1 title:1 healing:1 news:3 100:2 debt:1 bask:2 celebration:4 advance:2 reinvent:1 would:2 could:2 climbed:1 drug:1 7:1 credit:1 analysts:1 pure:1 mixed:1 today:1 already:3 useful:1 rallied:2 slipped:2 point:3 billions:1 6.6:1 another:3 says:1 market:11 pharmaceutical:1 industrials:1 computer:3 additional:3 puts:1 their:1 stretch:1 top:3 there:3 question:1 add:1 been:2 name:1 credit-ratings:1 start:3 2:1 too:1 way:1 plastics:1 investing:1 markets:2 opens:3 gives:1 wants:1 billion:8 ``:6 buy:2 door:3 manufacturers:1 drugs:1 share:1 company:2 but:3 1.9:1 fund:2 pricey:1 crank:1 lows:1 prices:1 valuation:3 those:1 he:1 helped:3 conglomerate:1 whether:1 hardly:1 edged:1 cash:2 n't:3 economic:1 ongoing:3 era:1 were:1 more:2 bidder:3 leaves:1 bet:2 gathering:1 proved:4 investors:2 1.3:1 almost:1 0.3:1 0.2:1 1.8:1 argument:3 biggest:2 '':5 player:1 itself:1 have:3 rally:3 bolstered:2 risk:1 lingering:1 recovery:1 4.2:1 patent:1 pay:2 make:4 sending:1 1:1 also:1 high:1 complex:1 economy:1 which:2 inch:1 you:3 grows:1 stock:13 week:3 's:19 price:3 after:5 most:1 fell:3 bolsters:1 position:1 services:3 such:2 stocks:5 data:1 recent:1 tricky:1 purchase:2 lower:3 sectors:1 futures:9 comments:1 sale:1 iffy:1 face:2 uptick:2 chief:3 edge:1 reputation:1 does:1 banks:2 entry:1 chemicals:1 corporate:1 updates:1 latest:1
stock_ABT r_up	traditional:1 prescription-drug:1 smaller:1 $:1 business:1 stent:1 million:1 long-running:1 agreement:1 battles:1 deals:2 outside:1 putting:1 rest:1 string:1 latest:1
stock_ABT r_down	biotech:1 right:1 regardless:1 medical-device:1 into:1 signs:1 some:1 expects:1 shape:1 devices:1 entering:1 year:2 's:2 spooked:3 soon:1 its:1 market:1 feared:1 information:1 rough:1 monitor:1 would:1 generic:1 bringing:1 legislation:1 your:1 may:1 worry:1 provides:1 biosimilar:1 might:1 app:1 chip:1 monitors:1 such:1 lawyers:1 get:1 drugs:1 hospitals:1 giant:1 period:1 wireless:1 connectivity:1 reason:2 doctors:1 path:1 strong:1 opportunity:1 acquisitions:1 sending:1 smartphones:1 like:1 third:1 level:1 --:1 markets:1 medical:1 see:1 experience:1 whether:1 benefit:1 planned:1 were:1 entry:1 quarter:1 maker:1 mergers:1
stock_ABT r_up	million:1 $:1 have:1 four-year:1 been:1 patients:1 cooperation:1 100:1 now:1 exercise:1 first:1
stock_ABT r_down	biotech:1 outcome:1 's:1 have:1 --:1 trials:1 company:3 months:1 implications:1 results:1 publish:1 three:1 important:1 could:1 drug:1 which:1 coming:1 serious:1 choppy:1 ride:1 independence:1
stock_ABT r_down	biotech:1 outcome:1 's:1 have:1 --:1 trials:1 company:3 months:1 implications:1 results:1 publish:1 three:1 important:1 could:1 drug:1 which:1 coming:1 serious:1 choppy:1 ride:1 independence:1
stock_ABT r_up	whose:1 prescription-drug:1 's:3 business:2 up:1 sales:1 lines:1 companies:1 focus:2 shares:1 trade:1 active:1 see:1 session:1 so:1 have:1 time:1 expected:1 tough:1 other:1 nice:1
stock_ABT r_up	saying:1 09:2 deck:1 focus:2 quarters:1 leads:1 session:3 6.3:2 still:1 its:11 24:1 whose:3 21:1 longstanding:1 lackluster:2 graph:2 segments:1 expectations:3 105:1 late:1 add:2 advisories:2 treatment:3 premarket:1 quarterly:2 8:1 through:1 sent:3 details:1 hit:1 year:1 3.65:1 results:4 wave:1 early:1 background:1 report:2 prescription:1 14.3:1 level:3 companies:5 accelerating:3 including:2 raised:1 higher:6 rheumatoid:1 added:2 better-than-expected:2 lifted:1 financial:2 estimates:1 past:1 114:1 actively:3 trading:4 exceeded:2 led:1 adds:1 lead:2 profit:13 since:1 shares:5 forecast:3 increase:2 3:1 future:1 7:2 beating:1 available:2 after:2 recently:1 view:1 conglomerate:2 reported:4 surprises:2 put:3 100:3 strong:5 beginning:1 $:8 gained:1 reaction:1 improved:1 climbed:4 37:3 36:15 drug:11 leapt:1 products:6 retreating:1 rose:13 retail:1 maker:1 first:1 comment:1 1.4:1 outlook:4 marginal:1 into:2 within:3 nutritional:4 two:1 down:2 downgrade:2 rising:1 throughout:1 decline:1 industrials:2 positive:3 top:3 third-quarter:8 2:1 spike:3 territory:2 500:7 roundup:1 advance:1 drugs:1 share:1 company:3 but:1 surprisingly:4 wake:2 gain:1 prices:2 rallying:3 analyst:1 11:1 made:1 14:2 showed:1 16:1 solid:2 up:4 devices:4 while:1 growth:6 were:1 export:1 steer:1 stronger-than-forecast:3 heart:3 months:1 1.1:3 1.2:1 1.3:2 almost:1 guidance:1 health-care:2 0.5:1 sales:13 helped:4 10,000:4 full-year:1 reports:5 weakened:2 topped:1 1:5 also:3 other:2 earnings:8 performance:1 stock:6 gaining:2 topping:1 89:1 's:11 boosted:2 price:1 arthritis:6 reach:3 much:3 fueled:1 4th:1 climbing:2 stocks:9 data:3 rallied:1 lower:1 3rd:1 amid:2 medical:1 futures:10 points:14 '09:4 time:1 2008:1 2009:2 corporate:1 latest:3
stock_ABT r_up	1.5:2 hit:1 closed:3 companies:1 whose:1 rose:1 since:1 1.8:1 up:3 shares:1 late:1 10,000:1 actively:1 trading:1 7:1 time:1 2008:1 stocks:1 500:1 first:1
stock_ABT r_down	heart:1 outlook:1 weaker:1 heart-rhythm:2 revenue:1 issued:1 share:1 results:1 third-quarter:1 challenges:1 report:2 full-year:1 dropped:1 reports:1 year:1 forecast:1 its:2 market:2 impact:1 decline:1 some:2 swung:1 $:1 million:1 reform:1 profit:1 stent:1 top:1 less:1 while:1 shares:2 day:1 late:1 issues:1 potential:1 health:1 details:2 tepid:2 implantable:1 estimates:1 markets:1 company:2 expected:2 200:1 plunge:2 loss:1 earnings:1 price:1 after:2 but:1 sales:2 defibrillators:1 weaker-than-expected:1 prices:2 than:2 earlier:1 sliced:1 grew:1 --:1 amid:1 medical:1 device:1 devices:2 morning:1 facing:1 stents:1 competitors:1 maker:1 below:1 drug-coated:1 activity:1 softness:1 plunges:1 guidance:1
stock_ABT r_up	reflect:1 prospects:1 's:2 gains:1 big:1 price:1 n't:1 does:1 impressive:1 company:1 stock:1
stock_ABT r_down	operations:1 executive:1 6.6:1 its:1 asthma:1 $:2 continued:1 rebound:1 overall:1 possibly:1 they:1 despite:1 investor:1 --:1 did:1 cholesterol:1 reduced:1 significantly:1 due:1 second:1 animal-health:1 makers:1 adds:1 profit:1 review:1 shares:1 forecast:1 unit:1 body:1 decline:1 sixth:1 withdrawal:1 continuing:1 reported:1 tripled:1 regulatory:1 come:1 acquiring:1 could:1 drug:3 products:1 disappointment:1 long-term:1 maker:1 comment:2 major:1 revenue:1 one:1 market:1 pharmaceutical:1 raise:1 their:1 third-quarter:3 cents:1 clinical:1 more:1 drugs:1 gain:1 benefits:1 than:1 whether:1 up:1 n't:1 while:1 venture:1 outcome:1 1.4:1 process:1 certain:1 sales:2 helped:2 examine:1 dropped:1 have:2 blockbuster:1 if:1 46:1 stake:1 potential:1 earnings:3 which:1 inch:1 higher:3 's:4 plans:1 reporting:1 billion:1 stock-price:1 short:1 joint:1 implications:1 sale:1 costs:1 2009:1
stock_ABT r_up	cost-cutting:1 's:1 help:1 ahead:1 profit:1 jumped:1 colon-cancer:1 42:3 results:1 drug:1 third-quarter:1 generic:1 version:1 analysts:1 surged:1 expectations:1 plan:1
stock_ABT r_down	advisory:1 shareholders:1 get:1 top:1 next:1 cast:1 compensation:1 officials:1 year:1 vote:1
stock_ABT r_up	heart:4 because:1 leaders:1 investors:1 share:1 soon:2 one:3 '':1 focusing:1 manager:2 been:2 have:2 our:1 faint:2 fifth:1 needs:2 cleared:2 top-performing:1 giving:2 there:2 political:1 due:1 comments:1 traders:1 their:1 fitting:1 has:1 company:2 expiring:2 product:2 's:6 sights:1 price:1 agreement:2 but:1 focus:1 fund:2 invested:1 updates:1 letter:1 not:2 replace:2 analyst:1 ``:1 stocks:1 like:2 --:2 fully:1 reform:1 compensation:1 worried:1 stents:2 bad:1 week:1 lose:2 starting:1 remains:1
stock_ABT r_down	1.4:2 6:1 1.7:2 says:1 people:1 reduce:1 results:1 awaited:1 roughly:1 down:1 year:1 further:1 its:1 embattled:1 cut:4 $:4 eagerly:1 7:3 between:1 save:1 2011:1 announced:1 ...:1 ``:2 jobs:2 plans:2 business:1 decline:1 drugs:1 company:3 after:2 workforce:1 simplify:1 restructuring:1 management:1 lay:1 effort:2 billion:4 '':2 off:2 released:1 structures:1 could:1 laying:1 up:3 morning:1 costs:2 products:1 cholesterol:1 slightly:1 order:1
stock_ABT r_down	civil:2 violated:2 ``:2 sales:2 ninth:1 through:1 determine:2 parties:2 its:2 information:1 said:2 including:2 disclosed:2 marketing:4 criminal:2 stock:1 activities:4 updated:1 's:2 seeking:2 sixth:1 price:1 background:1 regulatory:2 reimbursement:2 third:2 whether:2 drug:4 maker:2 connection:2 investigating:2 filing:2 laws:2
stock_ABT r_up	considering:1 --:1 outsourcing:1 according:1 antibiotics:1 effectiveness:1 decisions:1
stock_ABT r_up	right:1 sees:1 consider:1 investors:1 money:1 mutual-fund:1 '':1 manager:1 large-cap:1 touchy:1 decisions:1 market:2 subject:1 considering:1 stocks:3 would:1 agency:2 outsourcing:2 opportunities:1 according:2 role:1 best:2 troubling:1 effectiveness:1 excited:1 sent:1 function:1 treating:1 ``:1 's:2 very:1 most:1 reason:1 letter:1 article:1 now:1 those:1 arena:1 aren’t:1 --:1 many:1 infections:1 antibiotics:2 value:2 chairs:1 patients:1 can:1 published:1 essential:1
stock_ABT r_down	week:1 deal:1 companies:1 over:1 health-care:1 one:1 past:1 rising:1 year:1 speed:1 before:1 conference:1 mostly:1 long:1 payments:1 their:2 add:1 helps:1 between:1 fledgling:1 bid:1 more:1 firm:1 industries:1 pipelines:1 initiated:1 dividends:1 company:1 paid:1 coverage:1 during:1 than:1 last:1 --:1 reignite:1 flow:1 drug:1 keep:1 funded:1 biotechnology:1 executives:1
stock_ABT r_down	lots:1 big:1 study:1 attention:1 drug:1 small:1 drawing:1
stock_ABT r_up	broader:1 investors:1 less:1 embarks:1 sigh:1 fueling:1 negative:1 trading:2 clearing:2 questions:1 's:2 blockbuster:1 its:2 market:1 feared:1 arteries:2 lead:3 jumped:1 3:1 shares:2 than:2 1:1 add:1 clinical:1 biggest:1 new:3 decades:1 higher:3 wants:1 publicity:1 worse:1 drugs:2 after:1 fell:1 prices:1 stocks:3 analyst:1 pre-market:1 reaction:1 kind:1 showed:2 study:4 work:1 drug:4 n't:2 relief:1 cholesterol:3 making:1 clogged:2 stock:1 acquisition:1
stock_ABT r_down	heart:1 major:1 proved:1 help:1 1,100:2 over:1 dollar:1 site:1 up:1 stroke:1 marker:1 says:1 reducing:1 bolster:1 ultimately:1 arteries:1 ends:2 indexes:1 attack:1 above:2 violations:1 has:1 500:2 more:1 plant:1 's:2 risk:1 company:1 after:1 should:1 letter:1 manufacturing:1 than:1 posted:1 neck:1 effective:1 --:1 warned:1 according:1 surge:2 policies:1 push:1 found:1 plaque:1
stock_ABT r_down	heart:1 compared:1 's:2 significantly:1 insurer:1 did:1 study:1 cholesterol:1 reduce:1 drug:1 n't:1 attacks:1 generic:1 health:1 strokes:1 concludes:1 new:1 alternative:1 risk:1
stock_ABT r_down	heart:1 because:1 significantly:1 into:1 labels:1 reduce:1 sales:1 price:1 concludes:1 's:2 alternative:1 label:1 yet:1 its:1 compared:1 ads:1 would:1 products:1 beginning:1 generally:1 fast:1 touting:1 makers:1 health:1 promoting:2 consistent:1 new:3 eighth:1 has:1 might:1 company:1 stock:1 them:1 updated:1 risk:1 insurer:1 strokes:1 showing:1 results:1 analyst:1 running:1 uses:1 doctors:2 data:1 approved:1 reaction:1 benefits:1 consumers:1 did:1 study:2 drug:2 n't:4 attacks:1 barred:1 prescribing:2 so:1 cholesterol:2 think:1 generic:1
stock_ABT r_up	hit:1 week:1 's:1 last:1 drugs:1 got:1 over:1 according:1 favored:1 took:1 results:1 firm:1 trial:1 while:1 clinical:1 volumes:1 cholesterol:1 prescription:1 research:1 boost:1 market:1
stock_ABT r_up	comment:1 firm:1 over:1 results:1 hit:1 market:1 research:1 favored:1 clinical:1 got:1 boost:1 stock:1 week:1 's:1 drugs:1 took:1 updates:1 prices:1 last:1 prescription:1 12th:1 according:1 spokeswoman:1 trial:1 while:1 volumes:1 cholesterol:1
stock_ABT r_up	major:2 investors:2 being:2 years:2 drug:4 hit:2 its:2 market:2 shares:2 more:2 company’s:2 fuels:2 's:3 company:2 pushing:2 eight:2 highest:2 than:2 lupus:4 level:2 value:2 banking:2 experimental:2
stock_ABT r_up	prevent:1 deal:1 agreed:1 focus:2 competition:1 years:1 have:1 reached:1 its:1 financials:1 strength:1 generic-drug:1 grant:1 generic:2 28:1 been:1 version:1 postpone:1 has:1 2011:2 until:1 led:1 earliest:1 sooner:1 sales:1 no:1 stocks:4 than:1 property:1 rights:1 --:1 climbed:1 up:2 drug:3 cholesterol:3 drugmakers:2 maker:1
stock_ABT r_up	among:1 being:1 possible:1 deals:1 examined:1 insider-trading:1 violations:1
stock_ABT r_up	sector:2 heart:5 major:3 agency:1 financial:3 represent:2 issued:3 into:1 probe:1 share:2 sales:3 '':2 growth:3 trading:1 broader:1 surgery:3 technology:2 market:3 deals:1 business:1 ways:2 guidance:3 valve:1 medical-devices:2 expectations:3 comments:1 analyst:1 looking:2 insider:1 potential:1 above:3 new:2 outlook:1 has:2 2010:9 do:3 ``:2 mostly:3 big:2 price:2 attention:2 possible:1 but:2 forecasts:3 part:1 updates:1 strong:3 grow:2 10:1 several:1 amid:3 require:3 companies:2 transcatheter:2 comment:1 n't:3 small:2 investigating:1 replacement:3 other:2 valves:5
stock_ABT r_up	says:1 strengthen:1 agreed:1 global:1 share:1 billions:1 cash:1 trading:1 40:1 shot:1 after-hours:1 its:2 market:1 marking:1 $:6 pay:1 shares:4 bank:1 has:1 price:2 more:1 million:1 return:1 government:1 funds:1 company:1 rise:1 47:1 plan:2 than:1 after:3 purchase:1 last:1 14:1 dollars:1 up:3 repay:3 diagnostics:1 position:1 closing:1
stock_ABT r_up	trade:1 session:5 whose:4 20:1 $:2 rose:1 4:2 policy:2 has:1 11:1 violating:1 government:2 big:2 watch:2 --:1 warned:1 companies:5 deal:2 begin:2 up:1 rate:2 actively:4 trading:4 's:5 declined:3 2.4:2 assistance:2 shares:5 closed:1 falling:2 sliding:2 notable:1 losing:1 100:1 manufacturing:1 strike:2 declining:2 last:2 31:1 climbed:1 mixed:1 makes:1 among:3 loan:1 active:1 market:1 eye:1 due:2 2:2 interest:2 6:1 expected:1 500:5 becoming:2 biggest:2 subsidiary:1 deliberations:2 10:1 19:1 18:1 see:1 devices:1 were:1 making:1 spotlight:2 acquisition:1 1.3:1 dropped:3 moves:1 49:1 40:1 points:15 3.25:1 stock:3 gaining:2 plant:1 edged:2 after:2 fell:4 stocks:10 billion:2 lower:4 traded:1 futures:4 repay:2 practices:1 banks:2 assisted:1
stock_ABT r_down	fertile:1 over:2 unit:2 ground:1 pharmaceutical:1 $:8 granting:2 patent:2 decision:2 upheld:2 damages:2 interest:2 firms:1 added:2 's:6 offer:1 infringement:2 million:2 dealmaking:1 judge:2 response:2 billion:2 1.67:4 ruling:2
stock_ABT r_up	detailed:2 set:1 41:1 over:2 some:2 0.4:2 billions:1 years:1 ended:2 5.25:1 weaker:4 higher:2 6.1:1 carry:2 seem:1 improvement:2 its:2 special:2 after:4 drugs:1 strong:2 end:2 patent:1 rose:7 though:2 next:1 1:2 few:1 concerns:2 economy:2 pretty:1 policy:2 markets:2 500:4 stock:2 week:2 continues:2 's:2 slight:2 may:1 company:1 rise:2 monetary:2 hurt:2 were:2 protection:1 world:2 100:2 stocks:2 tighter:2 futures:6 gained:1 10:1 last:2 17:1 programs:2 boring:1 dollars:1 annual:1 steady:1 drug:1 liquidity:2 reports:2 appealing:1 points:6 products:1 lose:1 2:1 revenues:2 reliable:1
stock_ABT r_up	aided:1 cents:1 session:1 its:1 developer:1 given:1 $:1 candidate:1 rose:1 aftermarket:1 comments:1 also:1 which:1 6:2 falling:1 has:1 today:1 stock:1 ...:1 gains:1 possible:1 regular:1 during:1 analyst:1 54:1 up:1 drug:1 acquisition:1
stock_ABT r_up	cancer:1 results:1 surface:1 soaring:1 protein:1 its:1 $:3 shares:1 treatment:1 test:1 announced:1 ...:1 million:1 company:1 after:1 significant:1 kind:1 novel:1 target:2 32:3 up:1 morning:1 market-cap:1 found:1
stock_ABT r_down	bolstering:1 investors:3 presence:1 positioned:1 up:1 down:1 itself:1 pulling:1 year:3 go:1 its:1 out:1 category:1 space:1 gravity:1 two:2 stock:1 pure:1 new:2 has:1 reversed:1 noncore:1 goes:1 transactions:1 food:1 big:1 company:1 but:1 important:1 law:1 --:1 days:1 greet:2 way:1 grimace:2 more:1
stock_ABT r_up	attorney:1 statements:1 agreed:3 competition:3 alleged:3 states:3 settlement:5 makers:3 restitution:1 litigation:3 said:1 $:10 23:3 generic:3 pay:3 two:3 details:1 statement:2 units:3 4.5:1 's:3 million:4 part:4 general:1 additional:1 announcing:1 antitrust:3 --:3 drug:6 receive:1 costs:1 22.5:3 cholesterol:3 block:3
stock_ABT r_up	heart:2 major:2 version:1 owe:1 share:1 covers:1 up:2 relying:2 growth:3 devices:1 have:1 250:1 its:2 unit:1 said:2 $:1 also:2 stent:5 means:1 two:1 been:2 approved:4 failed:1 behind:1 other:1 treat:1 new:1 has:2 type:1 treatment:1 million:1 's:4 opening:2 drugs:1 price:1 arthritis:1 treatments:1 market:3 rest:1 milestone:2 device:1 approval:2 payment:2 prospects:1 fighter:1 largely:2 medical:1 sale:3 drug:1 patients:1 future:2 products:1 region:1 rheumatoid:1 maker:1
stock_ABT r_up	reversing:1 plastics:1 hard:1 officials:1 cans:1 allowed:1 's:1 children:1 fifth:1 previous:1 said:1 bottles:1 additional:1 make:1 young:1 comments:1 plastic:1 chemical:2 also:1 bike:1 health:1 taken:1 might:1 used:3 partly:1 stance:1 safe:2 tops:1 levels:1 background:1 not:1 such:1 appears:1 --:1 coat:1 industry:1 metal:1 harden:1 products:1 bottle:1 starting:1 inside:1
stock_ABT r_up	stores:1 lenders:1 deal:1 month:1 purchased:2 committed:2 counterfeit:2 pharmaceutical:2 said:3 consumers:2 over-the-counter:1 remains:2 sites:1 version:2 online:1 receiving:1 sold:1 nutrition:2 product:2 's:2 business:2 started:1 company:4 weight-loss:1 opposition:1 despite:1 complaints:1 last:1 like:1 --:2 warned:1 completing:2 variety:1 drug:1 auction:1 overseas:1 retail:1 acquisition:2
stock_ABT r_up	sector:2 sees:4 show:2 cited:1 some:2 stability:4 prices:2 slowed:2 reports:2 signs:2 improvement:2 knees:2 fronts:2 also:2 procedures:2 there:2 p.m.:1 source:1 expected:2 markets:4 heart-device:2 ``:3 but:4 pressure:2 modest:2 others:2 device:2 article:1 rebounds:2 '':3 companies:2 trends:2 analysis:1 recession:2 deferred:2 a.m.:1 hips:2 published:2 medical-device:2 replacement:2
stock_ABT r_down	heart:5 because:3 associated:1 causes:1 disease:1 regulatory:2 stroke:3 suspended:2 market:2 use:1 said:4 not:1 should:3 attack:3 too:2 medicine:2 pill:3 strokes:1 diet:3 regulators:1 weight-loss:1 studies:1 authorities:2 death:1 great:2 --:3 amid:1 sale:1 drug:1 attacks:1 patients:1 risks:3 pulled:1 history:1
stock_ABT r_down	comment:1 heart:3 because:2 tough:1 probe:1 disease:1 10,000:1 regulatory:2 stroke:2 buy:1 suspended:2 its:1 unit:1 pharmaceutical:1 said:4 additional:1 working:1 been:1 should:4 attack:2 market:4 under:1 medicine:2 details:1 meeting:1 pill:2 too:2 week:1 suggested:1 them:1 extended:1 's:1 risk:1 drugs:1 company:1 after:1 diet:3 conglomerate:1 weight-loss:2 plan:1 sold:1 authorities:2 removed:1 11:3 10:1 great:2 antitrust:1 --:3 study:1 put:1 days:1 patients:1 products:2 risks:2 higher:1 pulled:1 medicines:1
stock_ABT r_down	partial:1 move:1 expects:1 trade:1 session:1 including:1 comments:1 year-earlier:1 its:2 impact:1 whose:1 group:1 $:4 expectations:1 failed:1 premarket:1 quarterly:3 include:1 2010:1 pending:1 earnings:9 modestly:1 updated:1 gains:2 overall:3 focus:2 background:1 fall:1 headwind:2 excluding:3 follows:1 companies:1 consensus:1 benefit:1 double:1 higher:1 upward:1 estimates:1 trends:2 81:1 special:1 said:2 missed:1 profit:3 jumped:1 shares:3 forecast:2 increase:3 various:1 above:1 got:2 falling:1 boost:2 after:1 recently:1 acquisition-related:2 reported:3 active:1 beginning:1 digits:1 reaction:1 quarter:2 items:2 larger:1 drug:3 products:2 analysts:3 published:1 maker:3 first:1 fourth-quarter:6 revenue:3 into:2 rising:3 unit:1 pharmaceutical:1 story:2 due:5 expected:2 today:1 flat:6 ``:1 drugs:1 share:2 company:2 corrected:1 but:1 slides:2 gain:1 analyst:1 11:14 showed:1 rival:1 up:3 devices:1 while:3 were:1 similar:1 acquisition:4 numbers:1 biotech:1 cents:2 certain:1 health-care:2 turned:2 sales:8 '':1 reports:4 accounting:1 eked:1 tailwind:2 details:1 fourth:1 a.m.:1 stock:1 's:5 see:1 price:1 arthritis:3 fueled:3 such:1 stocks:1 4.25:1 79:1 short:1 largely:1 charges:6 virtually:1 medical:1 roughly:3 executives:1
stock_ABT r_up	fourth-quarter:1 help:2 saying:1 domestic:1 sales:2 expectations:1 7.3:1 full-year:1 growth:1 4:1 throughout:1 its:1 declined:1 surprises:2 recorded:1 projected:1 advisories:2 charge:1 orthopedics:1 rates:1 earnings:3 6:1 details:1 struggling:1 impairment:1 more:1 's:2 business:2 some:1 company:2 overall:1 but:1 favorable:1 knee:1 quarters:1 roundup:1 grew:1 currency:2 spine:1 companies:1 reports:1 future:1 latest:1 corporate:1 replacement:1
stock_ABT r_up	billion:1 heart:1 end:1 $:1 pay:1 agreed:1 long-running:1 legal:1 stents:1 disputes:1 battles:1 hefty:1 over:1 patents:1 more:1
stock_ABT r_up	sector:1 heart:1 says:1 forecaster:2 money:2 into:2 newsletters:1 long-running:1 slowing:1 down:1 battles:1 still:1 technology:1 said:1 end:1 $:1 puts:2 pay:1 there:1 legal:1 health:3 editor:1 buys:1 over:1 more:1 good:1 though:1 hefty:1 rise:1 disputes:1 stocks:1 care:3 billion:1 would:1 consumer-discretionary:1 stents:1 tech:2 whole:1 patents:1
stock_ABT r_up	direct:1 say:1 together:1 reached:1 partner:1 its:2 market:1 said:3 asthma:1 working:1 been:1 application:3 treatment:1 new:1 has:2 marketing:1 company:3 transferring:1 immediately:1 now:1 why:1 --:1 could:1 transferred:1 drug:1 n't:2 did:1 responsibility:1
stock_ABT r_down	operations:2 fourth-quarter:2 narrower:1 period:1 unveiled:1 shake:1 narrowed:1 settlement:2 management:2 's:1 plans:1 big:2 but:2 streamline:2 shrank:1 despite:2 payment:1 posted:1 loss:2 charges:1 up:2 steps:1 shook:1 maker:2 medical-device:2 latest:1
stock_ABT r_up	firm:1 pharmaceutical:1 buy:1 's:1 business:1 provided:1 --:1 sold:1 testing:1 drug:1 conglomerate:1 cleared:1 fibrosis:1 unit:1 cystic:1
stock_ABT r_up	heart:1 hoped:1 financial:1 investors:2 his:1 relieve:1 competitive:1 one:2 challenges:1 patience:1 growth:1 tiny:1 year:1 ship:1 its:1 decade:1 annually:1 slow:1 remains:1 top:1 device-maker:1 long:1 improvement:1 tight:1 going:1 take:1 medicine:1 include:1 markets:1 sliding:1 overcome:1 shows:1 product:1 used:1 's:6 plans:1 analysts:1 company:1 million:1 forecasts:1 most:1 restructuring:1 orthopedic:1 prices:1 implanted:1 running:1 former:1 last:1 pressure:1 soft:1 metal:1 joined:1 devices:1 n't:2 common:1 time:1 fresh:1 problem:1 heart-device:1 tubes:1 road:1
stock_ABT r_up	pharmaceutical:1 buy:1 20:3 --:1 company:1 have:1 offered:1 unit:1 more:1
stock_ABT r_up	comment:1 biotech:2 outlook:2 saying:2 expects:2 existing:2 expect:2 growth:1 optimistic:2 our:2 swung:1 its:2 '':2 said:3 adds:1 analyst:1 underestimate:1 due:2 legal:2 grow:2 charge:2 potential:1 details:1 fourth:2 net:2 2010:8 more:2 ``:2 continues:1 's:1 statement:2 business:2 10:4 earnings:1 company:3 rise:2 but:2 sales:2 driven:2 4th:1 than:2 positively:2 posted:1 loss:2 --:2 fourth-quarter:1 drug:3 flagship:2 continue:2 figures:1 management:1 quarter:3 view:2
stock_ABT r_down	comment:1 heart:5 marketed:2 campaign:1 reviewing:3 settlements:1 some:1 together:1 competition:1 system:1 '':2 against:1 another:3 portfolio:1 p.m.:1 data:3 its:1 unit:2 risk:1 pharmaceutical:1 given:3 said:4 adds:1 combination:3 suggests:2 generic:3 leading:2 agency:1 two:1 dismissed:1 makers:1 delay:1 may:1 version:1 treat:1 statement:1 clinical:3 postpone:1 has:1 cause:3 correct:1 ``:2 used:1 's:3 increased:1 parent:1 drugs:2 company:1 designed:1 problems:3 needs:1 setback:1 judge:1 using:1 stocks:1 lawsuit:1 suggest:1 patent:1 last:1 rhythms:1 irregular:1 antitrust:1 --:3 follows:1 could:3 alleging:1 drug:8 believes:1 probe:1 trial:1 patients:1 ongoing:1 ruling:1 published:1 entry:1 first:1
stock_ABT r_up	campaign:1 settlements:1 competition:1 against:1 second:1 comments:1 parties:1 its:1 unit:1 pharmaceutical:1 generic:3 leading:1 dismissed:1 makers:1 delay:1 details:1 postpone:1 has:1 's:1 drugs:1 setback:1 background:1 judge:1 lawsuit:1 case:1 patent:1 antitrust:1 --:1 alleging:1 drug:2 trial:1 ongoing:1 ruling:1 entry:1 starting:1
stock_ABT r_up	heart:1 stent:1 findings:2 people:1 float:1 share:1 results:1 brain:2 persuade:1 eligible:1 surgery:1 open:1 their:1 if:1 widely:1 different:2 arteries:5 just:1 puts:1 become:1 rather:2 removing:2 make:1 comments:1 prop:1 may:1 causing:3 details:1 which:1 instead:1 main:1 more:3 opt:1 risk:3 strokes:4 price:1 each:1 stop:2 break:1 putting:2 procedure:1 fresh:1 10-year:1 than:2 like:1 reimbursement:1 off:1 neck:4 whether:2 study:2 having:1 metal:3 side:1 large:2 stents:3 patients:2 officials:1 can:2 leaves:1 published:1 arrived:2 clogged:1 studies:2 medical:2 plaque:4
stock_ABT r_up	comment:1 biotech:4 relevant:3 background:1 investors:1 show:3 crushing:2 sales:4 billions:1 detail:1 high:1 known:3 examined:2 lung:3 still:1 its:5 market:1 said:6 based:3 appear:1 area:1 perform:1 deadly:3 writes:1 had:1 patients:3 shares:1 improvement:3 failed:2 other:1 treat:3 which:1 new:1 poised:1 has:1 fibrosis:3 momentum:2 treatment:1 development:3 eventually:3 play:2 's:4 company:6 potential:2 tackle:1 goals:2 key:3 altogether:2 hopes:3 news:1 analyst:1 strategies:1 disappointing:1 pipeline:1 several:1 assets:1 --:3 double:3 could:1 well:2 disease:3 drug:8 worth:1 n't:3 did:3 slide:1 indication:2 can:1 shelve:3 believed:1 meet:2 study:2
stock_ABT r_up	treating:1 use:1 used:1 's:6 combination:1 cancer:1 --:1 arthritis:1 patients:1 drug:1 standard:1 recommended:1 treatment:1 disease:1 rheumatoid:1
stock_ABT r_down	whose:1 conventional:1 's:6 people:1 --:1 sold:1 responded:1 tolerate:1 severe:1 drug:1 disease:1 active:1 recommended:1 not:2 therapy:1 treatment:1 known:1 has:1 options:1 condition:1 can:1
stock_ABT r_up	comment:1 wants:1 walking:2 trades:2 suitors:1 deal:2 focus:2 setback:1 trade:1 down:2 see:1 session:1 send:2 firm:1 year:2 partner:2 its:2 whose:1 said:1 stood:1 $:7 since:1 had:1 while:1 shares:3 late:2 rejecting:1 finally:2 been:1 which:1 expected:1 soar:1 development:2 product:2 after:2 's:6 offer:1 nod:1 company:1 million:2 agreement:1 60:1 bulk:2 drug:1 active:1 rare:1 buyout:1 than:1 panel:1 treating:1 aisle:2 pipeline:2 potential:1 last:3 takes:1 --:1 light:2 rebuffed:2 companies:1 up:4 disease:1 information:1 overtures:2 722:6 receives:1 more:2 approval:1
stock_ABT r_up	sector:1 one-year:2 focus:5 7.2:1 held:1 session:3 thanks:1 its:2 rundown:1 whose:3 $:2 merger:3 rose:3 guidance:1 had:1 outside:2 only:1 cling:2 follows:1 companies:3 morning:1 securities:1 overtures:1 18:1 higher:2 development:1 financial:1 deal:1 actively:3 trading:3 sight:1 's:3 2.6:1 gainers:1 shares:3 forecast:2 3:2 version:1 7:1 722:1 correct:1 indecisive:1 led:1 million:1 news:3 declining:2 pipeline:1 rebuffed:1 range:4 a.m.:1 mixed:2 major:1 market:1 little:2 top:1 due:2 start:1 2:1 biggest:2 markets:1 500:3 ``:1 offering:1 successful:1 bulk:1 prices:2 hold:1 11:1 13:2 wholesale:2 up:1 economic:1 stories:1 were:3 following:1 futures:5 investors:1 '':1 partner:1 rally:1 sell:1 run-up:2 tight:4 inventory:2 which:2 stock:6 gaining:2 product:1 added:4 edged:1 may:1 after:1 depths:1 fell:2 stocks:5 data:3 billion:1 assets:1 third:1 later:2 daily:1 depth:1 points:9 decliners:1
stock_ABT r_up	sector:1 0.8:1 financial:1 quarters:1 saying:1 acquired:1 days:1 60:1 second:1 added:1 trading:3 reports:1 rally:1 close:1 makers:1 index:1 stocks:6 actively:1 investors:2 lead:2 securities:1 rose:4 since:1 thanks:1 led:1 shares:1 its:1 advisories:2 session:1 4:2 which:1 consecutive:1 north:2 500:1 earnings:1 bets:1 billion:1 2.95:1 good:1 's:4 offering:1 get:1 successful:1 bid:2 after-hours:1 shoot:1 early:1 banks:2 eight:1 gain:2 they:1 not:1 2:1 highest:1 day:1 $:1 roundup:1 both:1 whose:1 whether:1 edge:1 future:1 30:1 companies:3 up:4 drug:3 investment:1 2000:1 points:4 surprises:2 small:1 2008:1 higher:1 corporate:1 straight:1 latest:1
stock_ABT r_down	rating:1 oncology:1 perch:1 being:1 move:2 session:2 6.3:1 its:1 ground:2 whose:2 cut:1 $:2 candidate:1 hit:1 risk:1 early:1 fall:1 disturb:1 like:2 lost:1 --:1 companies:3 cholesterol:1 speculation:1 economically:1 says:1 smooth:1 back:1 actively:2 trading:2 2.2:1 2.6:1 shares:6 increase:1 3:2 new:1 announced:1 led:1 lose:1 conglomerate:2 takeover:1 downgrade:2 news:1 strong:1 stage:1 could:1 drug:3 sensitive:1 products:3 analysts:1 mixed:1 retail:1 major:1 slipped:2 1.6:1 one:1 down:2 another:1 path:1 drove:1 market:1 conference:1 weekend:1 two:1 their:1 2:1 clinical:1 500:2 company:2 but:2 eyed:1 hold:1 analyst:2 high:1 edged:1 up:1 pace:1 were:3 heart:1 slid:3 investors:1 sales:1 disappointing:1 all-time:1 sell:1 veteran:1 also:1 take:1 tool:1 stock:1 week:1 's:2 after:1 most:1 fell:1 stocks:4 data:1 lower:4 center:1 medical:2 points:5 biotechnology:1 pulled:1
stock_ABT r_up	clog:1 examining:2 locations:1 against:1 artery:3 find:1 psoriatic:1 impact:2 arteries:2 $:1 conclusions:1 stent:7 show:2 failed:2 bypass:3 continued:2 has:1 first:1 do:2 risk:2 big:1 survival:2 practice:1 using:1 procedures:5 treating:1 regarding:1 like:1 progressive:1 --:6 fewer:1 chamber:2 recommendations:1 prevent:1 smaller:1 significantly:1 reduce:1 likely:1 added:1 design:1 year:1 surgery:3 medication:1 said:2 lead:1 review:1 crucial:2 while:2 version:1 new:4 arthritis:2 patient:2 healthcare:1 cholesterol:1 pumping:2 approaches:1 protection:1 active:1 article:1 change:1 improve:2 world:1 getting:1 attacks:3 study:8 annual:1 funded:1 according:1 drug:4 trial:1 a.m.:1 drug-coated:3 published:2 passing:1 narrow:1 studies:1 blood:1 among:2 major:1 question:1 two:1 well-known:1 addressed:1 diabetics:1 carry:1 watchdog:1 adults:1 conference:1 cost-effectiveness:1 1.3:1 anti-clotting:1 negative:1 tiny:1 fight:1 plain:1 combined:1 care:1 more:4 main:3 ``:4 treat:1 clots:1 but:5 hurt:1 released:2 link:1 newer:2 catch:1 than:2 made:1 sheds:1 showed:2 versions:1 18:1 cells:1 choices:1 n't:2 placed:2 patients:4 can:3 were:1 strategies:1 outcome:1 similar:2 could:1 pick:1 heart:10 addressing:1 months:1 have:2 deaths:1 well:1 sales:2 '':4 death:1 tissue:1 performed:1 follow-up:1 scar:1 greater:2 no:1 rather:1 deadly:1 also:3 recommended:1 potentially:1 which:2 bare-metal:1 fuels:2 repeat:1 's:14 strokes:1 after:1 outperformed:1 stay:1 less:1 designed:1 device:1 data:4 efforts:1 diabetes:2 billion:1 older:1 light:1 odds:2 metal:2 disease:1 analysis:1 uncovered:1 stents:6 dangerous:1 time:1 2009:1 researchers:1 left:1
stock_ABT r_down	years:1 still:1 its:1 giant:1 arteries:1 $:2 4:1 usage:1 his:1 increased:1 rebound:1 half:1 now:1 procedures:1 --:1 courses:1 thinners:1 likely:1 devices:2 year:1 further:1 makers:1 lead:1 away:1 while:1 prop:1 7:3 can:2 reaching:1 million:1 notable:1 bumps:1 base:1 awards:2 regulatory:1 generate:1 change:1 arrive:1 last:1 could:1 according:1 drug:1 patients:1 drug-coated:1 slightly:1 72:1 already:1 long:1 carry:1 total:1 open:1 market:1 use:1 tiny:1 their:1 until:1 more:1 billion:1 drugs:1 but:1 newer:2 he:1 value:2 compensation:1 limit:1 risks:1 were:1 define:1 heart:1 costly:1 sales:1 evidence:1 tissue:1 slip:1 slumped:1 seen:1 scar:1 saw:1 requirements:1 medical-devices:1 take:1 which:1 stock:1 repeat:1 's:4 combat:1 may:1 blood:1 salary:1 stents:2 pension:1 2008:1 2009:2 pulled:1 filing:1
stock_ABT r_down	badly:1 hurting:1 democracy:1 stockholders:1 whatever:1 else:1 n't:1 overseas:1 does:1 call:1 too:1 want:1 social:1 you:1 seem:1
stock_ABT r_up	sector:1 biotech:1 controversial:1 deal:2 health-care:1 see:2 another:1 vote:2 's:1 agrees:1 cut:2 overhaul:1 sit:1 board:3 funds:1 best-performing:1 dramatically:1 appointment:1 billionaire:1 approves:1 after:3 designated:1 appointments:2 stocks:1 tracking:1 industry:1 bill:1 bellwether:1 directors:1 action:2
stock_ABT r_up	bill:1 ripe:1 investors:1 reform:1 peril:1 health-care:1 approving:1 potential:1 sweeping:1 face:1 landscape:1
stock_ABT r_down	pharmaceutical:1 promises:1 citizens:1 run:1 big:1 industry:1 health-care:1 legislation:1 drug:1 also:1 benefit:1 long:1 cuts:1 senior:1 bills:1 could:1
stock_ABT r_down	huge:1 promises:1 run:1 pharmaceutical:1 --:1 industry:1 citizens:1 legislation:1 benefit:1 drug:1 also:1 savings:1 health:1 long:1 passed:1 senior:1 bills:1 could:1 care:1
stock_ABT r_up	already:1 proposed:1 issued:1 '':1 acid:1 market:1 information:1 two:1 asking:1 declined:1 which:1 new:1 sent:1 more:1 ``:1 's:2 complete:2 combination:2 pharmaceutical:1 drugs:1 company:1 delayed:1 letter:2 response:2 --:1 companies:1 drug:2 separately:1 announced:1 cholesterol:2 release:1 approve:1
stock_ABT r_up	forced:1 because:1 business:1 nutrition:1 some:1 sale:1 been:1 its:2 drug:1 lenders:1 abandon:1 overseas:1 has:1 maker:1 dispute:1
stock_ABT r_down	2000:2
stock_ABT r_down	because:1 agreed:1 nutritional:1 sales:1 175:3 its:4 issues:1 sell:1 forced:1 confirmed:1 cut:1 been:1 spokesman:1 has:2 resources:1 dispute:1 nutrition:1 earlier:1 business:3 pharmaceutical:1 some:2 company:1 after:1 restructuring:1 shifting:1 representative:1 lenders:2 not:1 debt:1 resolve:1 --:2 positions:1 failing:1 sale:1 drug:2 while:1 abandon:1 overseas:1 maker:2
stock_ABT r_up	because:1 ordered:1 over:1 within:1 some:1 one:1 have:1 ready:1 's:2 appetite:1 its:2 anti-obesity:1 improperly:1 deals:1 no:1 federal:1 nervous:1 marketed:1 system:1 been:1 looking:1 affecting:1 new:1 email:1 probe:1 executive:1 patient:1 prosecutors:1 drugs:3 company:1 hand:1 dampen:1 part:1 judge:1 approval:1 expand:1 he:1 central:1 longer:1 --:1 into:1 work:1 messages:1 submitted:1 large:1 whether:1 chief:1 diagnostics:1
stock_ABT r_down	saying:1 results:3 quarters:1 ended:1 session:1 its:2 whose:1 buyers:1 overhaul:1 headline:1 surprises:2 advisories:2 clipped:1 2010:2 earnings:7 gains:2 health-overhaul:1 focus:2 nearly:1 background:1 new:1 trade:1 retreat:1 follows:1 companies:4 higher:3 because:1 financial:1 some:1 see:1 first-quarter:1 adds:1 profit:1 shares:2 forecast:1 attracted:1 version:1 7.86:3 newly:1 correct:1 reported:1 active:1 strong:1 roundup:1 31:1 30:6 reports:1 a.m.:1 rose:1 mixed:1 slightly:1 first:1 among:1 outlook:1 industrial:1 nutritional:1 due:1 decrease:1 throughout:1 decline:1 industrials:1 legislation:1 two:1 expected:1 ``:1 partly:1 drugs:1 company:1 but:1 lowered:2 pre-market:1 '':1 15:1 solid:1 up:1 devices:1 while:1 future:1 0.1:1 health-care:3 sales:1 helped:2 pushed:2 full-year:1 dropped:1 technology:1 indexes:1 points:1 details:1 products:1 stock:2 's:2 though:1 price:1 reflect:1 fell:1 stocks:4 recent:1 6th:1 medical:1 edge:1 push:1 2009:5 corporate:1 profits:1 latest:1
stock_ABT r_down	financial:1 revenue:2 declines:1 drug:3 accounting:1 's:1 issues:1 developer:1 lead:2 profit:3 due:1 shares:1 forecast:1 2010:1 higher:2 led:1 hefty:1 company:1 after:1 reported:1 weaker-than-expected:1 gain:1 fall:1 stocks:3 lower:2 2009:1 reports:2 morning:1 activity:1 quarter:1 south:3
stock_ABT r_up	nutritional:1 sales:1 manager:1 dropped:1 home:3 partly:1 forecast:1 data:1 investment:1 fifth:1 giant:1 software:1 overhaul:1 lead:1 rose:1 housing:1 legislation:1 due:1 comments:1 its:1 rally:1 health:1 earnings:2 online:1 upbeat:1 technology:1 company:1 stock:1 led:2 first-quarter:1 gains:1 rebounding:1 drugs:1 weakness:1 price:1 earlier:1 seventh:1 results:1 reflect:1 lowered:1 retailer:1 updates:1 end:2 stocks:3 beginning:1 eighth:1 nearly:1 recent:1 reaction:1 15:1 ahead:1 solid:1 builders:3 medical:1 30:3 full-year:1 devices:1 2010:1 turn:1 while:1 products:1 '09:2 shares:1 higher:3 slightly:1 executives:1
stock_ABT r_down	just:1 baby:1 cure:1 linked:1 synthetic:1 develop:1 rather:1 administration:1 milk:1 symptoms:1 genetic:1 crackdown:1 eliminate:1 widely:1 formula:1 conditions:1 hope:1 treat:1 's:3 continuing:1 ulcerative:1 moving:1 focusing:1 than:1 colitis:1 organic:2 like:1 industry:1 disease:1 found:1 its:1
stock_ABT r_up	's:1 rose:1 company:1 51:1 n't:2 earnings:1 season:1 flu:1 quarter:1 cites:1 first:1
stock_ABT r_up	style:1 widows:1 just:1 investors:1 orphans:1 back:1 juice:2 returns:2 coming:1 not:1 dividend:2 more:1 they’re:1 any:1 best:2 strategies:2
stock_ABT r_down	heart:2 major:1 cancer:2 into:1 sales:1 see:2 hormone:1 names:1 year:1 terms:1 saw:1 if:2 information:1 group:1 additional:1 players:1 data:1 review:2 increase:2 strokes:2 safety:2 treat:2 which:1 under:1 include:1 company:1 brand:1 shows:1 used:2 's:4 risk:2 drugs:3 sixth:1 sold:1 largest:1 treatments:2 reshuffle:1 most:1 recent:1 fall:1 known:1 world:1 prostate:2 class:1 diabetes:2 conducting:2 15:1 --:3 industry:1 drug:1 attacks:2 products:1 2009:3 starting:1 top:1 mergers:1
stock_ABT r_down	stocks:1 only:1 reform:1 some:1 up:1 shares:1 ended:1 3:2 attractive:1 making:1 has:1 quality:1 more:1
stock_ABT r_down	emerging:2 financial:1 help:1 cancer:1 supply:1 into:1 move:1 number:1 '':2 growth:1 licensing:1 pain:1 its:1 quicken:1 pharmaceutical:1 said:1 presence:1 least:1 also:1 add:1 version:1 disclosed:1 which:3 cardiovascular:1 a.m.:1 entered:1 has:2 markets:2 correct:1 more:1 ``:2 terms:1 option:1 company:1 were:1 agreement:3 includes:1 gain:2 strong:1 than:1 15:1 14:1 rights:2 follows:1 medicines:1 drug:1 collaboration:1 n't:1 pace:1 products:3 published:1 growing:1 40:1 maker:1 medical-device:1 diseases:1
stock_ABT r_down	heart:1 emerging:2 least:1 pharmaceutical:1 deal:1 supply:1 some:1 expects:1 licensing:1 its:2 24:1 access:1 said:4 generic:1 give:1 two:1 comments:2 better:1 also:1 version:1 details:1 which:1 late:1 new:1 markets:2 company:1 stock:1 updated:1 's:3 schedule:1 drugs:1 share:1 price:2 reach:1 agreement:1 includes:1 gain:1 background:1 device:1 approval:1 analyst:1 received:1 15:1 countries:1 --:2 rights:1 companies:1 devices:1 stents:1 patients:1 products:1 drug-coated:1 chairman:2 clearance:1 other:1
stock_ABT r_up	sector:2 emerging:7 since:1 background:2 among:1 agreed:6 global:1 cheap:1 all:1 rest:1 trade:2 four:2 session:4 through:4 comments:3 go:1 followed:1 research:1 its:8 ground:1 patent:1 $:23 headline:1 rose:2 had:1 follows:1 source:1 setting:1 400:2 added:1 8:3 weeks:1 include:2 2011:1 2010:2 sent:4 chairman:1 division:2 over:5 4.5:1 hit:3 increased:3 foresee:1 government:1 domestic:3 6:1 rise:1 boosting:1 anticipated:1 early:3 worst:1 updates:1 they:3 formula:1 not:1 2:1 years:3 bringing:2 name:1 like:1 lost:1 --:3 biotechs:1 drop:3 companies:2 fewer:1 morning:1 deals:3 did:1 payments:1 definitive:1 18:1 worries:7 including:2 grab:1 '10:2 mergers:1 solutions:1 enjoy:1 bankruptcies:1 because:2 financial:3 version:1 deal:7 series:4 globe:3 back:1 competition:3 economies:2 3.6:1 3.7:6 3.4:1 economic:8 result:1 year:1 home:3 development:1 makers:6 declined:2 out:1 annually:2 said:4 gainers:1 extend:1 3rd:1 has:3 transactions:1 artificial:1 forecast:1 looking:4 pounding:4 difficulties:1 health:1 market:3 generics:1 new:4 budget:1 dominate:1 across:3 announced:2 ends:1 thrust:1 terms:1 business:7 wo:1 spot:1 payment:1 million:2 weak:3 agreement:1 blockbusters:2 conglomerate:1 difficulty:2 base:1 acquisitions:1 upfront:1 put:2 news:2 100:3 forecasts:1 beginning:2 speculation:1 reaction:1 almost:1 cautious:1 anything:1 pressure:2 many:1 modest:2 drug:12 costs:1 strains:1 range:3 products:2 stand:1 leading:1 identify:1 maker:3 clamp:1 outlook:1 tough:2 presence:5 into:6 address:1 period:1 private:1 down:2 regulatory:3 phones:1 equity:1 total:1 unit:4 conference:1 pharmaceutical:3 debt:3 their:7 spending:1 data:3 throws:1 system:1 been:2 next:2 pharmaceuticals:1 station:1 call:1 stock:7 which:4 biggest:1 flexible:1 branded:3 markets:10 9.1:1 500:3 more:2 flat:3 ``:2 buy:8 growth:4 programs:1 drugs:8 turned:1 company:6 acquire:2 agrees:1 39:1 but:1 founders:1 part:1 related:1 solar-powered:1 analyst:2 assets:3 past:1 financing:1 valued:3 ahead:1 solid:2 55:1 cap:2 cash:1 signed:1 n't:4 gathers:1 correct:1 bill:2 were:1 country:1 spotlight:2 investors:2 up:1 strengthen:4 expanding:1 correction:4 share:2 few:1 days:1 '':2 dropped:2 have:2 further:2 close:1 rally:1 spooked:1 work:1 gains:4 sell:4 capture:1 speakers:1 blockbuster:1 combination:3 territory:3 generic:9 pay:1 make:1 seeking:1 sidelined:1 shares:2 winners:1 details:1 fourth:1 weakness:1 plus:1 3.9:1 tool:1 higher:3 week:2 tumbled:3 analysts:1 's:22 plans:1 though:2 may:1 price:1 after:6 reach:1 persist:4 hand:1 fast-growing:1 fell:5 eight:1 previous:4 such:2 stocks:5 flourish:1 concerns:3 billion:12 lower:2 land:1 off:1 15.5:1 largely:3 mobile:1 futures:13 disease:1 face:3 bashing:2 chief:1 points:10 healthcare:2 2009:2 notion:1 latest:4
stock_ABT r_up	have:1 deal:1 soon:1 offer:1 investors:1 issues:1 size:1 sell:2 little:1 said:2 adds:1 $:1 bonds:1 late:1 3:1 parts:2 too:1 which:2 taken:2 new:1 has:2 three-part:2 unsecured:2 high-grade:1 buy:2 recently:2 plans:2 offering:3 seeking:1 very:1 big:2 benchmark-sized:2 billion:1 none:1 level:1 --:2 notes:2 launch:1 steps:2 found:1 senior:2 comes:1
stock_ABT r_down	since:1 just:1 heavily:1 results:1 month:1 find:1 causes:2 high-grade:1 $:9 late:1 parts:2 those:1 under:1 8:1 has:3 indicating:1 risk:1 combination:1 seeking:1 very:1 big:3 soon:1 break:1 bookrunners:1 milestone:1 investor:1 day:1 bank:1 countries:1 --:3 follows:1 notes:1 companies:1 benefit:1 steps:1 worries:1 found:1 unsecured:1 heavy:1 set:1 woes:1 second:1 recently:1 surgery:2 out:1 blue:1 index:2 said:5 adds:1 tensions:1 review:1 valve:2 patients:3 3:2 health:1 dominated:1 issues:1 quote:1 new:3 terms:1 benchmark-sized:1 sold:2 million:2 agreement:1 active:1 100:1 debt:2 received:1 last:1 license:1 taking:1 losses:1 drug:1 comes:1 first:1 among:2 major:2 via:1 supply:1 lending:1 little:1 investors:1 three:1 mark:1 few:1 too:1 taken:1 themselves:1 leaky:2 markets:2 500:1 ``:1 buy:1 offering:3 offer:1 company:1 priced:1 part:1 buying:1 10:3 none:1 showed:2 these:1 signed:1 below:1 could:1 closing:1 similar:2 study:2 heart:2 clip:2 chip:1 '':1 10,000:2 dropped:2 have:1 sell:1 again:1 different:2 suggest:1 bonds:1 40:1 swath:1 other:1 slammed:1 which:1 performance:2 really:1 three-part:1 tool:1 stock:2 bets:1 's:2 plans:1 broad:1 earlier:1 problems:2 fell:1 designed:2 device:2 data:2 payment:1 billion:2 futures:3 together:2 without:2 looked:1 points:3 time:3 banks:1 senior:1 valves:2
stock_ABT r_down	among:1 provided:1 terms:1 information:1 were:1 manager:1 offerings:1 syndicate:1 capital:1 following:1 based:1 markets:1 recent:1
stock_ABT r_up	whose:1 's:1 companies:1 focus:2 shares:1 active:1 see:1 session:1 trading:1 expected:1
stock_ABT r_down	heart:1 major:1 sampling:1 been:1 value:1 surgery:1 2.7:1 internal:1 viewed:1 out:2 documents:1 but:1 $:3 working:1 valves:1 remains:1 drug-company:1 top:1 handed:1 3:1 interested:1 unit:1 samples:2 has:1 gave:2 development:1 do:1 program:1 's:3 million:2 free:1 said:1 240:1 doctors:1 replacement:1 data:1 billion:2 valued:1 --:1 medicines:1 official:1 according:2 drug:2 n't:4 while:1 2007:2 making:1 heart-device:1 require:1 first:1
stock_ABT r_down	emerging:2 help:1 over:2 focus:2 years:2 6.2:1 7.5:1 its:6 before:1 24:1 adding:1 giant:1 $:3 rose:1 revenue:1 better:1 citing:1 attractive:2 premarket:1 5:2 has:2 2011:1 combination:1 five:2 half:1 --:2 tumors:1 team:1 found:1 view:1 financial:1 people:1 estimates:1 see:1 begun:1 said:3 jumped:1 spokesman:1 shares:3 current:1 above:1 approach:1 business:1 opening:1 broker:1 constructive:1 regulatory:1 article:1 downgraded:1 pharma:1 roundup:1 pipeline:2 study:1 changed:1 drug:5 trial:1 published:1 action:1 promotion:2 maker:1 experimental:1 first:1 upgraded:2 bell:1 strategic:2 simply:1 news:1 live:1 catalysts:1 submit:1 next:2 genetic:1 clinical:1 certain:1 markets:2 more:1 ``:5 buy:3 drugs:2 neutral:3 approval:1 than:1 novel:1 double:2 patients:1 can:1 making:2 margin:1 0.8:1 larger:1 sees:1 expanding:2 sales:2 '':5 if:1 breaking:1 lung-cancer:1 also:1 intends:1 potential:1 potentially:3 profile:1 's:2 plans:2 track:1 after:1 fell:1 shrank:1 risk/reward:2 meaningful:1 recent:1 acquisitions:2 longer:1 drive:1 upside:2
stock_ABT r_up	upgraded:1 rating:1 slid:3 1.7:1 sees:2 results:1 60:1 ended:1 actively:3 trading:3 3.3:1 rally:1 recently:2 positive:1 skin-cancer:1 whose:3 22:1 4.2:1 rose:3 shares:6 their:1 points:9 7:1 500:3 buy:1 's:5 increased:3 after-hours:1 but:3 wake:1 stocks:3 12:2 companies:3 drug:1 trial:1 session:3 upside:2 analysts:1 were:2 mixed:3
stock_ABT r_up	because:1 busts:1 issued:1 global:1 find:1 infections:1 years:1 produced:1 attempts:1 1.7:1 pulling:1 something:2 have:1 linked:1 market:1 eye:1 $:1 learn:1 rose:1 disease:1 long:1 makers:1 finally:1 version:1 unit:1 way:1 under:1 scant:1 new:1 damaging:1 giants:1 then:1 's:3 string:1 views:1 broad:1 after:2 treatments:1 results:1 launching:1 midst:1 eye-care:1 effort:1 relying:1 those:1 billion:1 both:1 developing:1 medicines:1 older:1 companies:1 solution:1 analysts:1 positive:1 failures:1
stock_ABT r_up	help:2 caused:1 agreed:2 results:1 month:1 ended:1 6.5:1 session:2 through:1 its:1 announcement:1 $:6 rose:1 4:1 8:1 has:1 gains:1 break:1 200-day:1 2:1 lost:1 follows:1 companies:2 50:1 worries:1 deal:3 euro-zone:1 actively:2 trading:2 index:1 televised:1 sentiment:1 bailout:1 million:2 address:1 100:1 manufacturing:1 last:1 spill:1 study:1 losses:1 drug:1 pick:1 traded:2 slipped:1 point:2 575:4 strong:1 positive:1 much:2 9.5:1 500:4 treatment:2 mostly:1 but:1 part:2 stabilizing:1 15:1 bellwether:1 up:2 toward:1 spotlight:1 slid:1 0.4:1 again:1 develop:2 pay:2 40:1 1:2 stock:1 extended:1 's:3 earlier:1 nationally:1 helping:1 fell:6 moving:1 cleaning:1 improving:1 oil:1 stocks:3 data:2 lower:2 average:1 futures:4 2000:1 points:8
stock_ABT r_down	major:1 actively:1 trading:1 market:1 rundown:1 4.7:1 gainers:1 rose:1 biggest:2 500:1 stock:1 gaining:2 's:3 fell:1 stocks:3 declining:2 session:1 grew:1 companies:1 daily:1 points:1 after-hours:1 mixed:1 decliners:1 traded:1
stock_ABT r_down	replace:1 year:1 said:1 850:1 $:6 pay:1 due:1 next:1 1.75:1 3:1 closed:1 has:1 expires:1 million:2 900:1 line:1 come:1 billion:2 financing:1 notes:1 cash:1 three-year:1 fresh:1
stock_ABT r_down	comment:1 advisers:1 '':1 bring:1 likely:1 determine:1 further:1 its:2 developer:1 blow:1 said:3 asthma:1 working:1 perform:1 trials:1 there:1 detail:1 whether:1 clinical:1 low:1 way:1 before:1 new:1 dealt:1 final:1 launching:1 treatment:1 ``:1 's:1 company:1 after:1 forward:1 fell:1 significant:1 hopes:1 approval:1 now:1 analyst:1 must:1 --:1 drug:1 viable:1 considered:1 can:1 were:1
stock_ABT r_down	tech-savvy:1 kind:1 's:2 also:1 big:2 hospital:3 up:1 standards:1 bring:1 while:1 does:1 take:1 sets:1 technology:3 bet:2 apart:1
stock_ABT r_up	have:1 deal:2 people:2 years:1 picked:2 run:1 its:2 unit:2 out:1 pharmaceutical:2 said:2 $:2 least:1 only:1 dividends:1 worth:2 10:1 's:2 increased:1 business:2 seeking:2 familiar:2 million:2 fund:1 eight:1 buyer:2 recent:2 purchase:2 could:2 companies:1 up:2 matter:2 invests:1
stock_ABT r_down	have:2 deal:1 people:1 profitability:2 manager:2 picked:1 its:1 unit:1 pharmaceutical:1 said:1 $:1 only:2 behind:2 decade:2 buys:2 worth:1 them:2 's:1 business:1 seeking:1 familiar:1 million:1 buyer:1 stocks:2 recent:1 purchase:1 solid:2 could:1 up:1 matter:1
stock_ABT r_up	2008:1 slow:2 financial:1 since:1 companies:1 earlier:1 fears:2 sales:3 revive:2 quarterly:1 crisis:1 corporate:1 tapping:1 peak:1 year:1 biggest:1 drop:1 investor:2 borrowing:1 market:1 bond:4
stock_ABT r_down	1.1:4 departing:1 over:1 executive:1 accept:2 interim:3 year:1 run:3 unit:3 take:1 announcement:1 said:2 $:4 basis:3 retiring:2 top:4 since:1 shares:2 pharmaceuticals:3 disclosed:1 's:9 details:1 firm:2 head:3 retire:1 return:1 elsewhere:2 business:3 pharmaceutical:1 big:2 company:5 spot:1 regulatory:1 president:1 returning:2 opportunity:2 former:3 30,000:2 last:1 vice:1 official:3 drug:2 filing:1 more:2 products:1 bought:2 maker:1 medical-device:2
stock_ABT r_up	roundup:1 private-equity:1 's:1 related:1 morning:1 news:1
stock_ABT r_up	investors:1 over:1 global:1 domestic:1 month:1 economic:1 second-straight:1 recovery:1 top:1 concerns:1 health:1 drawn:1 markets:1 stock:1 funds:1 defensive:1 focusing:1 volatile:1 care:1 goods:1 sectors:1 performers:1 amid:1 pace:1 were:2 growing:1 consumer:1
stock_ABT r_down	prevent:1 antibodies:3 human:1 cells:1 they:1 two:1 identified:1 discovered:2 strains:1 can:1 have:1 scientists:1 known:1 90:1 believe:1 announced:1
stock_ABT r_down	comment:1 deal:6 share:1 heating:4 throughout:1 its:4 market:5 bolster:4 marking:4 said:4 $:10 comments:1 analyst:2 details:1 plans:4 million:4 seventh:1 eight:1 updates:1 prices:1 appears:4 buying:4 480:4 up:4 value:1 competitors:1 products:4 five:1 lineup:4 latest:4
stock_ABT r_up	saying:1 double-digit:1 another:1 investors:1 biotech:1 sales:1 offset:1 focus:2 quarters:1 heavyweight:1 growth:1 drug:2 slip:2 stronger-than-expected:1 its:1 buoyed:1 said:1 surprises:2 revenue:1 flat:1 advisories:2 earnings:5 quarterly:1 lower-than-expected:1 brace:1 stock:1 modestly:1 's:1 after:1 results:1 falls:2 early:1 reported:1 were:1 barrage:1 gain:1 fall:1 report:2 stocks:2 day:1 roundup:1 futures:1 companies:1 reports:2 costs:1 future:1 testimony:1 action:1 corporate:1 acquisition:1 latest:1
stock_ABT r_up	operations:1 advisory:3 show:3 results:1 years:1 including:1 questions:1 its:2 adding:1 1.14:1 $:2 rose:1 should:2 failed:1 has:2 earnings:3 string:1 expectation:1 breast:2 fall:1 advanced:1 --:2 did:1 benefit:2 continue:1 indication:1 higher:1 series:1 growth:1 trading:1 second-quarter:4 thinks:1 2.4:1 offsetting:1 adds:1 bottom:1 profit:1 review:1 marketed:1 shares:1 looking:1 reported:1 regulatory:1 panel:5 reaction:1 quarter:1 drug:2 products:1 studies:3 asked:1 cancer:4 revenue:1 down:1 another:1 vote:2 considering:1 pharmaceutical:2 use:1 additional:1 two:1 been:1 clinical:2 chemotherapy:1 flat:4 company:1 gain:1 line:1 removed:1 analyst:1 those:1 disappointing:1 made:1 whether:1 18:1 up:1 devices:1 n't:1 patients:1 acquisition:2 certain:1 health-care:2 sales:1 expenses:1 weighed:1 experts:1 reports:2 accounting:1 increased:1 information:1 variety:1 makers:1 build:1 several:1 stock:1 's:4 price:1 after:1 drag:2 said:2 device:2 stocks:3 recent:2 acquisitions:1 lower:3 longer:1 charges:1 virtually:1 medical:2 costs:1 2009:1 dragged:1
stock_ABT r_down	operations:1 agreed:1 results:1 years:1 ended:1 portfolio:1 its:3 fifth:1 $:2 rose:1 facility:1 second-quarter:2 better:1 systems:3 violations:2 has:1 earnings:2 string:1 background:1 buoyed:2 --:2 warned:2 diabetes:2 stock:1 inspection:1 because:1 some:1 3.7:1 growth:2 stronger-than-expected:1 83:1 offsetting:1 profit:2 broad:1 intraday:1 downturn:1 reported:1 base:1 acquisitions:1 offset:1 100:1 manufacturing:2 gained:2 both:1 losses:1 reports:1 involving:2 testimony:1 makes:1 maker:1 reversing:1 revenue:1 another:1 throughout:1 unit:4 pharmaceutical:2 weathered:1 2:1 statement:1 branded:1 500:1 flat:2 buy:1 drugs:2 company:3 gain:1 triple-digit:1 than:1 11:1 made:1 15:1 18:1 up:2 devices:2 were:1 acquisition:3 double-digit:1 investors:1 cents:1 certain:1 share:1 sales:2 0.7:1 periods:1 generic:1 costs:2 details:1 higher:1 product:1 added:2 's:5 generic-drug:1 after:1 barrage:1 letter:1 device:1 build:1 recent:1 billion:2 purchase:1 medical:2 futures:3 1.29:1 points:3
stock_ABT r_up	represent:1 emerging:1 significant:1 partnership:2 share:1 focus:1 talks:3 rushing:1 market:5 huge:1 said:1 adds:1 would:1 vaccines:3 other:1 potentially:3 details:1 which:1 new:1 markets:1 stock:1 's:4 drugs:3 updates:1 background:1 prices:1 such:1 companies:1 drug:1 venture:3 growing:1 grab:1 first:1
stock_ABT r_down	cut:1 countries:1 pinch:1 medicines:1 including:1 they:1 pay:1 prices:1 feeling:1 makers:1
stock_ABT r_up	emerging-market:1 purchases:1 's:2 companies:1 but:1 n't:1 ruling:1 fierce:1 making:1 competition:1 out:1
stock_ABT r_up	prompting:1 human:1 find:1 pharmaceutical:1 trials:1 been:1 new:1 's:2 big:1 acquire:1 pressure:1 they:1 license:1 tested:1 medicines:1 barely:1 companies:2 've:1 n't:2 products:1 biotechnology:1 experimental:1
stock_ABT r_up	medication:1 prompting:1 process:1 tested:1 supplement:1 human:1 find:1 pharmaceutical:1 ingredients:1 trials:1 been:1 suit:1 new:1 wants:1 's:2 involuntary:1 big:1 acquire:1 pressure:1 effects:1 they:1 scary:1 license:1 clarify:1 medicines:1 barely:1 companies:2 've:1 n't:2 products:1 biotechnology:1 identifies:1 side:1 experimental:1
stock_ABT r_up	comment:1 reaction:1 weight-loss:2 's:4 committee:2 evaluating:2 advisory:2 --:2 treating:2 review:2 drug:4 day:2 2:4 safety:2 background:1 obesity:2 before:2 analyst:1 risk:2
stock_ABT r_up	major:1 futures:2 1.3:1 move:1 '':1 actively:2 rising:2 calendar:1 balance:1 awaiting:1 3.8:1 strategists:1 whose:2 4.7:1 strong:1 recovery:1 would:1 rose:3 43:1 shares:2 traders:1 quantitative:1 easing:1 market:1 which:2 disappoint:1 has:1 meeting:1 500:3 scheduled:1 11:1 ``:1 's:1 said:1 may:1 big:1 'd:1 they:1 fresh:2 not:2 100:1 stocks:2 data:1 advanced:1 gained:3 12:1 like:1 announcing:1 32:1 climbed:2 companies:2 against:1 points:9 economic:1 were:2 action:1 trading:2 outcome:1
stock_ABT r_up	gained:1 whose:1 climbed:1 actively:1 17:1 rose:1 45:1 companies:1 shares:1 points:3 trading:1 6.2:1 closed:1 were:1 after-hours:1 session:1 stocks:1 500:1 higher:1
stock_ABT r_down	engagement:1 suitors:1 cancer:1 revenue:1 offset:1 dollar:1 sales:2 pandemic:1 likely:1 growth:2 rising:1 shares:1 human:1 3.1:1 healthcare:1 its:2 market:1 out:1 said:1 $:3 no:1 rather:1 much:1 there:1 comments:1 fall:1 other:1 rein:1 drawn:1 net:1 plasma:1 more:1 royalties:1 product:1 after:1 's:3 plans:1 year:1 may:1 share:1 company:1 million:1 buyback:1 slipped:1 fell:1 pursuit:1 background:1 wedding:1 world:2 despite:1 austerity:1 than:1 vaccine:1 reaction:1 900:1 measures:1 longer:1 slowed:1 --:2 shotgun:1 flu:1 full-year:1 drug:1 profit:2 products:1 reforms:1 warned:1 overseas:1 maker:2 8:1
stock_ABT r_up	comment:1 consider:2 investors:1 dividend-paying:2 n't:1 names:1 have:2 its:1 market:1 out:1 blow:1 flagship:1 busy:1 asthma:1 deal:1 offer:1 detail:1 been:2 safety:2 treatment:1 surprise:1 you:1 bored:1 frustrated:1 more:1 development:1 product:1 's:2 said:2 roster:2 dividends:1 stop:1 delayed:1 depths:1 flown:1 latest:1 terminated:1 strategists:1 stocks:2 analyst:1 paying:1 both:1 has:3 launch:2 healthy:1 well:1 licensing:1 drug:1 leave:1 --:1 yields:2 can:1 plumbing:1 efforts:1 stock:1 pulled:1 maker:1 bond:1
stock_ABT r_up	said:1 medical:1 retire:1 devices:1 drug:1 plan:1 injectable:1 maker:1
stock_ABT r_down	slashes:1 outlook:2 six:1 heart-rhythm:1 revenue:2 sales:2 certain:1 charge:1 shaky:1 surprisingly:2 used:1 biggest:1 global:1 spinal:1 slowed:1 cost:1 businesses:1 shares:1 year:3 first-quarter:1 surgery:1 throughout:1 its:3 declined:1 comments:1 giant:2 said:2 recently:1 triggered:1 jumped:3 agency:1 due:1 recommending:1 forecast:2 environment:1 52-week:1 recommended:1 other:1 earnings:3 statement:1 6:2 defibrillators:4 details:1 health-care:1 low:1 87:3 product:1 arthritis:1 's:8 increased:1 big:1 weakness:2 company:2 use:2 treatments:1 but:3 results:1 markets:1 pressure:2 fell:2 prices:1 taking:1 toll:1 analyst:1 earlier:1 legal:1 fiscal:1 sending:1 like:1 surprising:1 --:1 amid:2 medical:1 up:1 devices:2 lowered:2 products:1 healthcare:1 rheumatoid:1 maker:1 medical-device:3
stock_ABT r_up	sector:1 tougher:1 betting:1 reforms:1 find:1 comfortable:1 second:1 itself:1 pills:2 huge:1 medications:1 would:1 patent:1 there:1 three:1 fiction:2 may:1 regulation:1 health:1 new:3 's:3 pharmaceutical:1 drugs:1 commercial:1 but:1 diet:3 doctors:1 trouble:1 fad:2 care:1 hits:1 ahead:1 healthy:1 could:1 months:1 companies:1 face:1 prescribing:1 quarter:1 experimental:1
stock_ABT r_down	because:1 bottles:1 products:1 could:1 two:1 caps:1 lens:1 parts:1 contact:1 recalled:1 solutions:1 compromise:1 has:1
stock_ABT r_up	hospital:1 explain:1 health-care:1 driver:1 editors:1 stem:1 cell:1 say:1 costs:1 profits:1 plaintiffs:1 should:1 themselves:1 yanked:1
stock_ABT r_up	ends:1 prepare:1 auction:1 some:1 legislation:1 cell:1 changes:1 hospitals:1 public:1
stock_ABT r_down	do:2 group:1 help:1 both:1 did:1 advisers:1 well:3 up:2 bear:1 down:2 select:1 gauge:1 looks:1 another:1 bull:1 markets:1 market:2
stock_ABT r_down	drugs:1 billion:1 said:2 's:4 $:1 business:1 3.7:1 --:1 agreed:1 22:1 had:1 6100:1 generic:1 buy:1 statement:1 unit:1 closed:1 healthcare:1 acquisition:1 solutions:1
stock_ABT r_up	customer:1 tests:1 said:1 some:1 ``:1 '':1 complaints:1 recalled:1 blood:1 following:1 failures:1 has:1 screening:1
stock_ABT r_up	biotech:3 own:3 supply:1 some:1 ``:1 one:4 twist:3 have:1 using:1 its:3 unusual:3 said:3 alternate:1 should:1 spokesman:1 potential:3 details:1 fourth:1 boardroom:3 has:4 spat:3 screening:1 firm:3 tests:1 lot:3 allegations:3 stop:1 number:1 reported:3 regulators:3 carrying:1 recalled:3 blood:1 complaints:1 insider-trading:3 product:1 beginning:1 customer:1 '':1 directors:3 customers:1 following:1 failures:1
stock_ABT r_down	advisory:3 ordered:1 help:2 saying:1 being:2 sights:1 remove:1 committee:1 year:1 label:1 its:1 market:3 subject:1 considering:1 federal:2 review:1 been:1 should:3 safety:1 --:1 has:1 used:1 's:4 warnings:1 drugs:1 problems:1 diet:1 stay:2 weight-loss:2 decide:2 panel:2 whether:2 drug:3 n't:1 turn:1 patients:1 heart:1 asked:2 history:1
stock_ABT r_up	all:1 consider:1 proposed:2 being:1 move:1 setback:2 including:1 committee:1 go:1 its:1 issues:2 cardiovascular:1 pharmacy:1 causing:2 treatment:1 has:1 details:1 tests:1 risk:2 big:2 background:1 fall:2 report:2 salmonella:1 uphill:1 like:2 --:5 reasonable:1 obesity:3 investigators:1 says:1 questions:1 some:1 battle:1 year:1 further:1 subject:1 expert:1 review:1 since:1 patients:1 shares:2 safety:3 medicine:1 new:1 newly:1 weight-loss:2 members:1 panel:4 suggested:1 restrictions:1 last:1 shelves:1 study:1 drug:7 keep:1 faces:1 residents:1 placebo:1 experimental:1 raised:1 cancer:1 previously:1 down:1 raises:1 vote:1 should:1 market:2 pharmaceutical:2 unusual:1 would:1 unknown:1 due:2 been:1 attack:1 recommend:1 launching:1 known:1 removed:2 potential:1 raising:1 pull:1 middle:1 whether:2 work:1 cash:1 while:1 those:1 risks:2 making:1 treated:1 say:1 history:1 heart:3 investors:1 cited:2 10,000:1 stroke:1 itself:1 advising:1 increased:1 sell:2 compared:1 once:2 40:2 field:2 concerns:2 split:3 sick:1 sat:1 product:1 's:4 strokes:2 price:1 problems:3 documents:1 eight:2 preliminary:2 data:1 approved:1 looked:2 without:1 serious:1 voting:1 having:1 latest:2
stock_ABT r_down	heart:2 raises:1 pharmacy:1 market:1 expert:1 due:2 should:1 concerns:2 split:2 recommend:1 's:2 strokes:2 problems:2 weight-loss:2 removed:2 panel:2 shelves:1 whether:2 drug:3 --:1 risks:2 advising:1
stock_ABT r_up	advisory:3 medication:1 key:1 ``:1 through:1 against:1 committee:2 yes:1 overweight:1 additional:1 no:1 federal:2 question:2 members:1 whether:2 potential:4 safety:2 voted:3 9:2 5:2 population:1 obese:1 product:1 used:1 's:8 drugs:1 problems:2 seventh:1 rejected:2 weight-loss:2 background:1 concerns:2 panel:2 outweigh:1 benefits:2 carried:2 --:1 12th:1 work:2 well:2 drug:5 n't:2 did:2 individuals:1 risks:2 long-term:1 asked:1 first:1
stock_ABT r_down	cutbacks:1 3,000:5 layoff:1 force:1 version:1 deal:1 am:1 one:1 '':1 have:1 11th:1 avoided:1 its:3 unit:1 pharmaceutical:1 said:1 adds:2 would:1 patent:1 had:1 severe:1 forecast:1 pressures:1 3:1 other:1 earnings:1 largest:1 taken:1 announcements:1 has:1 correct:1 stock:1 cost-cutting:1 ``:1 's:3 expirations:1 though:1 drugs:1 price:1 measures:1 effect:1 tries:1 cut:1 years:1 wring:1 analyst:1 fifth:1 recent:2 faced:1 reaction:1 made:1 rival:1 medical:1 work:1 companies:1 drug:1 savings:1 products:1 follows:1 small:1 more:1 maker:1 acquisition:1 history:1
stock_ABT r_down	outlook:1 medical:1 presence:1 unchanged:1 year:1 ``:1 rest:1 one:1 '':1 production:1 guidance:1 beetle:1 quality:1 its:1 giant:1 said:1 $:1 area:1 recalling:2 review:1 their:2 charge:1 internal:1 5:1 earnings:2 formula:4 learned:2 containers:2 take:1 product:2 after:1 plans:1 drugs:1 company:2 million:3 but:1 hurt:1 plant:1 five:1 possibility:1 wo:1 found:1 baby:4 100:1 remote:1 recall:2 could:2 devices:1 maker:1 n't:1 common:1 small:1 recalls:2 leaves:1 comes:1
stock_ABT r_down	show:1 over:1 years:1 prices:2 its:2 cut:2 $:5 agile:2 better:2 has:1 agreed:3 10:1 five:1 formula:2 continued:1 lost:1 performing:1 list:1 recalls:1 dip:2 set:1 force:2 reduce:2 kidney-disease:2 our:1 makers:1 said:2 ways:1 shares:2 looking:1 3:6 safety:1 international:3 learned:1 shows:1 never:1 million:4 possibility:1 host:1 expire:1 contamination:1 could:1 months:2 regulators:1 drug:6 drug-coated:1 studies:1 top:1 patents:1 revenue:1 450:3 replace:1 chronic:3 least:3 market:1 bolster:1 city:1 story:1 jobless:2 prepare:1 recalling:1 create:2 two:1 been:1 next:3 their:3 live:1 rates:2 containers:1 more:3 ``:3 pipelines:1 company:1 released:1 baby:2 than:1 pull:1 made:1 rights:3 avoiding:1 work:2 up:1 devices:1 patients:1 heart:1 certain:1 '':3 have:1 blockbuster:1 kidney:1 develop:3 pay:3 six:2 indexes:2 adverse:1 concerns:1 split:2 several:1 events:1 product:2 plans:2 treatments:1 data:1 types:1 diabetes:1 remote:1 disease:1 stents:1 costs:2 experimental:3 organization:2 came:1
stock_ABT r_up	deal:1 computing:2 innovative:2 go:1 still:2 investment:1 even:1 judges:2 said:1 raise:2 chosen:2 make:1 less:1 long:1 its:1 returns:2 score:1 systems:2 way:1 has:2 2010:1 wants:1 ...:2 's:1 complete:1 dependent:1 after:1 categories:2 winners:1 but:1 wireless:2 most:2 takeover:1 technologies:2 bank:1 he:1 17:2 banking:1 must:2
stock_ABT r_down	respond:1 enable:1 smaller:1 goal:1 likely:1 much:1 mount:1 companies:1 patients:1 drug:2 only:1 2:2 studies:1 late-stage:1
stock_ABT r_up	limited:1 force:3 625:3 challenged:3 process:1 '':1 computer:3 voiced:1 thinks:1 concern:1 $:4 patent:3 pay:3 proposed:1 should:1 potentially:1 damages:3 widely:1 instead:1 200:1 ``:1 used:1 which:1 infringement:3 million:3 disruptive:1 lawsuit:3 billion:1 pursue:1 could:3 up:3 maker:3 verdict:3 changes:2 industry:2 medical-device:1
stock_ABT r_up	heart:7 compare:2 weight:2 people:2 move:1 study:1 sales:1 increased:3 days:1 '':3 regulatory:1 stroke:3 pulling:4 increase:1 may:1 year:1 further:1 collaboration:1 availability:2 yanked:1 cardiovascular:2 information:1 said:5 voluntary:1 their:2 data:1 detail:2 pharmacy:1 modest:2 very:2 attack:3 concerns:3 health:3 questioned:1 safety:1 justified:2 markets:2 price:1 achieve:2 stock:1 ``:3 's:5 risk:7 halting:1 strokes:2 stop:1 company:3 after:1 problems:2 diet:1 scrutiny:1 possibly:1 regulators:4 weight-loss:4 updates:1 background:2 coming:1 not:2 prescription:2 continued:2 you:2 released:1 suggested:1 loss:2 made:1 off:2 last:1 shelves:3 --:4 amid:1 taking:1 having:1 request:2 increases:2 drug:9 events:2 regulator:1 attacks:2 patients:3 following:2 serious:2 more:1 its:1 asked:1 comes:1
stock_ABT r_up	physician:1 says:1 many:1 drug:1 households:1 likely:1 still:1 present:1
stock_ABT r_up	after:1 court:1 proceed:1 cancer:1 drugs:1 lawsuits:1 alleging:1 subsidiaries:1 two:1 rejected:1 makers:1 drug:1 state:1 link:1 breast:1 between:1 including:1 appeal:1 several:1 can:1
stock_ABT r_up	examining:1 dogged:1 anti-obesity:1 variety:1 drugs:1 some:1 sold:1 humans:1 regulators:1 dog:1 n't:1 whether:1 only:1 safety:1 effects:1 treatment:1 genetically:1 health:1 side:1 issues:1 breeds:1
stock_ABT r_down	``:1 breed:1 says:1 certain:1 correlation:1 dog:1 analysis:1 side:1 '':1 suggests:1 potential:1 effects:1 disagrees:1 preliminary:1 's:2 drug:1 between:1
stock_ABT r_up	'better:1 hunt:1 20:3 pickers:1 bonds:1 continues:1 list:1 gander:1 yield:1 say:1 have:1 dividend:1 stocks:1 than:1 stock:1
stock_ABT r_down	heart:1 said:1 patient:1 stent:1 enrollment:1 move:1 due:1 its:1 delay:1 rollout:1 could:1 suspended:1 device:1 's:1 catheter:1 has:1 issue:1 study:1
stock_ABT r_down	sector:1 saying:1 emerging:1 since:2 pointing:2 less:2 over:1 labels:1 results:2 quarters:1 top:1 held:1 session:1 its:4 digest:1 cardiovascular:1 litigation:1 looking:1 $:1 22:1 stent:3 measure:1 expectations:1 1.18:1 edge:2 better:1 advisories:2 outlooks:1 4:1 has:1 details:3 move:1 declined:1 gains:2 continues:2 overall:1 finish:1 firmer:2 early:3 grew:1 worst:3 updates:2 background:2 surprise:3 report:3 day:1 areas:1 promising:1 58:1 excluding:1 called:1 --:2 conditions:1 drop:5 companies:2 heart:2 bad:3 withdrawal:4 small:1 higher:2 soft:1 heavy:1 ahead:1 financial:2 suspended:1 declines:1 some:1 back:1 bounce:1 batch:2 3.6:1 rate:3 added:2 trading:1 exceeded:1 cholesterol:1 temporary:1 hamper:1 3.8:1 decelerating:1 index:1 said:3 adds:1 3rd:1 profit:3 broad:1 though:1 rose:4 projected:1 comments:2 rival:1 increase:2 safety:3 defibrillators:1 formula:1 previous:1 boost:1 bellwethers:1 impact:1 patient:1 business:1 rolled:1 implantable:1 handful:1 focus:2 acquisition-related:1 reported:3 base:1 market-share:1 key:2 offset:2 repurchase:3 100:2 strong:1 beginning:1 gained:4 both:1 feeling:1 last:1 recovering:1 most:1 broad-based:1 study:2 months:1 ranges:1 drug:5 costs:10 prior:1 negative:1 products:1 analysts:2 drug-coated:1 graph:1 share:1 other:2 reclaim:1 comment:1 among:1 cancer:1 revenue:3 ground:1 others:5 year:1 third-quarter:5 down:3 rollout:1 unfolded:1 rising:2 another:2 throughout:4 open:1 crisis:1 market:3 limited:1 figure:1 dealt:1 efforts:1 spending:1 one-day:1 due:4 grow:1 start:2 program:1 growth:1 treat:1 expected:2 markets:1 patients:1 500:2 more:2 roundup:1 ``:1 drugs:4 benefiting:1 company:4 billion:1 peers:1 but:1 landed:1 sharply:1 basis:1 baby:1 line:1 slowdown:1 despite:1 than:5 those:2 posted:1 10:1 12:2 14:1 16:1 recall:4 enrollment:1 up:3 devices:4 hike:3 international:1 while:3 future:1 baby-formula:3 were:3 pressure:1 10th:1 similar:1 could:2 1.5:2 losses:1 associated:4 surprises:2 investors:4 health-care:1 0.5:1 sales:6 weighed:3 reports:4 have:5 9.75:1 swung:1 yet:1 risk:1 looked:1 issue:2 against:1 drubbing:2 began:1 six:1 fears:3 40:12 delay:1 also:1 high:1 potential:1 erase:1 earnings:13 new:1 layoffs:3 stock:3 week:1 product:1 used:2 's:11 warnings:1 may:4 price:2 problems:1 effect:1 diet:3 analyst:1 fueled:2 helped:3 fell:2 two:1 device:1 catheter:1 stocks:2 prostate:1 concerns:3 diabetes:1 rallied:1 lower:1 short:1 lead:1 scenario:1 charges:1 medical:1 futures:4 well:2 lost:3 maker:1 mortgages:3 stents:2 high-growth:1 points:12 weigh:2 latest:1 corporate:1 nearly:2
stock_ABT r_up	pushes:1 retire:1 down:1 commissioners:1 vote:1 moves:2 makers:2 before:1 ratio:1 deal:1 justice:1 decision:3 shares:1 interest:1 's:3 stokes:1 but:1 not:1 diabetes:3 loss:1 medical:1 drug:3 approve:1 comes:1
stock_ABT r_down	all:1 into:1 move:1 month:1 itself:2 shares:1 approval:2 several:1 been:1 news:1 throughout:1 next:1 its:2 sell:2 unusual:1 said:1 additional:1 had:2 treatment:1 comments:1 yet:1 their:1 details:1 new:1 has:1 's:2 stock:1 premium:1 same:1 big:1 company:2 after:2 drug:3 takeover:1 nearly:1 half:1 last:1 trying:1 approved:1 raising:1 built:1 made:1 attempt:1 success:1 lost:1 launch:1 --:1 odds:1 months:1 cash:1 value:1 n't:1 without:1 analysts:1 weight-loss:1 time:1 latest:1
stock_ABT r_up	shed:1 well:1 move:1 high:1 regulatory:1 something:1 such:1 effort:1 confirms:1 tools:1 out:1 pharmaceutical:1 unusual:1 rumors:2 not:1 seek:1 same:1 research:1 quash:2 statement:1 therapies:1 's:1 may:1 exactly:1 quite:1 takeover:2 others:1 put:1 rejection:1 diagnostic:1 bode:1 bar:1 improved:1 triggers:1 did:1 light:1 companies:1 disease:1 drug:1 n't:1 --:1 benefit:1 weight-loss:1 stand:1 making:1
stock_ABT r_down	pharmaceutical:1 shed:1 improved:1 triggers:1 tools:1 exactly:1 companies:1 disease:1 diagnostic:1 benefit:1 stand:1 light:1 research:1 seek:1
stock_ABT r_up	hitting:1 notice:1 help:1 investors:1 come:1 could:1 but:1 sign:1 n't:1 finally:1 dividends:1 fresh:1 starting:1 highs:1 today:1 around:1
stock_ABT r_down	respond:1 less:1 sign:1 second:1 year:1 its:2 marking:1 said:1 six:1 off:1 next:1 confident:1 treat:1 weeks:1 has:1 2011:2 week:1 's:5 than:1 get:1 rejected:1 weight-loss:1 regulatory:1 approval:1 requests:1 rejection:1 --:1 drug:4 can:1 time:1 meet:1 obesity:2
stock_ABT r_down	investors:1 over:2 reassert:1 likely:2 quality:1 rounds:1 market:1 if:1 needs:1 leading:1 there:1 long:1 their:1 dominance:1 economy:1 junk:2 government:1 stop:1 they:1 stocks:3 stimulus:1 many:1 anticipate:1 continue:1 so:1 more:2
stock_ABT r_up	hurdles:1 said:1 potential:1 market:1 drugs:1 industry:1 clear:1 commercial:1 remain:1 drug:1 likely:1 continue:1 place:1 long:1 weight-loss:1 despite:1 regulatory:1 makers:1 steer:1 executives:1
stock_ABT r_down	doldrums:2 even:2 's:4 results:2 enough:2 cure:2 election:2 not:2 stocks:2 might:2
stock_ABT r_up	doldrums:1 even:1 's:2 results:1 enough:1 cure:1 election:1 not:1 stocks:1 might:1
stock_ABT r_down	week:1 hits:1 's:1 hard:1 due:1 contract:1 next:1 doubt:1 diabetes:1 ties:1 hearing:1 public:1 subject:1
stock_ABT r_up	ago:1 's:2 $:1 cancer:1 company:1 million:1 bought:1 shares:1 than:2 chairman:1 15:1 has:1 treated:1 medical:1 decade:1 more:2
stock_ABT r_down	sector:1 diversifying:1 's:2 their:1 drugs:1 rivals:1 pharmaceuticals:1 going:1 way:1 prescription:1 reducing:1 other:1 exposure:1
stock_ABT r_up	sector:2 diversifying:2 's:4 their:2 drugs:2 rivals:2 pharmaceuticals:2 going:2 way:2 prescription:2 reducing:2 other:2 exposure:2
stock_ABT r_down	gets:1 patient:1 gold:1 --:1 standard:1 detection:1 remain:1 said:1 done:1 test:1 one:1 best:1
stock_ABT r_down	tests:1 used:1 develop:1 syndrome:1 supply:1 could:1 called:1 chronic:1 determine:1 fatigue:1 blood:1 which:1 racing:1 linked:1 if:1
stock_ABT r_down	determine:1 1.3:3 assess:1 chronic:1 owes:1 research:1 linked:1 if:1 develop:1 $:3 copyright:1 federal:1 syndrome:1 supply:1 next:1 outside:1 setting:1 which:1 new:1 racing:1 tests:2 used:1 jury:1 infringement:1 processing:1 step:1 fatigue:1 blood:2 ruled:1 billion:1 handling:1 these:1 could:1 called:1
stock_ABT r_up	billion:1 jury:1 $:3 copyright:1 1.3:3 infringement:1 pay:1 between:1 high-profile:1 battle:1 rival:1 following:1 court:1 ruled:1 makers:1 must:1
stock_ABT r_down	week:1 articles:3 must-read:1 beaten:1 value:1 down:1 more:1 secret:1 five:1 stocks:1 checks:1 out:1
stock_ABT r_down	advisory:1 raised:2 already:2 proposed:2 revenue:1 increasingly:1 developed:2 into:1 half:1 some:2 one:2 second:1 year:3 vote:1 surgery:1 antidepressant:2 next:2 its:1 fifth:1 developer:1 information:1 confirmed:1 said:3 asthma:1 additional:1 federal:1 guidance:1 agency:2 two:2 comments:1 than:1 favor:1 preparing:1 won:1 treatment:4 which:2 2011:3 price:1 stock:1 gaining:1 's:5 combination:2 drugs:3 sixth:1 showing:1 but:3 costs:1 pressure:2 market:2 weight-loss:4 favorable:1 background:1 fall:1 manufacturing:1 analyst:1 panel:1 planned:1 effective:2 being:4 met:2 --:3 boost:1 launch:1 drug:3 standards:2 rather:1 patients:2 reflecting:1 deferral:1 obesity:1 revenues:1 starting:2 2010:3 blood:2
stock_ABT r_down	heart:2 omega-3:1 executive:1 allegations:1 sales:3 competition:1 device:1 promise:1 drug:1 year:3 need:2 acid:1 its:1 he:2 threats:1 $:1 federal:1 hospital:2 had:1 barred:2 1:1 does:1 questioned:1 which:1 branded:1 patients:2 details:1 materialize:1 product:1 practice:2 's:6 allegedly:2 after:2 them:2 hundreds:2 soon:1 did:2 hired:2 putting:2 nearly:1 despite:1 report:1 prescription:1 lymphoma:1 recent:1 billion:1 last:3 database:1 --:3 consultant:2 according:2 anytime:1 n't:3 stents:2 chief:1 popular:1 cardiologist:2 shows:1 makes:1 think:1 investigators:2 first:1
stock_ABT r_down	advisory:1 proposed:1 agreed:4 executive:1 soon:1 not:2 underlying:1 its:1 setbacks:1 $:8 had:1 entities:1 does:1 voted:1 under:1 suffered:1 pill:1 government:3 nearly:2 they:3 despite:1 report:3 like:1 materialize:1 prescription:1 --:7 always:1 medicines:1 companies:1 settle:4 follows:1 popular:1 obesity:1 often:1 national:1 competition:1 accused:1 pricing:1 year:2 inflated:4 makers:4 said:4 threats:1 federal:4 outside:1 won:1 reimbursements:3 told:1 after:1 million:1 affiliates:3 weight-loss:1 article:1 manufacturing:1 panel:1 last:1 drug:8 'white:1 published:1 makes:1 think:1 first:1 omega-3:1 affiliated:1 vote:1 thumbs-up:1 their:3 scheme:4 ``:1 drugs:1 lists:1 favorable:1 prices:3 rare:1 approval:1 branded:1 n't:1 can:1 care:2 proprietary:1 certain:1 engaged:3 sales:1 '':1 experts:1 have:4 need:1 technology:1 acid:1 pay:1 get:3 1:1 other:1 details:1 which:1 interview:1 place:1 you:1 several:1 higher:3 product:2 's:5 advice:1 reporting:1 produce:2 but:1 capacity:1 recent:1 billion:1 programs:3 charges:4 medical:2 anybody:1 anytime:1 chief:1 costs:1
stock_ABT r_down	advisory:2 proposed:1 agreed:3 allegations:1 pitch:3 settlement:2 avenue:2 defraud:2 setbacks:1 rapid:1 $:9 tablet:1 had:1 280:1 suffered:1 thousands:3 pill:1 hope:1 customers:3 rise:1 increases:1 they:3 foot:1 --:4 medicines:1 endorses:1 companies:6 settle:4 obesity:1 some:2 pricing:1 recommendation:1 further:1 inflated:2 makers:6 out:3 medications:2 giving:3 avoid:1 crucial:1 discounts:1 won:1 provides:1 denied:1 litigation:1 business:3 million:5 threatened:1 weight-loss:2 news:1 likelihood:1 panel:2 both:1 rare:1 computers:1 drug:7 published:2 passing:3 approval:2 vote:3 thumbs-up:1 additional:1 positive:1 their:4 combined:2 wrongdoing:1 door:1 drugs:1 rejected:1 sales:1 part:1 favorable:1 doctors:3 prices:2 subsidiary:1 up:3 backing:1 year:1 salespeople:2 spruce:3 rally:2 pay:4 agency:1 same:3 other:1 which:1 test:1 several:1 's:2 after:1 diet:2 said:3 but:1 charges:2 federal:1 costs:1 time:3
stock_ABT r_up	shop:1 comment:1 major:1 help:1 year:1 negative:1 investor:1 have:1 recommendation:2 vote:2 follow:1 its:1 before:1 drugs:1 n't:1 but:1 puts:1 rivals:1 positive:3 fix:1 agency:1 had:1 two:1 also:1 does:1 health:1 provides:1 clinical:1 insurers:1 hope:1 stock:1 firm:1 updated:1 's:4 which:2 received:1 may:1 earlier:1 studies:1 diet:1 increases:1 weight-loss:1 rejected:1 prices:1 approval:2 likelihood:1 concerns:1 panel:3 both:1 would:1 ahead:1 --:3 doc:1 needed:1 companies:1 drug:1 their:1 recommendations:1 clears:1 easing:1 panels:1 similar:1 other:1
stock_ABT r_up	sell:1 growing:1 suitors:1 offering:1 variety:1 --:1 industry:1 company:1 global:1 access:1 quick:1 likely:1 itself:1 diagnostics:1 buyer:1 attempt:1 appeal:1 its:1
stock_ABT r_up	tentatively:1 after:1 ordered:1 $:3 pay:1 violated:1 million:1 drug:1 52:1 finding:1 state:2 practices:1 nearly:1 marketing:1 judge:1 has:1 its:1 maker:1 law:1 pricing:1
stock_ABT r_down	heavy:1 all:1 final:1 deal:1 companies:1 back:1 marked:1 scaled:1 struggle:1 focuses:1 long:1 year:1 's:1 estimated:2 its:2 before:1 sell:1 $:3 initial:2 had:1 4.8:1 least:1 shares:1 failed:1 been:1 which:1 has:1 company:1 stock:1 week:2 tests:1 after:1 terms:1 offering:1 offer:1 price:2 million:2 weak:1 finish:1 volume:1 plan:1 winter:1 13:1 15:1 hiatus:1 registered:1 up:1 public:1 deals:1 range:1 planned:2 were:1 whole:1 maker:1 issuance:1
stock_ABT r_down	blue:1 index:1 caps:1 's:2 chips:1 list:1 midcaps:1 includes:1 know:1 dividend:1 small:1 fresh:1 senior:1 stocks:1 payers:1 analyst:1
stock_ABT r_down	saying:1 because:1 false:2 give:2 drugs:1 22:1 some:1 results:3 used:2 facilities:1 strips:5 names:1 have:1 year:1 fail:1 stores:1 working:1 low:3 try:1 different:1 2010:1 monitoring:1 raise:1 would:1 no:1 lots:1 treat:1 agency:1 distributed:1 elevated:1 their:2 health:1 attractive:1 online:1 test:4 new:1 reading:1 pill:1 announced:2 glucose:7 tests:2 earlier:1 's:1 combination:1 government:1 may:4 company:1 million:2 systems:1 introduce:1 following:1 regulators:1 brand:1 rejected:1 they:1 sold:1 longer:1 abandoned:1 --:1 recall:4 medical:1 devices:1 lead:1 separately:1 patients:1 today:1 cholesterol:1 marketed:1 under:1 efforts:1 retail:1 maker:1 care:1 blood:4
stock_ABT r_down	because:1 people:1 global:1 used:1 strips:1 optimistic:1 year:1 even:1 recalling:1 give:1 patients:1 their:1 causing:1 health:3 low:1 new:1 pill:1 million:1 's:1 combination:1 earlier:1 introduce:1 regulators:1 rejected:1 they:1 improving:1 news:2 diabetes:1 abandoned:1 potentially:1 could:1 work:1 morning:1 bad:1 testing:1 risks:1 cholesterol:1 efforts:1 know:1
stock_ABT r_up	financial:1 painkiller:2 '':1 have:2 year:1 linked:2 out:2 pharmaceutical:1 confirmed:1 whom:1 trials:2 damage:2 been:2 crisis:1 may:2 clinical:2 new:1 type:1 2010:3 giants:1 ``:1 's:1 drugs:2 ponder:1 halted:2 joint:2 moment:1 concerns:2 those:2 blame:1 look:1 most:1 posts:1 popular:1
stock_ABT r_up	figure:2 tougher:1 year:1 number:1 years:2 escaped:2 looks:1 during:1 's:1 its:2 relatively:2 24:1 pharmaceutical:2 21:3 monthly:1 higher:1 yet:2 environment:1 few:1 potential:1 safety:1 low:2 new:2 has:2 2010:7 18:1 shows:2 website:1 partly:1 25:1 drugs:3 got:1 delayed:1 but:2 blockbusters:1 modest:1 reflecting:1 others:1 regulatory:1 approval:1 drought:2 approved:3 types:1 recent:3 down:1 concerns:1 won:1 --:1 amid:1 industry:2 drug:1 n't:2 reports:1 ongoing:1 2007:1 were:1 2008:3 2009:3
stock_ABT r_up	among:1 her:1 dividends:1 veteran:1 companies:1 picks:1 favorites:1 growing:1 cash-rich:1
stock_ABT r_down	breadth:2 named:2 large-cap:1 administration:2 health-care:1 tax:2 major:2 deep:2 disappointing:1 bring:2 second:1 code:2 corporations:2 led:2 brings:2 staff:2 conference:2 mulls:2 he:2 said:2 overhaul:2 able:1 brief:2 comments:2 should:1 spokesman:1 dividends:1 new:2 grow:2 several:1 2010:1 economy:2 executive:2 ``:4 his:2 's:2 our:2 big:1 understanding:2 job:2 press:2 credentials:2 stocks:1 former:2 stage:1 '':2 jobs:2 boast:2 created:2 --:2 starting:1 experience:2 chief:2 can:2 time:2 comebacks:1 corporate:2 added:2 secretary:2
stock_ABT r_up	breadth:1 named:1 already:1 investors:1 administration:1 twists:1 executive:1 tax:1 major:1 deep:1 brief:1 '':1 bring:1 code:1 experience:1 corporations:1 need:1 led:1 market:1 staff:1 conference:1 said:1 overhaul:1 pay:1 political:1 three:1 comments:1 grow:1 mulls:1 time:1 new:1 sway:2 stock:1 boast:1 ``:2 his:1 's:1 our:1 brings:1 attention:1 understanding:1 job:1 shifting:1 key:1 press:1 credentials:1 former:1 he:1 jobs:1 especially:1 sectors:3 created:1 --:1 turns:1 could:2 priorities:1 spokeswoman:1 chief:1 can:1 applies:1 economy:1 corporate:1 added:1 secretary:1
stock_ABT r_down	own:1 being:1 developed:1 chunk:1 executive:1 sales:1 including:1 expect:1 blockbuster:1 pills:1 said:1 away:1 rivals:1 does:1 take:1 's:1 big:1 arthritis:2 he:1 --:1 drug:1 n't:1 rheumatoid:1
stock_ABT r_down	body:1 heart:1 said:1 received:1 stent:1 there:1 launch:1 late:1 hopes:1 device:1 designed:1 fully:1 regulatory:1 approval:1 has:1 2012:1
stock_ABT r_up	again:1 recovery:2 dividends:2 writes:1 start:1 pay:1
stock_ABT r_down	over:1 go:1 our:1 cold:1 terms:1 pharma:1 bullish:1 equipment:1 bearish:1 long:1 their:1 winners:1 electrical:1 2010:1 stock:1 's:1 groups:1 ask:1 such:1 short:1 kept:1 calls:1 picks:1 n't:1 pace:1 can:1 benchmarks:1
stock_ABT r_down	saying:2 feedback:1 developed:2 '':1 regulatory:1 including:1 analysis:1 want:2 skin:2 need:1 further:1 next:1 its:2 said:1 date:1 additional:1 research:2 potential:1 treat:2 has:2 indicating:1 more:2 psoriasis:2 ``:1 plans:1 may:2 evaluate:1 company:1 applications:2 regulators:2 authorities:1 condition:2 later:1 drug:2 filing:1 while:1 steps:1 studies:1 called:1 experimental:2
stock_ABT r_up	pharmaceutical:1 slid:1 said:1 's:1 launch:1 company:1 after:1 n't:1 disclosed:1 oral:1 treatment:1
stock_ABT r_up	1.5:1 among:1 ended:1 actively:3 trading:3 dropped:2 approval:1 pain:1 moves:1 its:1 declined:3 whose:3 4.1:1 rose:1 tumble:1 shares:3 1:1 points:7 market:1 which:1 biggest:1 500:3 dispute:2 gaining:1 's:3 marketing:1 notable:1 13:1 falls:2 fell:2 news:1 stocks:5 declining:1 balking:1 11:2 lower:2 lost:1 17:2 32:1 companies:3 up:1 while:1 session:3 after-hours:1 mixed:1 making:1 traded:2
stock_ABT r_up	challenges:1 partner:1 its:1 out:2 carriers:1 indexes:2 figuring:1 tumbles:2 new:1 might:2 launching:1 donors:1 pain:1 infection:1 blood:1 key:1 fall:2 news:1 balking:1 work:1 turn:1 slide:1
stock_ABT r_down	heart:1 rolling:1 rising:1 likes:1 its:1 out:1 said:1 stent:1 balloon:1 new:1 has:1 might:1 catheter:1 affected:1 payouts:1 timeline:1 delayed:1 but:1 device:1 such:1 estimate:1 stocks:1 did:1 cash:1 n't:1 problem:1 veteran:1
stock_ABT r_down	operations:3 over:3 focus:2 years:2 session:5 including:2 shares:4 6.1:1 cuts:4 its:3 issues:2 24:1 whose:4 some:1 cut:2 20:1 $:5 23:1 merger:1 rose:4 economy:1 policy:1 2011:5 polled:1 details:3 rise:1 watch:2 early:1 background:1 new:2 trade:1 austerity:1 excluding:1 --:2 drop:3 companies:4 pharma:1 6.4:10 after-hours:1 stock:2 view:2 1,900:3 force:3 efforts:1 estimates:1 related:1 freeze:1 see:1 actively:3 trading:3 7th:1 recently:1 little:1 slew:1 said:5 reform:1 profit:1 jumped:1 below:1 comments:1 forecast:2 pressures:2 health:2 digest:1 closed:1 masking:1 lower-than-expected:1 impact:1 measures:1 jobs:3 commercial:3 monetary:1 acquisition-related:1 reported:3 restructuring:2 active:1 100:1 manufacturing:3 beginning:2 21:2 gained:4 projected:1 ahead:1 industry:2 climbed:3 job:1 12000:1 disappointment:1 climb:2 better-than-expected:1 changes:2 maker:2 executives:1 fourth-quarter:4 revenue:1 awaited:1 1st:1 throughout:1 earning:1 market:2 pharmaceutical:4 8.3:1 would:3 spending:1 come:1 due:1 next:2 reduction:1 2:9 growth:1 expected:2 call:1 care:2 markets:1 500:4 ``:2 tax:1 company:2 15:1 look:1 work:3 up:1 while:2 cost:1 were:1 following:1 slid:1 changed:1 associated:1 investors:1 share:1 sales:1 pushed:1 drug:2 slip:1 need:1 needs:1 5.3:1 5.5:1 also:1 points:12 earnings:11 several:2 dips:2 higher:5 finish:1 's:9 after:1 most:2 lay:3 device:1 stocks:5 response:2 acquisitions:1 lower:1 off:3 largely:1 charges:1 traded:2 medical:1 futures:4 well:1 face:2 reports:1 costs:7 healthcare:1 weigh:2 corporate:3 pronouncements:1 latest:2
stock_ABT r_down	comment:1 fourth-quarter:2 associated:1 surprises:2 investors:1 revenue:1 issued:1 health-care:1 period:2 quarters:1 helped:1 cue:2 map:1 reports:1 year:1 plan:2 inflated:2 year-earlier:2 said:3 overhaul:1 companies:1 offers:1 profit:1 rose:3 saw:1 28:3 expectations:1 forecast:1 better:1 advisories:2 citing:1 costs:1 speech:1 details:1 2011:1 corporate:1 earnings:4 road:1 product:1 's:1 company:1 sales:2 volume:1 next:1 4th:1 gain:2 saying:1 latest:1 prices:1 invest:1 94:6 recall:1 roundup:1 short:1 last:1 6th:1 future:1 plunged:2 drug:1 spending:2 large:2 divestiture:2 while:2 fell:1 investors’:2 graph:1 higher:2 slightly:2 maker:2 experimental:1 effects:1
stock_ABT r_down	heart:2 betting:1 competition:1 '':1 judge:1 's:1 should:2 its:3 if:1 given:1 said:3 court:1 $:5 48:1 stents:2 federal:2 pay:2 winner:1 detail:1 tiny:2 approved:1 shingles:1 won:1 treatment:1 which:1 appeal:1 leader:2 painful:1 location:1 bets:1 ``:1 his:2 jury:3 statement:1 big:1 week’s:1 million:3 milestone:1 ask:1 subsidiary:2 overturn:1 disappointed:1 payment:1 triggers:1 482:4 patent:2 verdict:2 ruling:1 profits:1
stock_ABT r_down	heart:1 ago:2 investors:1 fourth-quarter:2 full-year:2 51:1 over:1 year:2 moved:2 years:1 drug-stock:1 strongest:1 session:4 trading:4 against:1 corporations:2 68:1 jury:1 2.1:1 still:1 2.7:2 6.9:1 confusing:1 one:2 whose:3 actively:3 pointing:2 lead:2 8.9:1 rose:2 top:1 since:2 shares:3 2:1 9.8:1 best:2 closed:1 biggest:2 gets:1 final:1 500:3 higher:4 picture:1 hormone:1 's:3 gains:2 rules:1 reporting:2 took:1 worries:1 ended:2 sharply:2 gainers:1 stocks:5 gained:2 13:2 off:1 lost:1 unrest:1 1998:2 climbed:3 companies:5 up:5 drug:2 2010:4 open:1 points:9 opens:1 after-hours:1 mixed:1 more:1 traded:2 profits:2 50:2
stock_ABT r_up	major:2 it’s:1 shot:1 want:1 they:1 move:1 setback:1 down:2 not:1 economic:1 experts:1 value:1 another:2 recommendation:1 close:1 recently:1 market:1 before:1 needs:1 said:1 $:3 agency:1 had:1 detail:1 shares:1 delay:1 their:1 outside:1 clinical:1 fuel:1 has:1 stock:2 's:4 300:1 price:1 million:1 rejected:1 halted:1 step:1 weight-loss:2 73:1 updates:1 71:1 early:1 approval:1 come:1 than:1 recovery:1 sending:1 expense:1 rejection:1 --:1 corporate:1 request:2 up:2 drug:2 trial:2 through:1 more:1 traded:1
stock_ABT r_up	major:1 because:1 shot:1 have:1 makers:1 high:1 likely:1 proves:1 another:2 approval:1 its:2 market:1 cardiovascular:1 cut:1 $:1 space:1 decision:1 detail:1 why:1 delay:1 their:1 clinical:1 health:1 treatment:1 biggest:1 new:1 diet:1 before:1 pill:1 more:1 such:1 's:3 risk:1 distance:1 300:1 price:2 million:1 problems:1 treatments:1 rejected:1 nation:1 weight-loss:1 updates:1 71:1 news:1 one:1 shows:1 than:1 bar:1 expense:1 rejection:1 --:2 study:1 cap:1 kept:1 drug:3 large:1 trial:1 without:1 long-term:1 stock:2 leaves:1 latest:1
stock_ABT r_up	2000:2
stock_ABT r_down	job:1 lack:1 back:1 growth:1 including:1 drug:1 humming:1 lead:1 lawsuits:1 promoting:1 take:1 above:1 economy:1 illegally:1 plans:1 missing:1 rebound:1 mounts:1 increases:1 uses:1 sharply:1 not:1 dividend:1 approved:1 up:1 12000:1 regulators:1 link:1 makes:1 profits:1
stock_ABT r_down	comment:1 fourth-quarter:1 large-cap:1 executive:3 period:1 oversaw:1 improving:1 manager:1 rising:1 perspective:1 helm:1 margins:1 said:1 group:1 since:1 detail:1 been:1 earnings:1 has:2 stock:1 retire:1 's:3 company:1 sales:1 reported:1 device:1 former:2 --:1 medical:1 drug:1 chief:1 replaced:1 2007:1 healthcare:1 maker:2 better-than-expected:1
stock_ABT r_up	sector:2 troubled:1 force:1 plunge:1 20:1 sinks:2 it’s:1 laying:1 off:1 drug:2 41:1 order:1 product:1 focus:1 mixed:2 news:1 work:1 inhaled-insulin:1 its:2
stock_ABT r_up	enjoy:1 seven:1 medication:1 associated:1 soars:1 orphan:2 setback:2 years:1 down:1 trading:2 have:1 exclusivity:1 its:1 market:1 information:1 additional:1 would:1 provide:1 granted:1 28:1 shares:3 shingles:1 treat:1 8:3 sliding:1 treatment:1 status:1 pain:3 means:1 company:1 falls:2 slides:2 fall:1 early:2 news:1 stocks:1 rebounds:1 approved:2 condition:1 rebounding:1 designation:1 receive:1 drug:4 while:1 were:1 following:1 order:1
stock_ABT r_down	product:1 's:1 greater:1 drugs:1 into:1 use:2 trouble:1 while:1 won:1 run:1 signaling:1 broader:1 regulators:1 approval:1 surgery:1 obesity:1 condition:1
stock_ABT r_up	even:1 body:1 detect:1 's:1 blood:1 these:1 study:1 though:1 least:1 suggests:1 virus:1 can:1 taken:1 root:1 monkeys:1 difficult:1
stock_ABT r_up	raised:1 prompting:1 cents:1 share:1 0.7:1 cash:2 trading:1 have:1 year:1 its:2 market:1 pharmaceutical:2 shareholders:1 $:1 48:3 ways:1 been:1 looking:1 quarterly:2 consecutive:1 firms:1 has:1 9.1:3 stock:1 firm:1 payout:1 return:1 increased:1 stockpiling:1 company:2 after:1 early:1 increases:1 wake:1 excess:1 dividend:2 recent:1 buybacks:1 represents:1 months:1 up:1 surge:1 recession:1 became:1 were:1 increase:1 spend:1 latest:1
stock_ABT r_up	pharmaceutical:1 head:1 organization:1 business:1 company:1 retire:1 one:1 businesses:1 medical-products:1 combining:1 into:1 international:1 its:1
stock_ABT r_down	comment:2 president:1 appeals:1 into:1 retire:2 patent-infringement:1 one:1 businesses:1 medical-products:1 combining:1 reached:1 its:1 size:1 pharmaceutical:1 said:1 court:1 $:3 decision:1 28:1 been:1 spokesman:1 reduction:1 board:1 international:1 has:1 company:2 announced:1 week:1 head:1 move:1 's:1 business:1 1.8:3 reversed:1 internally:1 billion:1 59:1 last:1 effective:1 vice:1 could:1 against:1 n't:1 organization:1 senior:1
stock_ABT r_up	heart:2 because:1 supply:1 catheters:1 cows:1 its:1 unit:1 confirmed:1 asthma:1 trigger:1 avoid:1 tiny:1 live:1 potential:1 policy:1 used:1 's:1 plans:1 sitting:1 big:1 stop:1 most:1 pigs:1 traffic:1 supplying:1 disruption:1 considered:1 attacks:1 devices:1 facing:1 stents:1 near:1 install:1 changes:1
stock_ABT r_up	comment:1 heart:1 because:1 supply:2 into:1 catheters:2 sales:3 mental-health:1 including:1 devices:2 its:3 unit:2 staff:1 confirmed:1 said:2 funding:1 took:1 stent:2 top:1 two:1 tiny:1 declining:1 rivals:1 potential:1 details:1 which:1 supplies:1 weeks:1 has:1 seeks:1 customers:1 used:1 's:1 get:1 may:1 stop:1 threatened:1 long:1 soon:1 disruption:2 market:1 cutting:1 newer:1 focus:1 regulatory:1 approval:1 supplying:1 ago:1 most:1 taking:1 biologics:1 face:1 facing:1 stents:1 while:2 steps:1 install:1 own:1 share:1
stock_ABT r_down	1.4:1 sector:1 shed:3 already:1 1.6:2 birthday:2 celebrating:1 second:2 session:3 trading:3 3.3:1 whose:3 26:1 22:1 shares:3 points:6 closed:1 9:1 500:3 good:1 's:3 market’s:1 underway:1 75:1 fell:3 bull:1 stocks:3 10:1 lower:3 8.7:1 lost:3 companies:3 value:1 actively:3 after-hours:1 traded:2 bet:1
stock_ABT r_up	comment:1 all:2 tap:2 hoping:2 being:2 into:2 coming:2 sales:1 competition:2 one:2 four:1 second:2 including:2 reducing:2 its:2 market:2 help:2 throughout:1 generic:2 six:2 projected:1 research:2 symptoms:2 drugs:2 details:1 which:2 newly:2 main:2 painful:2 's:2 reaction:1 may:2 company:1 arthritis:2 met:2 important:2 lucrative:2 goals:2 key:2 offset:2 years:2 analyst:1 condition:2 loss:2 pipeline:2 include:1 success:2 reported:2 --:2 studies:2 drug:7 trial:4 rheumatoid:2 called:2 late-stage:4
stock_ABT r_down	said:1 's:1 company:1 executive:1 chief:1 officer:1 new:1 naming:1
stock_ABT r_up	say:1 economic:1 experts:1 drug:2 your:1 counterfeit:1 make:2 their:1 health:1 sick:2 downturn:1 tips:1 selling:1 drugs:1 hazardous:1 safe:1 stay:1 thriving:1 you:2 websites:1 products:1 can:3 scams:2
stock_ABT r_down	consent:2 agreed:1 actions:1 one:1 signed:1 years:1 out:1 decree:2 takes:1 puts:1 agency:1 three:1 signals:1 tight:1 take:1 under:1 has:1 correct:1 's:3 problems:1 giant:1 scrutiny:1 most:1 hands:1 regulatory:2 manufacturing:2 effort:1 plants:1 drug:2 matter:1 can:1 serious:1 maker:1
stock_ABT r_down	billion:3 little:1 's:1 $:3 could:1 year:1 sales:1 35:1 shrink:1 base:1 40:1 between:1 67:1 writes:1
stock_ABT r_down	over:1 some:1 private:1 one:1 currency:1 year:1 terms:1 its:1 unable:1 area:1 writes:1 been:1 investment:1 better:1 matured:1 which:1 has:2 issue:1 's:2 government:1 company:1 but:1 convertible:1 battling:1 gotten:1 companies:1 foreign:1 banking:1 repay:1 repayment:1 fully:1 2009:1 creditors:1 bond:1
stock_ABT r_down	...:1 4.1:1 after:1 up:1 shares:1 trading:1 reports:1 close:1 following:1 news:1 open:1 came:1 before:1
stock_ABT r_up	sector:1 ...:1 one-year:1 right:1 's:2 look:1 we:2 big:1 bill:1 anniversary:1 past:1 'd:3 health:2 have:1 year:1 overhaul:1 has:1 treated:1 care:2
stock_ABT r_up	assessing:1 like:1 warnings:1 whether:1 could:1 behavioral:1 problems:1 colors:1 artificial:1 should:1 carry:1 foods:1 kids:1 reports:1 time:1 not:1 worsen:1 their:1 first:1
stock_ABT r_up	jury:1 violate:1 license:1 antitrust:1 did:1 awarding:1 but:1 agreement:1 n't:1 damages:1 found:2 laws:1 breached:1
stock_ABT r_up	major:1 brakes:1 price:1 companies:1 drug:1 increases:1 pressing:1 including:1 groups:1 put:1 religious:1
stock_ABT r_up	billion:3 plastics:2 $:3 deal:3 company:2 said:1 specialty:1 4.8:2 cash:2 valuing:1 chemicals:3 buy:2 buys:2 maker:1
stock_ABT r_down	errors:1 's:4 process:1 developed:1 medical:1 arthritis:1 reduce:1 resistance:2 drug:1 than:1 project:1 patients:1 found:1 weigh:1 rheumatoid:1 study:1 more:1
stock_ABT r_down	soars:2 growth:1 rally:1 out:1 generate:1 seeks:1 more:1 company’s:1 dividends:1 after:1 weak:1 hopes:2 90:1 stocks:1 data:1 than:1 solid:1 study:1 flow:1 cash:1 drug:1 release:1 economy:1 better-than-expected:1
stock_ABT r_down	sector:1 aided:1 emerging:1 stent:2 show:1 diluted:2 top:1 dollar:1 adjusted:1 years:1 session:1 including:1 operations:1 cede:1 blow-out:1 its:4 help:2 impact:1 whose:1 $:2 1.11:2 rose:1 expectations:2 than:1 better:1 stalled:1 employee:3 has:2 reduce:1 details:1 hip:1 ...:1 gains:1 showing:1 watch:1 results:5 updates:2 background:1 continued:1 net:1 excluding:2 --:1 companies:1 fortunes:1 morning:3 facing:1 either:1 stock:4 replacement:1 woes:1 acquired:3 series:1 pals:1 some:2 related:1 batch:1 growth:4 trading:1 exceeded:2 's:12 margins:1 makers:4 gross:1 adds:1 lead:3 profit:1 though:1 contributed:3 shares:1 forecast:2 increase:3 various:1 new:1 newly:3 assumes:1 business:2 pharmaceutical:1 reported:4 restructuring:2 operating:1 franchise:1 strong:2 beginning:2 gained:1 quarter:1 ahead:1 broad-based:1 could:1 drug:6 foreign:3 range:2 analysts:1 graph:2 traded:1 hospital:1 first:1 comment:1 major:1 revenue:3 revive:1 such:1 decline:3 figure:1 basis:2 5th:1 due:1 rivals:1 2:1 markets:4 500:1 funds:1 drugs:3 estimates:3 company:5 diversified:1 slump:1 reiterated:2 fuel:1 competition:1 quarterly:1 surged:1 analyst:1 10:2 made:1 15:1 14:12 17:3 up:1 project:1 while:3 actively:1 stories:1 can:1 were:2 spotlight:2 acquisition:2 1.4:1 1.5:1 weaker:1 associated:4 investors:1 certain:2 health-care:2 sales:4 currency:1 full-year:2 accounting:1 rally:3 11th:1 expirations:1 no:1 patent:1 large:1 other:1 earnings:12 income:2 performance:1 you:1 layoffs:3 offered:1 higher:1 added:1 first-quarter:4 index:1 our:1 price:2 problems:1 reflect:1 fell:1 device:2 robust:1 stocks:3 data:1 recent:1 acquisitions:5 lower:1 3rd:2 charges:2 amid:1 medical:1 futures:2 cushioned:1 generic:1 costs:6 tech:1 weigh:2 lineup:1
stock_ABT r_up	saying:1 surprises:2 quarters:1 session:1 trading:1 reports:1 points:3 whose:1 rose:1 shares:1 advisories:2 earnings:1 7:1 500:1 higher:1 roundup:1 added:1 's:1 closed:1 stocks:1 gained:1 18:1 future:1 companies:2 53:1 actively:1 after-hours:1 corporate:1 latest:1
stock_ABT r_down	share:2 tablets:1 market:2 sell:1 said:1 lead:1 generic:1 stent:2 make:1 version:1 treatment:1 which:1 new:2 has:1 final:1 led:1 company:2 depression:1 got:1 hopes:2 approval:3 received:2 improved:2 --:2 drug-coated:2 called:2
stock_ABT r_up	fence:1 agreed:1 executive:1 share:1 competition:1 month:1 have:1 licenses:1 ring:1 next:1 its:2 said:2 adds:2 3rd:1 generic:1 5th:1 agency:1 comments:2 discuss:1 various:1 units:1 safety:1 effectiveness:1 brand:1 buy:1 's:5 price:1 4th:1 background:1 analyst:1 panel:1 attempt:1 --:2 drug:2 19:2 cholesterol:1 anti-cholesterol:1 patents:1 first:1
stock_ABT r_up	investors:1 one:1 topic:1 talking:1 arise:1 portfolio:2 your:2 disappear:1 end:2 it’s:1 royal:1 opportunities:1 has:1 might:1 across:1 sort:1 do:1 ends:1 after:1 wedding:1 not:1 thing:1 bond:2 mean:2
stock_ABT r_up	says:1 investors:1 one:1 manager:1 economic:1 year:1 market:1 mutual:1 investing:1 nervous:1 veteran:1 should:1 events:1 stock:1 bonds:3 but:1 fund:1 not:1 stocks:2 derail:1 short:2 commodities:2 growth:1
stock_ABT r_down	's:2 $:7 puts:1 pay:1 million:1 list:2 2010:1 him:1 ten:1 pharma:1
stock_ABT r_down	used:1 's:1 neck:1 --:1 stent:1 granted:1 expanded:1 arteries:1 treat:1 approval:1 clogged:1
stock_ABT r_up	heart:2 all:1 because:2 pin:2 process:1 cited:1 three:1 '':2 visible:1 imaging:1 including:1 remove:1 world-wide:1 ring:2 yet:1 its:2 fifth:1 confirmed:2 affects:1 review:1 sale:1 system:2 withdrawn:2 equipment:1 details:1 leaky:2 markets:1 ``:2 used:2 patient:1 after:1 but:1 delivery:2 part:2 recalled:2 designed:1 fall:2 catheter:5 one:1 cases:1 died:1 case:1 has:2 off:3 being:1 recall:1 days:1 together:2 n't:1 fell:1 can:2 surgery:1 make:1 valves:2
stock_ABT r_up	heart:1 major:1 autoimmune:2 often:1 causes:2 disease:2 chronic:2 large:2 colon:2 analysis:1 watched:1 best:1 before:1 even:1 n't:2 arteries:1 8.5:2 lining:2 severe:2 16.5:2 clinical:2 treatment:3 new:1 weeks:6 moderate:2 9.3:2 week:2 do:1 after:2 's:6 option:1 though:1 pose:1 ulcerative:2 cheaper:1 met:2 eight:4 closely:1 248:2 colitis:4 placebo:2 showed:1 getting:1 did:1 study:3 percentage:2 according:1 drug:3 52:4 try:1 stents:1 patients:5 risks:1 rose:2 clogged:1 endpoints:2 treated:2
stock_ABT r_up	heart:1 major:1 often:1 analysis:1 watched:1 best:1 before:1 even:1 n't:2 arteries:1 treatment:1 new:1 do:1 option:1 though:1 pose:1 cheaper:1 closely:1 showed:1 getting:1 did:1 study:1 according:1 drug:1 try:1 stents:1 patients:1 risks:1 clogged:1
stock_ABT r_up	good:1 's:1 less:1 drugs:1 make:1 companies:1 drug:1 treatment:1 same:1 news:1 makes:1 those:1
stock_ABT r_down	oncology:2 cancer:1 executive:2 raised:1 ninth:2 questions:1 vote:1 thinks:1 fifth:2 sell:1 given:1 decision:2 marketed:1 comments:2 should:1 priority:1 application:1 clinical:1 safety:1 details:4 test:2 new:1 effectiveness:1 status:1 's:5 after:1 diagnostic:2 expected:2 involving:1 timing:2 beginning:2 panel:1 --:1 12th:2 study:1 drug:2 whether:1 continue:1 similar:1 experimental:1
stock_ABT r_up	payout:1 looking:1 sure:1 company’s:1 investors:1 healthy:1 make:1 dividend-paying:3 companies:1 but:1 includes:1 assess:1 need:1 likely:1 continue:1 yield:1 loves:1 carefully:3 stocks:2 stock:1
stock_ABT r_down	raised:1 revised:1 outlook:1 growth:1 questions:1 label:1 its:2 pharmaceutical:1 said:1 based:1 leverage:1 discussion:1 marketed:1 expectations:1 elevated:1 should:2 clinical:1 safety:1 include:1 's:1 company:1 but:1 results:1 lowered:1 device:1 panel:1 effectiveness:1 --:1 study:1 keep:1 continue:1 medical:1
stock_ABT r_up	's:1 spectrum:1 across:1 high:1 near:1 three-year:1 market-cap:1 sees:1 opportunity:1 its:1 500:1
stock_ABT r_down	cancer:1 core:1 over:1 sales:2 one:1 13,000:1 against:1 year:1 its:1 pharmaceutical:1 said:1 $:1 million:2 trial:2 had:1 three:1 increase:1 clinical:1 which:2 test:1 280:1 meeting:1 betting:1 do:1 used:1 's:3 risk:1 drugs:1 company:1 arthritis:2 blockbusters:1 reflect:1 offsetting:1 biologic:1 hopes:1 data:1 loss:1 last:1 older:1 --:1 boost:1 annual:1 well:1 according:1 drug:3 n't:3 flagship:1 patients:2 products:1 rheumatoid:1 maker:1 patents:1 head-to-head:1
stock_ABT r_down	comment:2 prevent:2 already:1 heart:5 researcher:1 certain:2 reduce:2 industry:1 disease:2 '':1 alone:1 actively:1 trading:1 against:1 statin:2 11th:1 cardiovascular:1 blow:1 adding:2 officials:1 would:2 failed:1 rose:1 harness:1 shares:1 good:1 looking:2 drugs:1 3:1 clinical:3 health:1 4:1 fourth:1 finding:2 --:5 attacks:3 2011:1 events:2 500:1 higher:1 known:1 ``:1 after:2 's:8 risk:3 whose:1 strokes:3 put:1 cholesterol:3 stop:1 treatments:2 early:2 were:1 halted:1 designed:1 saying:1 cardiac:1 stocks:1 than:1 involving:1 session:1 weapon:1 lower:1 look:1 17:1 n't:2 whether:2 statins:1 study:1 climbed:1 companies:1 up:1 drug:3 looked:1 trial:4 patients:2 points:3 stopped:1 graph:1 did:2 efforts:1 more:1 traded:1 taking:1
stock_ABT r_down	1.5:2 climbed:1 weight:2 spring:2 over:2 move:2 down:2 paper:2 tablets:2 combining:1 flight:2 electronic:1 its:2 unit:2 8.1:1 25:2 5.2:1 said:4 actively:1 winter:2 22:1 rose:1 irony:1 distributed:2 shares:1 health:1 treatment:1 which:2 issue:2 company:2 500:1 higher:1 's:11 closed:1 whose:1 manuals:4 line:2 records:1 cut:2 plan:2 military:1 100:2 stocks:1 exposure:1 session:1 past:2 namesake:2 pounds:4 follows:2 required:2 companies:1 up:1 against:2 traditional:2 trial:2 trading:1 points:3 place:2 airline:2 after-hours:1 weigh:2 pilots:6 documents:2
stock_ABT r_up	says:1 few:1 strokes:1 study:1 increase:1 may:1 too:1 mean:1
stock_ABT r_down	promoted:1 illegally:1 document:1 not:1 government:1 whether:1 company:1 probe:1 according:1 drug:1 held:1 regulators:1 settle:1 uses:1 talks:1 court:1 has:1 approved:1
stock_ABT r_down	comment:2 suspend:2 says:2 proposed:2 sixth:2 testing:3 cash:2 13th:2 second:2 sufficient:2 its:3 market:2 size:2 n't:2 said:4 additional:3 would:2 comments:2 clinical:5 details:2 conduct:3 appeal:2 ever:2 grows:2 stock:4 development:3 requested:2 tests:2 plunge:2 's:4 plans:6 drugs:2 doubt:2 company:3 after:3 reach:2 diet:3 seventh:2 regulators:3 levels:2 updates:4 background:2 prices:4 news:2 estimate:2 beginning:2 fifth:2 high:2 bar:2 third:2 explore:2 markets:2 taking:2 request:2 unnecessary:2 drug:5 foreign:2 defends:2 trial:4 obesity:2 more:2 asked:3 experimental:3
stock_ABT r_down	operations:2 named:2 investors:1 executive:2 years:2 see:2 through:2 committee:2 year:1 led:2 its:2 functions:2 merger:4 leading:2 him:2 member:2 role:2 chairman:2 which:2 largest:2 surprise:1 meeting:1 across:2 combined:2 's:7 form:2 company:4 traffic:2 plenty:1 new:2 former:2 bank:2 he:2 --:2 32:2 could:1 spent:2 banking:2 2001:2 airline:2 buzz:1 businesses:2 completing:2
stock_ABT r_up	heart:2 appeals:1 metal:1 over:1 some:1 intellectual:1 four:1 patents:1 have:1 sought:1 coatings:1 along:1 scoring:1 court:2 which:1 2010:1 ruling:2 way:1 big:1 earlier:1 backed:1 frequently:1 relating:1 companies:1 stents:2 victories:1 affirmed:1 drug-coated:1 were:1 property:1 came:1
stock_ABT r_up	medication:1 associated:1 executive:1 known:1 because:1 its:1 use:1 said:1 top:1 marketed:1 profitability:1 recommending:1 which:1 injury:1 nutrition:1 risk:1 business:1 atop:1 leadership:1 hopes:1 spur:1 change:1 recent:1 has:1 improved:1 limits:1 rival:1 drug:1 muscle:1
stock_ABT r_up	catch:1 imports:1 executive:1 customers:1 '':1 facilities:1 curb:1 year:1 helm:1 margins:3 total:1 its:1 fifth:1 generates:1 closer:1 again:1 said:3 court:1 baby:1 profit:3 veteran:1 profitability:1 seller:1 opener:1 safety:1 unit:2 which:2 formula:2 matched:1 boost:1 atop:1 stock:1 nutrition:3 ``:1 health-care:1 's:4 plans:1 business:2 food:1 price:1 health-overhaul:1 took:1 sales:1 leadership:1 updates:1 recent:1 hopes:1 eye:1 law:1 spur:1 change:1 improve:1 building:1 has:1 improved:1 16:1 --:2 rival:1 cap:1 up:1 sells:1 conference:1 costs:1 those:1 can:1 were:1 top:1 trying:1
stock_ABT r_up	turmoil:1 now:1 better:1 bonds:2 beat:2 dividends:2 over:2 offer:1 than:1 blue-chip:1 writes:1 income:1 many:1 stocks:1 top:2
stock_ABT r_down	cancer:1 people:2 dose:4 curb:1 measure:2 suffer:2 open:2 its:2 digest:2 out:2 feeding:2 lead:2 provide:2 hospital:1 had:2 food:2 enough:2 unable:2 which:2 suit:1 new:2 fibrosis:2 immunity:1 more:2 may:2 capsule:4 produce:2 therapy:2 they:2 approval:2 harnessing:1 pancreatic:6 38:2 reducing:1 portion:2 properly:2 each:2 replacement:2 cystic:2
stock_ABT r_up	global:4 years:3 comments:2 its:1 based:2 $:6 stent:4 charge:2 4:5 role:1 remaining:1 background:2 eroded:2 --:6 significantly:2 testing:1 some:1 competition:2 devices:1 eliminating:2 said:2 decision:1 per:1 exit:7 leader:1 jobs:2 business:1 million:1 peer:1 declining:2 competes:1 created:1 industry:2 leaving:1 drug-coated:5 major:1 already:1 cancer:1 throughout:2 market:15 pharmaceutical:1 puts:1 tiny:1 slumping:1 molecular:2 ``:2 buy:1 offer:1 grabs:1 company:6 plants:2 target:1 up:3 aims:1 project:2 pace:2 following:2 next-generation:2 closing:2 called:1 acquisition:1 heart:3 sees:2 share:5 sales:5 '':2 player:1 keep:2 stents:4 47:1 make:1 stake:1 same:1 tight:2 concerns:2 5:1 details:2 's:7 plans:2 price:1 cement:1 blood:1 billion:6 off:2 calls:2 amid:2 later:1 metal:1 1,000:2 valuing:1 diagnostics:2
stock_ABT r_up	cancer-drug:1 biotech:3 unintended:1 help:1 speed:1 its:1 eye:2 shares:1 ahead:1 medicine:1 meeting:1 firm:1 's:1 jumps:1 lift:1 approval:1 stocks:3 consequences:1 exits:1 drug:2 reviews:1 stents:1 energizes:2
stock_ABT r_up	firm:1 dividends:1 drug:1 tradition:1 continue:1 its:1 raising:1
stock_ABT r_up	upfront:2 395:2 reached:2 85:2 fee:2 develop:2 $:4 pay:2 also:2 potential:2 treatment:4 which:2 psoriasis:2 arthritis:2 's:2 company:2 million:4 agreement:6 includes:2 milestone:2 companies:2 up:2 products:2 payments:2 rheumatoid:2
stock_ABT r_down	wants:1 's:2 risk:1 statins:1 retool:1 towel:1 throws:1 diabetes:1
stock_ABT r_down	among:1 help:1 kidney:1 released:1 may:1 study:1 condition:1 disease:1 drug:1 according:1 chronic:1 patients:1 treat:1 mid-stage:1 new:1 frequently:1 data:1 progressive:1 experimental:1
stock_ABT r_up	raised:1 effectiveness:1 prescription:1 study:1 since:1 results:1 drug:1 volume:1 questions:1 cholesterol:1 's:2 has:1 its:1 declined:1
stock_ABT r_up	heart:1 use:1 often:1 attacks:1 treat:1 study:1 $:1 new:1 disease:1 suggests:1 patients:1 suffering:1 too:1 doctors:1 quick:1 artery:1 20,000:1 procedure:1 common:1
stock_ABT r_down	opportunities:1 catalysts:1 have:1
stock_ABT r_up	whose:1 watch:2 companies:1 shares:1 trade:1 active:1 see:1 session:1 expected:1
stock_ABT r_down	emerging:2 help:2 dollar:3 outlook:1 rest:1 ending:1 course:1 including:3 signs:1 talks:1 debt-ceiling:2 headlines:1 initiations:2 its:8 ground:1 impact:2 $:8 investor:1 had:1 citing:1 lawmakers:1 2011:1 details:1 updated:1 big:2 rise:1 watch:2 results:1 early:1 updates:1 background:1 performance:1 continued:6 --:6 outperform:2 50:13 morning:1 stock:4 view:4 some:1 see:2 growth:7 year:1 our:4 index:2 said:3 parent:1 3rd:1 profit:3 comments:1 forecast:1 does:2 juggernaut:1 progress:4 falling:2 dominate:1 sluggish:2 prescriptions:2 approvals:2 reported:3 regulatory:2 100:1 debt:2 beginning:3 gained:2 pipeline:2 broad-based:2 study:2 36:1 drug:3 trial:2 rose:7 slightly:1 housing:1 raised:3 ceiling:2 revenue:5 throughout:1 pharmaceutical:4 strong:1 additional:1 data:1 5th:1 there:1 add:1 been:1 clinical:2 spike:3 markets:2 500:1 ``:3 share:4 company:3 pleased:2 new:2 gain:5 second-quarter:5 raising:1 '':3 up:2 optimism:1 n't:2 while:4 're:2 today:1 spotlight:2 weaker:3 proprietary:2 investors:1 resolving:1 health-care:1 tax:3 sales:5 helped:3 full-year:3 reports:2 seen:2 blockbuster:2 technology:1 also:5 earnings:11 9:3 commentary:1 several:2 economy:2 product:2 's:5 price:2 earlier:2 date:1 robust:1 segment:2 recent:2 medical:2 futures:4 well:2 cheer:1 points:3 debate:1
stock_ABT r_up	advisory:1 saying:1 defect:1 29:2 reports:2 use:1 additional:1 federal:1 surprises:2 patients:1 also:1 genetic:1 advisories:2 safety:1 earnings:2 panel:1 more:1 's:3 seeking:1 backed:1 comeback:1 quarters:1 data:1 $:2 roundup:1 companies:1 drug:1 while:1 future:1 pediatric:1 making:1 male:1 corporate:1 latest:1
stock_ABT r_down	less:2 issued:1 others:1 product:1 including:1 7.4:1 market:1 dominates:1 appear:1 would:1 provide:1 contains:1 reality:1 only:1 potential:1 role:1 treatment:4 which:1 2010:1 new:2 pill:1 play:1 full:1 's:1 option:1 mostly:1 combination:1 treatments:1 but:1 sales:1 blue-chips:1 effects:1 coming:1 debt:1 data:1 than:1 $:1 billion:1 regimen:2 working:1 third:1 developing:1 --:4 disease:1 drug:1 maker:1 continue:1 quarter:1 side:1 came:1 risky:1
stock_ABT r_down	heavy:1 because:1 less:2 tax:1 sales:1 disease:1 mostly:1 7.4:1 spinoff:1 its:1 market:1 dominates:1 but:1 $:1 would:1 provide:1 contains:1 compelling:1 only:1 potential:1 potentially:1 treatment:4 animal:1 which:1 2010:1 health:1 bill:1 pill:1 product:1 full:1 's:1 option:1 business:1 leaning:1 combination:1 treatments:1 new:1 scrutiny:1 viewing:1 effects:1 coming:1 article:1 role:1 data:1 billion:1 regimen:2 quarter:1 working:1 third:1 antitrust:1 --:4 developing:1 sale:1 drug:1 maker:1 continue:1 published:1 including:1 toward:1 side:1 came:1
stock_ABT r_down	sell:1 lowers:1 's:2 business:1 maximum:1 dose:1 recommended:1 baby-formula:1 evaluating:1 prepares:1
stock_ABT r_down	opposition:1 deal:1 some:1 businesses:1 its:2 sell:3 pharmaceutical:1 giant:2 said:1 $:1 due:1 comments:1 dairy:2 5:1 has:1 2010:1 noncore:1 nutrition:2 's:4 business:3 company:1 million:2 background:1 agreement:2 restructuring:1 part:1 lenders:2 debt:1 off:1 --:5 required:1 signed:2 repay:1 divest:1 starting:1 called:1
stock_ABT r_down	1.7:1 filed:1 player:1 associates:1 trading:1 2.5:1 $:2 pay:1 acquire:1 three:1 than:1 insider:1 announced:1 more:1 complaint:1 his:1 's:1 plans:1 million:2 baseball:1 others:1 buyout:1 former:1 made:1 ahead:1 charges:1 settle:1 illegal:1 professional:1 profits:1 charged:1
stock_ABT r_up	his:1 court:1 ahead:1 insider:1 provide:1 baseball:1 agreed:1 some:1 three:1 against:1 fight:1 player:1 trading:1 potential:1 5:3 others:1 professional:1 buyout:1 ammunition:1 former:1 charged:1
stock_ABT r_up	major:1 overpriced:1 bargain:1 increasingly:1 some:1 results:1 competitive:2 years:2 bring:1 second:2 used:1 bust:1 questions:2 its:1 market:3 make:1 really:1 stocks:1 would:1 positive:2 away:1 seems:1 two:1 least:1 your:1 come:1 more:1 effectiveness:1 meeting:1 shows:2 all:1 full:1 multiple:2 risk:1 cheap:1 time:1 treatments:1 but:1 bringing:1 reported:2 step:1 effects:1 one:1 data:4 than:1 look:2 great:1 increasing:1 fit:1 effective:1 --:4 many:1 study:2 required:1 sclerosis:2 likely:1 drug:4 side:1 n't:1 trial:1 remain:2 caveat:1 enter:1 latest:1 medical:1 experimental:2 first:2
stock_ABT r_up	adviser:1 his:1 's:1 campaign:1 company:1 against:1 four:1 important:1 shareholder:1 drug:1 members:1 unseat:1 has:1 board:1
stock_ABT r_up	appeals:2 challenged:2 into:5 preserving:3 allegations:2 ninth:2 one:2 '':2 judge:5 drug:5 exclusivity:3 federal:3 market:3 sell:2 blockbuster:2 patent:7 beginning:2 had:2 copies:2 2019:5 details:2 upheld:3 pill:3 stock:2 preserve:2 ``:2 's:10 detail:2 seventh:2 cheaper:2 protection:2 prices:2 effort:2 calls:2 --:6 barring:2 generic:2 ruling:2 16th:2
stock_ABT r_up	happy:1 tears:1 end:3 crusade:2 s:1 latest:1 come:1 he:1
stock_ABT r_down	n't:3 done:1 yet:1
stock_ABT r_up	encouraging:1 '':1 chronic:2 determine:1 cholesterol:1 80:1 its:1 said:2 raise:1 trials:1 granted:1 fight:1 cell:1 prognosis:1 genetic:2 clinical:1 helps:1 test:2 white:1 molecular:1 type:1 common:1 ``:1 good:1 's:3 form:1 boosted:1 after:1 leukemia:4 results:1 reported:1 detect:1 designed:1 diagnostics:1 cases:1 diagnostic:1 business:1 most:1 --:1 infections:1 according:1 drug:2 patients:1 can:1 were:1 found:1 clearance:1 head:1 maker:1 blood:1
stock_ABT r_up	says:1 investors:1 pro:1 some:1 results:1 looks:1 broader:1 market:1 long:1 should:1 which:1 largest:1 mend:1 has:1 into:1 his:1 's:1 weakness:1 quarterly:1 favorites:1 device:1 world:1 buying:1 like:1 announcing:1 solid:1 long-term:1 maker:1
stock_ABT r_up	than:2
stock_ABT r_down	hire:1 incentives:1 offering:1 state:1 loophole:1 offered:1 within:1 tax:2 while:1 one:1 companies:1 job:1 growth:1 businesses:1 plan:1 close:1 promote:1 corporate:1 workers:1 designed:1
stock_ABT r_up	load:1 shrinks:1 win:1 market:1 rapid:1 pay:1 agency:1 rewarding:1 lung-cancer:1 genetic:1 's:4 targeted:1 dividends:1 therapy:1 approval:1 approved:1 rare:1 tumors:1 companies:1 drug:1 patients:1 latest:1
stock_ABT r_up	benefit:1 tests:1 like:1 targeted:1 likely:1 but:2 diagnostic:1 patients:1 identify:1 can:1 therapies:1
stock_ABT r_up	shop:1 less:2 money:1 month:1 report:1 purchasing:1 using:1 22:2 had:3 shortcut:1 actually:1 0.5:1 has:1 them:1 bonds:1 safe:1 break:1 they:1 not:1 during:1 argues:2 investor:1 lost:1 countries:1 identifying:2 companies:2 set:1 list:1 some:2 back:1 past:2 cost:1 home:1 insurance:1 even:1 provided:1 appear:1 research:1 print:1 ability:1 were:1 story:1 credits:3 protection:1 put:1 dividend:1 safer:1 protect:2 her:1 country:1 larger:1 discussed:1 against:2 times:1 credit:1 s:3 point:1 previously:1 betting:1 sovereign:1 corporations:2 use:1 would:1 two:1 been:1 their:1 way:1 survive:1 today:1 ``:1 funds:1 stress:1 gain:1 than:4 he:1 wherewithal:1 kind:1 made:2 default:2 while:1 can:1 many:1 property:1 risky:1 1.7:1 investors:1 almost:1 tax:1 argument:1 0.6:1 periods:1 have:3 seen:1 payers:1 information:1 compared:1 spreads:1 same:1 instance:1 recommended:1 arguments:1 which:1 subsidiaries:1 bets:2 multiple:1 may:1 yesterday:1 tied:1 most:1 courtesy:1 70:4 multinationals:1 proxies:1 weekend:1 recent:1 lower:2 seize:1 3-7:1 starting:1 costs:1 corporate:1
stock_ABT r_down	even:1 do:2 such:1 says:1 risk:1 higher:1 blue-chip:1 top:1 some:1 prosper:1 n't:2 matter:1 yields:1 low:1 income:1 dividend:1 firms:1 stocks:3 than:1 best:2 out:1
stock_ABT r_up	help:1 valuable:1 month:1 down:3 likely:1 weather:2 portfolio:2 beyond:1 your:2 market:2 writes:1 recession-proof:2 storms:3 same:1 3:2 markets:1 head:1 batten:1 today’s:1 stocks:3 true:1 weathering:1 extreme:1 tactics:1 assets:1 level:1 hatches:3 keep:1 choppy:1
stock_ABT r_down	all:1 associated:1 certain:1 timing:2 rate:1 including:2 drug:1 reports:1 says:1 alternative:1 blockbuster:1 its:1 market:2 said:2 adverse:1 trials:1 veteran:1 also:1 yield:2 clinical:2 health:1 rates:1 markets:1 across:1 higher:1 comparable:1 buy:2 drugs:1 dividends:1 arthritis:1 problems:1 treatments:1 but:1 reported:1 death:1 letter:1 hopes:1 dividend:2 line:1 those:1 treating:1 volatile:1 showed:1 oral:1 solution:1 analysis:1 pill:1 trial:1 can:1 were:1 serious:1 rheumatoid:1 other:1 experimental:1
stock_ABT r_down	billion:1 's:2 $:1 could:1 sales:1 see:1 peak:1 says:1 2.6:1
stock_ABT r_up	because:1 executive:1 years:1 drug:1 arm:1 said:1 top:1 candidates:1 has:1 more:1 partly:1 diseases:1 but:1 focusing:1 than:1 recent:1 acquisitions:1 license:1 fewer:1 deals:1 drug-discovery:1 promising:1
stock_ABT r_down	prospects:1 takeover:1 's:1 target:1 according:1
stock_ABT r_up	comment:1 development:1 sees:1 secure:1 proposed:1 year:1 regulatory:1 approval:2 heels:1 throughout:1 said:1 positive:1 potential:1 safety:3 details:1 conduct:1 2014:2 reviving:1 stock:1 week:1 after:1 's:1 plans:1 resume:1 price:1 earlier:1 rejected:2 regulators:1 diet:3 background:1 new:1 hopes:2 news:1 last:1 third:1 --:3 rival:1 could:1 drug:4 trial:1 were:1 updates:1 grounds:2
stock_ABT r_down	development:1 said:1 2014:1 showed:1 resume:1 meetings:1 after:1 yesterday:1 late:1 planned:1 approval:1 path:1
stock_ABT r_up	physicians:1 said:1 like:1 consumers:1 stents:1 --:1 implants:1 make:2 defibrillators:1 companies:1 devices:1 face:1 challenges:1 spinal:1 note:1 continue:1 trips:1 fewer:1 implantable:1 offices:1 medical:1
stock_ABT r_down	suggests:1 right:1 consider:2 get:1 month:1 into:1 safe:1 back:1 falls:2 simple:1 finally:1 too:1 which:1 act:1 timing:1 8:2 model:1 stocks:2 soon:1 market:2 volatility:2
stock_ABT r_up	``:2 's:2 deliver:1 companies:1 '':2 state:1 looks:1 stable:1 regardless:1 economy:1 earnings:1
stock_ABT r_up	deck:1 money:3 unlikely:1 need:1 moves:2 yet:1 market:1 out:1 little:1 top:1 5:2 storm:1 instead:1 has:1 tolerance:1 yield-hunting:2 risk:1 get:1 most:2 now:2 borrowers:1 trader:3 points:1 making:2 corporate:1 bond:1
stock_ABT r_up	lowest:1 because:1 says:1 projection:1 facility:2 we:1 years:1 '':1 quotes:2 year:1 throughout:1 its:1 additional:1 disruptions:1 point:1 expectations:1 analyst:1 current:1 their:1 production:1 earnings:2 2011:3 details:1 slashes:1 ``:1 's:2 1/2:1 company:2 problems:1 sales:2 job:1 fell:1 slashed:1 2:1 continued:1 than:1 bigger:1 represents:2 --:4 shipping:1 thought:1 quarter:2 maker:1 medical-device:1
stock_ABT r_up	operations:5 background:2 less:4 move:3 allegations:2 splitting:1 years:1 four:4 baby:2 session:6 businesses:4 comments:1 broader:4 portfolio:1 headlines:1 settlement:2 decisions:1 its:13 whose:5 $:11 dividing:1 also:1 rose:7 expectations:2 should:1 charge:3 other:3 disclosed:1 allow:2 continued:2 7:1 details:3 include:3 remaining:2 divergent:1 4.4:2 customers:1 global:1 risk:1 government:2 very:1 watch:5 possible:1 foremost:1 early:1 updates:2 they:1 surprise:2 report:1 world:1 trade:3 new:1 name:2 6.7:2 staples:4 lost:3 --:17 54:2 companies:13 53:1 morning:1 tech-sector:1 benefit:1 predicted:2 each:1 including:2 higher:6 rheumatoid:1 investors’:1 shed:4 set:4 trend:1 51:2 successfully:1 separated:1 see:1 actively:5 trading:5 value:1 year:1 separating:2 edged:2 drove:2 investment:1 out:1 index:4 said:6 potential:2 missed:2 profit:3 blue-chip:4 recorded:2 remain:4 shares:7 increase:1 favor:1 investigation:2 health:4 adapt:1 closed:1 formula:2 approach:1 price:2 arthritis:1 recently:2 dropped:1 handful:1 continuing:1 diagnostic:2 restructuring:1 add:1 defensive:4 diagnostics:2 active:1 news:4 generates:1 strong:8 unauthorized:2 care:4 advance:4 quarter:1 industry:1 climbed:1 positioning:1 reports:3 keep:2 sensitive:4 fell:5 products:12 analysts:3 mixed:10 traded:4 after-hours:4 plan:1 biologics:1 named:2 slipped:2 revenue:6 third:1 into:4 nutritional:2 number:4 third-quarter:3 down:3 66:3 away:1 computer:2 results:2 throughout:1 telecommunications:4 unit:5 pharmaceutical:7 shareholders:4 rises:3 much:2 would:1 powered:4 8.9:1 breakup:1 create:1 two:7 pharmaceuticals:7 2:5 stock:3 way:1 expected:2 9.5:1 branded:2 500:3 more:3 wants:1 flat:2 ``:1 0.2:2 through:1 premarket:1 company:14 but:6 sales:4 chips:2 shortfall:2 upbeat:2 hopes:2 spin:4 analyst:1 '':1 13:2 12:1 14:2 publicly:2 19:3 split:2 up:1 devices:4 probe:1 while:1 economic:2 were:4 promoted:2 making:1 17:2 could:1 history:1 1.5:4 slid:2 proprietary:2 minds:1 investors:8 1.3:1 0.1:2 bigger-than-expected:2 diversification:1 health-care:1 0.5:2 0.4:2 0.7:2 weighed:7 caution:4 drug:4 close:1 sells:2 blockbuster:1 check:1 gains:4 sell:2 fourth-quarter:4 different:2 fiscal:2 generic:2 things:1 make:1 45:1 able:1 planned:1 complex:1 stemming:2 earnings:19 which:5 command:2 economy:7 gaining:1 added:6 's:23 plans:5 separate:3 valuation:2 footprints:1 sets:1 utilities:4 forecasts:2 most:1 levels:1 uses:2 72:1 adds:1 stocks:11 data:2 recent:1 billion:2 lower:1 short:2 off:4 assets:1 sectors:4 charges:3 medical:13 later:2 cover:2 notebook:2 points:15 so:4 components:4 healthcare:1 consumer:4 responded:2 came:4
stock_ABT r_up	saying:1 all:1 help:2 over:1 4th:1 quarters:1 quotes:1 exclusivity:1 settlement:2 litigation:3 25:4 $:1 graph:1 advisories:2 under:3 2014:3 2013:3 details:1 risk:1 possibly:2 fall:1 defibrillator:1 2nd:1 loss:2 --:14 companies:1 loses:1 cholesterol:2 quarter:1 diabetes-drug:1 because:1 says:1 deal:1 headwinds:1 related:1 morning:1 said:1 profit:1 comments:1 research:1 52-week:1 version:2 provides:1 new:1 conditions:1 terms:2 business:1 weak:1 agreement:1 reported:1 expire:1 offset:2 news:1 strong:1 beginning:2 antipsychotic:1 roundup:2 pipeline:1 launch:3 certainty:1 drug:3 protection:1 context:1 surprises:2 financial:1 top:1 comment:1 tough:2 heart-rhythm:1 feel:1 intellectual:1 third-quarter:1 rising:1 another:1 reached:1 throughout:1 market:4 decline:1 takes:1 5th:1 due:1 much:1 low:1 expected:1 important:1 ``:3 selling:1 company:3 removes:1 but:2 gain:2 prices:1 posted:1 're:1 smart:1 property:1 industry:1 heart:1 weaker:1 sees:1 certain:1 sales:3 '':3 say:1 reports:1 blockbuster:1 5.7:1 generic:4 imminent:1 setting:1 5:3 earnings:3 which:1 you:2 stock:1 begin:1 's:6 plans:2 may:1 collaboration:1 fell:2 future:1 third:1 amid:1 maker:1 patent:5 costs:2 time:1 corporate:1 filing:1 medical-device:1 latest:1
stock_ABT r_down	billion:1 pharmaceutical:1 head:1 said:1 $:3 developing:1 drugs:1 company:1 annual:1 sales:1 than:1 1:1 potential:1 experimental:1 several:1 generate:1 unit:1 more:1
stock_ABT r_down	good:1 upcoming:1 corporate:1 watch:2 reports:1 early:1 dominating:1 earnings:1 another:1 headlines:1 makes:1 acquisition:1 otherwise:1
stock_ABT r_up	limited:1 autoimmune:1 mobility:1 doses:1 spinal:1 signs:1 reducing:1 its:1 given:1 said:1 lead:1 symptoms:1 which:1 new:1 cause:1 shows:1 five-year:1 pain:1 joint:1 fuse:1 fatigue:1 125:1 active:1 assessed:1 severely:1 effective:1 spine:2 study:2 disease:1 drug:1 morning:1 patients:1 can:2 were:1 position:1 fixed:1 bone:1
stock_ABT r_up	heart:2 medication:1 tap:1 omega-3:1 increasingly:1 fish:1 global:1 results:1 high:1 dietary:1 performed:1 have:1 acid:1 its:1 market:1 conference:1 pharmaceutical:1 said:1 develop:1 consumers:1 stent:2 pharmaceuticals:1 only:1 does:1 health:1 build:1 has:1 division:1 product:1 's:2 company:1 regulators:1 uses:1 demand:1 approved:1 both:1 sell:1 prescription:1 like:1 being:1 conscious:1 --:1 according:1 drug:1 n't:1 trial:1 healthcare:1 growing:1 become:1 consumer:1 having:1 experimental:1
stock_ABT r_down	among:1 deal:1 infections:1 agreed:2 share:2 known:1 89:1 hepatitis:3 80:1 blockbuster:1 its:1 market:2 $:5 no:1 pay:2 placing:1 per:2 better:1 potential:1 which:1 new:2 over:1 mainly:1 stock:1 billion:1 premium:1 drugs:2 big:1 company:1 acquire:1 treatments:2 virus:1 updates:1 background:1 prices:1 additional:1 11:1 reaction:1 developing:1 --:3 just:1 companies:1 drug:1 tiny:1 race:1 products:1 analysts:1 highlights:1 growing:1 employees:1 bet:1 nearly:1
stock_ABT r_down	bolster:1 drug-eluting:1 said:1 heart:1 stent:1 charge:1 move:1 while:1 its:2 current:1 quarterly:1 regulators:1 future:1 adding:1 have:1 expected:1 next-generation:1 approved:1 profits:1 earnings:1
stock_ABT r_down	but:1 pharma:1 could:1 technicians:1 revisit:1 long-term:1 say:1 promise:1 lows:1 indices:1 sees:1 one:1
stock_ABT r_up	right:1 financial:1 help:1 your:1 before:1 patent:1 its:1 start:1 treatment:1 goes:1 biggest:1 you:1 week:1 tests:1 's:2 business:1 company:1 news:1 trying:1 day:1 case:1 protect:1 pitting:1 industry:1 disease:1 against:1 morning:1 growing:1
stock_ABT r_down	plant:1 increasing:1 's:3 manufacturing:1 big:1 cited:1 posed:1 drug:2 reliance:1 challenges:1 regulators:1 contractors:1 lapses:1 highlighting:1 troubled:1 quality:1 makers:1 manufacturer:1
stock_ABT r_up	excessive:1 doing:1 you’re:1 individual:1 have:1 any:1 market:3 cut:2 no:1 concerned:1 genius:1 volatile:2 way:1 you:1 stock:2 isn’t:1 then:1 designs:1 risk:2 mostly:1 retirement:1 one:1 investor:1 day:1 volatility:1 favors:1 trader:1 smooth:1 times:2 become:1 ride:1
stock_ABT r_up	named:1 executive:1 year:1 stint:1 seen:1 its:1 out:1 wiped:1 hepatitis:1 next:1 which:1 new:2 has:1 stock:1 retire:1 recently:1 gains:1 after:1 but:1 early:1 succeed:1 nearly:1 during:1 drug:1 chief:1 three-year:1
stock_ABT r_up	profitable:1 off:1 plans:1 business:1 medical-devices:1 into:1 focus:1 stand-alone:1 public:1 pharmaceuticals:1 company:1 franchise:1 increasing:1 spin:1 its:2 bigger:1 more:1
stock_ABT r_up	right:1 financial:1 help:1 underperforming:1 moves:1 your:1 grow:1 units:1 instead:1 kick:1 economy:1 's:1 business:1 wary:1 weak:1 but:1 important:1 focusing:1 news:1 day:1 acquisitions:1 off:2 like:1 many:1 companies:1 morning:1 risky:1
stock_ABT r_up	purchases:2 oncology:2 prevent:2 previously:2 distribute:2 primary:2 one:2 globally:2 through:2 medical-products:2 end:2 had:2 two:4 been:2 custom:2 other:2 agreements:4 which:4 under:6 2014:2 2018:2 core:2 extended:4 's:2 brand:2 maintains:2 infusion:2 jointly:2 agreement:2 promote:2 rights:2 --:4 companies:2 products:6 sets:2 distribution:2
stock_ABT r_down	leukemia:2 shed:2 guidance:2 autoimmune:2 1.1:2 revenue:4 cents:2 well:4 partnership:1 some:2 outlook:4 trade:2 7.3:2 actively:4 trading:2 priorities:2 have:1 year:2 recently:2 spin-off:1 its:12 unit:1 diseases:2 even:2 index:4 cut:2 end:1 5.5:1 48:1 rose:1 top:2 though:2 treatment:2 shares:7 1:1 points:3 lymphoma:2 declined:2 fourth:2 expected:2 lowered:2 company:2 earnings:2 agreement:2 's:9 microprocessor:2 whose:2 contracts:2 share:2 couple:2 said:2 problems:2 13:1 terminate:2 hurt:2 fell:3 because:2 changing:2 line:2 stocks:2 potential:2 $:2 lower:2 portfolio:2 room:1 lost:2 chronic:2 according:2 premarket:2 companies:4 told:2 drug:5 prior:2 session:4 including:2 were:2 following:1 raised:2 climb:1 quarter:4 traded:2 maker:5
stock_ABT r_up	session:1 index:2 lower:1 's:1 1.1:1 lost:1 1.3:2 whose:1 companies:1 shed:1 shares:1 actively:1 trading:1 after-hours:1 stocks:1 traded:1 declined:1
stock_ABT r_down	500:3
stock_ABT r_down	them:1 gets:1 gains:1 defy:2 anyway:1 but:1 fickle:2 market:2 letter:1 capital:1 doesn’t:1 writes:1 worry:1
stock_ABT r_down	certain:1 nutritional:1 sales:1 trade:1 helped:1 see:4 growth:1 substantially:1 headlines:1 forecast:1 decline:1 said:1 profit:1 rose:1 decision:1 research:1 dominate:1 higher:3 draw:1 's:6 pediatric:1 includes:1 blowout:1 bid:3 attention:1 watch:4 but:1 results:1 early:1 they:1 others:1 active:1 stocks:1 session:1 12:1 could:1 well:1 takeout:1 more:1 costs:1 products:1 analysts:3 horizon:1 quarter:2 investors’:1 latest:1
stock_ABT r_down	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_ABT r_down	supply:1 10:3 toward:1 $:1 government:1 clutch:1 million:1 companies:1 agencies:1 drug:2 tropical:1 2020:1 diseases:1 nearly:1 new:1 push:1 aid:1 800:1 out:1 wipe:1 increased:1
stock_ABT r_up	pills:1 such:1 costly:1 cancer:1 rather:1 highlights:1 drug:1 fakes:1 simple:1 version:1 rising:1 threat:1 injectable:1 found:1 than:1 therapies:1 counterfeit:1
stock_ABT r_up	regulator:1 raised:1 said:1 's:1 weight:1 effective:1 people:1 possible:1 drug:1 helping:1 concerns:1 but:1 lose:1 long-term:1 obesity:1 side:1 effects:1
stock_ABT r_down	's:1 consider:1 targeting:1 patent:1 rheumatoid:1 bid:1 arthritis:1 treatment:1 subsidiary:1 save:1 lawsuit:1 its:1
stock_ABT r_up	named:1 investors:1 health-care:1 years:1 challenges:1 year:2 rally:1 market:2 giant:1 leading:1 been:1 should:1 few:1 finally:1 winners:1 trash:1 dogs:1 stock:1 ``:1 move:1 's:3 far:1 phase:1 such:1 past:1 last:2 largely:1 many:1 '':1 passing:1 think:1
stock_ABT r_up	's:1 prescription:1 lead:1 could:1 drug:1 more:1 weight-loss:1 which:1 new:1 backed:1 approval:1 first:1 than:1 decade:1 panel:1
stock_ABT r_up	``:2 good:1 solid:1 earnings:1 deliver:1 bad:1 times:1 '':2 manager:1 growth:1 can:1 picks:1 some:1 stocks:1 his:1 looks:1
stock_ABT r_up	bullish:3 record:1 long-term:1 worst:2 best:3 not:2 timers:1 balance:1 market:1 stock:1
stock_ABT r_up	hit:1 get:1 merger:2 industry:1 medical:1 small-cap:1 companies:1 up:1 here:2 years:1 pressures:1 likely:1 boom:2 coming:1 device:3 says:1 margin:1 analyst:3
stock_ABT r_up	session:2 whose:2 's:2 companies:2 shares:2 trade:2 actively:2 expected:2
stock_ABT r_down	reactions:1 says:1 do:1 into:1 life:2 '':1 need:1 unveiled:1 year:1 spinoff:1 its:2 out:1 pharmaceutical:2 moniker:1 evokes:1 prove:1 two:1 their:1 which:1 heritage:1 new:2 really:1 today:1 ruling:1 division:1 ``:3 's:5 parent:1 separate:1 company:2 jolted:1 word:1 spin:1 suggested:1 off:1 name:2 industry:1 later:1 companies:1 up:1 planned:1 mixed:1 biotechnology:1 more:1 discoveries:1 patents:1
stock_ABT r_down	disclosure:1 releasing:1 investors:1 selective:1 critics:1 certain:1 medical:1 changed:1 drug:1 society:1 said:1 policy:1 data:1 its:1 after:1
stock_ABT r_up	given:1 investors:1 depressing:1 news:1 has:1 more:1
stock_ABT r_down	billion:1 would:1 's:2 look:1 proposed:1 whether:1 taking:1 hard:1 some:1 29:1 diseases:1 access:1 merger:1 patients:1 used:1 impede:1 treat:1 costly:1 drugs:1 $:1
stock_ABT r_down	assess:1 heart:1 drugs:1 trials:1 better:1 recommended:1 clinical:1 risks:1 obesity:1 panel:1 more:1
stock_ABT r_up	drugs:1 patients:1 hepatitis:1 two:1 most:1 virus:1 small:1 studies:1
stock_ABT r_up	's:2 arthritis:1 ulcerative:1 been:1 drug:1 has:1 approved:1 colitis:1
stock_ABT r_down	week:1 heavy:1 industrial:1 's:3 features:1 well:1 reports:1 dose:1 construction:1 earnings:1 activity:1 calendar:1 manufacturing:1 data:1 other:1
stock_ABT r_up	among:1 people:1 one:1 see:1 trading:1 year:1 close:1 its:1 said:1 $:1 mortgage:1 petroleum:1 least:1 largest:1 9:1 include:2 selling:1 's:2 business:1 far:1 familiar:1 applications:1 active:1 stocks:2 billion:1 would:1 could:1 deals:1 matter:1 so:1
stock_ABT r_up	among:1 investors:1 sales:1 trade:1 helped:1 actively:1 through:1 's:3 headlines:1 blockbuster:1 rose:1 44:3 shares:1 hitting:1 growth:1 earnings:1 expected:1 sort:1 first-quarter:1 measures:1 watch:2 early:1 continued:1 companies:1 drug:1 session:1 corporate:1
stock_ABT r_down	sees:1 show:1 into:1 health-care:1 results:1 merit:1 earners:1 its:1 giant:1 split:1 stable:1 quarterly:1 has:1 more:1 questionable:1 's:1 separate:1 track:1 both:1 prospects:1 like:2 companies:1 together:1 while:1 products:1 act:1
stock_ABT r_up	regimen:1 drugs:1 completing:1 after:1 patients:1 hepatitis:1 according:1 four:1 most:1 virus:1 treatment:1 combining:1 new:1 weeks:1 study:1 experimental:1
stock_ABT r_up	hormone:1 's:2 stimulates:1 success:1 company:1 cell:1 credit:1 production:1 red:1 decision:1 bet:1 blood:1
stock_ABT r_up	turning:1 being:1 recall:1 stung:1 devices:1 eye-health:1 drugs:1 market:1 new:1 toward:1 company:1 damaging:1
stock_ABT r_up	health-care:1 trading:1 have:1 investment:1 hedge-fund:1 traders:2 insider:1 pending:1 gave:1 's:2 worse:1 far:1 early:1 investigating:1 than:1 buying:1 advance:1 word:1 whether:1 could:1 deals:1 banker:1 done:1 senior:1 2009:1
stock_ABT r_up	emerging-market:1 pinning:1 basics:1 get:1 company:1 ambitions:1 down:1 consumer-products:1 part:1 prepares:1 chili:1 its:1
stock_ABT r_down	cancer:1 some:1 brain:1 likely:1 lung:1 sells:1 its:1 kidney:1 pharmaceutical:1 cut:1 develop:1 generic:2 their:1 much:1 has:1 seeking:1 drugs:1 75:4 cutting:1 liver:1 prices:2 treating:1 medicines:1 companies:1 up:1 drug:1 cancers:1 businesses:1 efforts:1 maker:1
stock_ABT r_up	billion:1 1.6:3 $:3 federal:1 pay:1 agreed:1 marketed:1 allegations:1 drug:1 state:1 settle:1 uses:1 authorities:1 off-label:1 improperly:1
stock_ABT r_up	major:1 medication:1 setback:1 high:1 second:1 its:1 said:1 raise:1 had:1 failed:1 which:1 type:1 ``:1 good:1 designed:1 hopes:1 '':1 industry:1 drug:1 large:1 cholesterol:1 study:1
stock_ABT r_down	acquisitions:1 's:1 morning:1 banking:1 biggest:1 news:1 more:1 mergers:1 bankruptcy:1
stock_ABT r_up	do:1 muscles:1 's:3 greater:1 want:1 antitrust:1 business:1 country:1 agency:1 request:1 challenges:1 flexing:1 investigations:1 new:1 firms:1 powers:1 its:1 more:1
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	week:1 molecular:1 releases:1 cancer:2 society:1 drugs:1 shift:1 away:1 continuing:1 treatments:1 cells:1 medical:1 clinical:1 features:1 unique:1 data:1 display:1 target:1
stock_ABT r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	people:1 condition:1 results:1 known:1 signs:1 blockbuster:1 its:3 psoriatic:1 conference:1 delay:1 said:1 affects:1 support:1 severe:1 symptoms:2 majority:1 clinical:1 treatment:1 which:2 new:1 include:2 treat:1 's:2 estimates:1 bid:1 arthritis:2 ulcerative:2 expansion:1 700,000:1 released:1 uses:2 regulatory:1 approval:1 active:2 approved:2 colitis:2 treating:1 has:1 improved:1 moderate:1 medical:1 disease:2 drug:2 trial:1 patients:1 expand:1 2009:1 rheumatoid:1 could:1
stock_ABT r_down	clients:1 raised:1 via:1 's:2 $:1 biotech:1 far:1 companies:1 could:1 million:1 year:1 bankers:1 crop:1 soon:1 so:1 have:1 capital:1 new:1 balance:1 markets:1 staring:1
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_down	turmoil:1 retirement:2 way:1 programs:1 rather:1 ease:1 rise:1 offer:1 economic:1 interest:1 into:1 plunge:1 than:1
stock_ABT r_down	executive:3 quarters:1 through:1 shares:1 its:3 looking:1 20:1 $:2 had:1 capabilities:1 should:1 add:2 offers:1 disclosed:2 has:1 local:3 split:1 division:1 global:1 nation:1 background:1 --:5 fully:1 list:1 integrated:1 team:1 says:1 companies:2 estimates:1 3.0:1 year:1 11th:1 2.0:1 2.5:1 said:1 comments:1 research:2 current:2 senior:1 health:1 unit:1 new:1 leader:1 tie-up:1 business:4 sold:1 conglomerate:1 leadership:1 operating:1 based:1 manufacturing:3 country:1 could:2 products:3 analysts:2 first:1 tax-free:1 via:1 previously:1 into:2 manage:1 62:1 aimed:1 establish:1 market:1 per:1 pharmaceutical:2 shareholders:1 three:1 markets:1 more:1 nutrition:5 company:3 serve:1 trying:1 than:1 look:1 up:1 value:1 distribution:3 1.5:1 strengthening:1 proprietary:1 health-care:1 share:2 sales:3 unveiled:1 huge:1 functions:2 end:1 also:1 other:1 chairman:1 which:2 income:1 survey:1 =:5 development:2 independent:1 's:2 plans:3 separate:1 price:1 problems:1 76:1 included:1 develop:1 grow:1 diabetes:1 center:3 well:1 having:1 chief:1 biotechnology:1 model:1 filing:1
stock_ABT r_up	200:1 use:1 early-stage:1 which:1 among:1 trials:1 tumors:1 genes:1 companies:1 drug:1 analyzes:1 clinical:1 including:1 interest:1 test:2 new:1 attracting:1 than:1 more:1
stock_ABT r_up	shed:2 animal-health:10 certain:2 focus:3 strategic:2 through:2 human:3 its:5 unit:9 sell:3 $:4 pharmaceuticals:3 shares:3 also:1 disclosed:1 new:1 price:2 details:2 hone:2 updated:2 's:5 plans:2 business:1 company:3 background:2 first:2 part:3 preparing:3 separation:2 prepares:2 assets:2 valuation:2 eighth:2 pegs:2 billion:4 15:2 name:1 called:2 --:6 18:2 fifth:2 drug:3 filing:2 stock:2 maker:3 plan:3
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	comment:1 1.5:1 3.0:1 win:3 fall:1 estimates:1 sales:3 quarters:1 list:1 have:2 2.0:1 2.5:1 based:1 pharmaceutical:3 requirements:2 working:2 rejects:1 federal:1 pay:2 decision:1 outside:1 per:1 labor:1 current:1 their:2 written:1 details:1 exempt:1 =:5 overtime:2 analysts:2 do:2 salespeople:1 's:2 income:1 rules:1 share:1 under:1 removes:1 hours:2 operating:1 significant:3 opinion:1 included:1 court:1 law:1 provision:1 those:1 ruled:3 --:5 industry:3 companies:3 drug:4 n't:2 survey:1 ruling:1 position:1
stock_ABT r_up	do:1 hours:1 working:1 overtime:1 pay:1 companies:1 sales:1 drug:1 n't:1 their:1 have:1 ruled:1
stock_ABT r_down	pact:1 buffs:1 into:1 fitness:1 entering:1 shake:1 distribution:1 athletes:1 called:1
stock_ABT r_down	affordable:1 outlook:1 associated:1 challenging:1 1.5:1 into:1 usher:1 close:1 further:1 concentration:1 its:2 overhaul:1 $:1 federal:1 positive:1 least:1 citing:1 health:1 stable:1 new:1 brand:1 risks:1 meant:1 billion:1 's:2 drugs:1 marketing:1 company:1 consolidation:1 lowered:1 off-label:1 provision:1 payment:1 probes:1 settling:1 medicines:1 era:1 discussing:1 industry:1
stock_ABT r_up	refund:1 all:1 set:1 1.1:1 investors:1 give:1 requiring:1 people:1 one:1 likely:1 experiments:1 controversial:1 dividend:1 altered:1 payers:1 insurance:1 best:1 whose:1 difference:1 publication:1 would:1 equities:1 terrorists:1 fears:1 two:1 stocks:2 find:1 looking:1 health:3 goes:1 money:1 genetically:1 care:1 worth:2 higher:1 blueprint:1 million:1 's:3 get:2 sparked:1 but:1 forward:1 virus:1 part:1 they:1 not:1 news:1 law:2 provision:1 $:1 paying:2 search:1 slack:1 refunds:1 created:1 breed:1 companies:1 up:1 morning:1 premiums:1 paper:1 yields:1 planned:1 pick:1 making:2 spend:1
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	made:1 drug:1 than:1 weight-loss:1 medicine:1 obesity:1 more:1 approved:2 decade:1 first:1
stock_ABT r_up	hit:1 ranking:1 right:1 's:5 takes:1 billing:1 give:1 top:1 annual:1 behind:1 reputation:1 survey:1 our:1 once:1 more:1
stock_ABT r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_down	billion:1 said:1 end:1 $:1 people:1 thinking:1 familiar:1 could:1 private:1 early:1 go:1 2007:1 3.7:1 year:1 ready:1 's:1 eye-care:1 company:2 public:1 taken:1
stock_ABT r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	said:1 products:1 manufacturers:1 caused:1 university:1 testing:1 unsafe:1 foreign:1 surrounding:1 errors:1 safety:1 accuse:1 uncertainty:1 baby:1 dairy:1 selling:1 other:1
stock_ABT r_up	1.5:1 own:1 hoping:1 investors:1 companies:1 mind:1 quarters:1 included:1 3.0:1 2.0:1 find:1 2.5:1 caveats:1 per:1 next:1 current:1 income:1 new:1 =:5 good:1 's:1 some:1 company:1 bear:1 operating:1 groups:1 prices:1 based:1 must:1 pipeline:1 target:1 list:1 drug:1 while:1 estimates:1 survey:1 analysts:2 time:1 share:1 acquisition:1
stock_ABT r_up	building:1 heads:1 permits:1 starts:1 housing:1 up:3 back:1 earnings:1 's:2
stock_ABT r_down	less:2 adjusted:1 trade:2 session:2 medical-products:2 portfolio:2 headlines:1 still:1 its:3 rundown:1 expectations:1 second-quarter:3 late:2 has:2 details:1 expirations:2 rise:1 watch:4 early:1 background:1 not:2 now:2 continued:2 like:2 excluding:1 --:3 companies:4 facing:2 says:1 some:2 competition:2 second:2 actively:2 trading:1 exceeded:1 separating:2 makers:2 decline:2 large:2 space:2 profit:2 marketed:2 integration:2 shares:2 forecast:1 consistently:2 new:2 business:2 exchange:1 reported:1 restructuring:3 weight-loss:4 offset:1 active:1 approval:2 named:2 could:1 drug:8 foreign:1 fell:2 analysts:2 drugs:2 traded:2 comment:1 among:1 outlook:1 revenue:4 into:2 year:1 down:1 throughout:1 unit:1 pharmaceutical:3 two:4 least:2 2:7 interest:1 expected:2 hopefuls:1 more:2 ``:2 health-care:3 month:2 company:8 debate:2 but:1 reiterated:1 sizable:2 gain:1 midst:2 than:2 posted:2 11:9 room:2 publicly:2 whether:2 up:1 growth:4 2012:2 called:2 say:2 investors:1 certain:1 contribute:1 sales:1 weighed:1 full-year:1 diverse:2 have:1 confirms:1 if:2 sell:2 marking:2 end:1 patent:2 agency:2 shifts:2 other:3 split:3 better:2 planned:2 's:10 see:1 track:1 earnings:5 problems:2 modest:1 4th:1 stocks:1 approved:4 off:1 charges:3 mask:2 cushioned:2 generic:2 costs:2 corporate:1
stock_ABT r_down	saying:1 revenue:1 companies:1 health-care:1 quarters:1 growth:1 surprises:2 integration:1 advisories:2 earnings:2 11:1 's:3 company:1 restructuring:1 fell:1 continued:1 second-quarter:1 roundup:1 charges:1 mask:1 reports:1 future:1 corporate:1 latest:1
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	heart:8 countries:2 says:4 questions:2 being:4 developed:2 move:2 year:2 focus:4 '':2 prices:2 tag:2 raises:2 suspended:4 partner:2 patient:4 throughout:4 its:4 2.5:6 plans:2 said:2 adds:2 $:6 3rd:2 generic:2 had:4 hepatitis:8 access:2 low-cost:2 other:2 safety:4 treat:4 which:2 medicine:2 details:4 suffered:4 has:4 cause:4 price:2 stock:2 ``:2 earlier:2 's:8 intended:4 company:4 after:4 paid:2 failure:8 updates:2 background:4 known:4 buy:2 promote:2 beginning:4 potential:2 billion:6 reaction:2 high-quality:2 versions:2 --:12 issue:4 study:8 developing:2 disease:4 drug:14 n't:4 experimental:2 analysts:2 serious:2 first:2 called:2 acquisition:4 liver:4
stock_ABT r_up	heart:3 says:1 questions:1 being:1 developed:1 move:1 focus:1 '':1 prices:1 tag:1 comments:1 suspended:2 year:1 's:2 its:2 2.5:2 $:2 had:1 hepatitis:3 potential:1 safety:1 treat:2 which:1 suffered:2 has:2 cause:1 price:1 stock:1 ``:1 earlier:1 patient:2 intended:2 raises:1 company:2 after:2 paid:1 failure:3 liver:2 known:1 buy:1 beginning:1 billion:2 17th:1 issue:1 study:3 disease:2 drug:5 n't:1 experimental:1 serious:1 called:1 acquisition:1 updates:1
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	compared:1 's:2 improved:1 people:1 developed:1 study:1 mid-stage:1 disease:1 drug:1 symptoms:1 clinical:1 closely:1 doses:1 watched:1 placebo:1 experimental:1
stock_ABT r_up	excessive:1 tax:2 have:1 cuts:1 children:1 group:1 $:2 media:1 their:1 attack:1 concerns:1 expiring:1 oil:1 poster:1 100:2 drug-company:1 made:1 benefits:1 --:1 57:2 policies:1 fresh:1 left:1 wealthiest:1 executives:1
stock_ABT r_down	case:1 charges:1 including:1 former:1 players:1 second:1 involving:1 baseball:1 unveiled:1 professional:1 insider-trading:1 round:1
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_down	development:1 said:1 patient:2 intended:1 hepatitis:1 hospitalized:1 after:1 disease:1 drug:1 were:1 safety:1 treat:1 interest:1 others:1 has:1 discontinued:1 died:1 liver:1
stock_ABT r_up	treatment:1 patient:4 said:2 would:1 provide:1 benefit:1 hepatitis:2 safety:2 treat:2 interest:2 has:2 questioned:1 development:2 's:1 intended:2 hospitalized:2 after:2 liver:2 others:2 meaningful:1 died:2 --:1 disease:3 drug:2 whether:1 patients:1 were:2 discontinued:2
stock_ABT r_down	1.5:1 companies:1 estimates:1 quarters:1 3.0:1 2.0:1 2.5:1 based:1 per:1 current:1 income:1 =:5 good:1 missing:1 share:1 operating:1 included:1 data:1 list:1 trial:1 survey:1 analysts:2
stock_ABT r_down	advisory:2 saying:1 back:1 not:1 say:1 officials:1 caution:1 unusual:1 would:1 federal:2 benefit:1 health:2 treatment:3 outbreak:1 cause:1 public:1 today:1 product:1 's:8 dental:1 use:2 but:1 cutting:1 coverage:1 backed:2 news:1 panel:2 --:1 many:1 disease:2 drug:2 patients:3
stock_ABT r_down	1.5:1 companies:1 estimates:1 quarters:1 hiring:1 3.0:1 high-profile:1 2.0:1 investment:1 2.5:1 based:1 per:1 its:1 current:1 income:1 international:1 =:5 banker:1 firm:1 share:1 de:1 expansion:1 operating:1 included:1 midst:1 list:1 securities:1 survey:1 analysts:2
stock_ABT r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_down	among:1 neck:1 physicians:1 whether:1 many:1 taking:1 prevent:1 patients:1 drug:1 debate:1 stents:1 stroke:1 place:1 best:1 have:1 artery:2 surgery:1 over:1 therapies:1 treatment:1
stock_ABT r_down	sees:1 cited:1 setback:1 month:1 unlikely:1 approval:1 tough:2 throughout:1 continent:1 cites:1 declined:1 sell:1 delay:1 said:1 would:1 decision:1 there:1 comments:1 next:1 environment:2 details:1 recommend:1 treatment:1 's:1 marketing:1 company:1 long:1 diet:2 delayed:1 races:1 regulatory:2 president:2 approved:1 10:1 getting:1 --:3 drug:3 regulator:1 slide:1 obesity:1 its:1
stock_ABT r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	likes:1
stock_ABT r_down	--:1 granted:1 ulcerative:1 disease:1 drug:1 patients:1 treat:1 wider:1 approval:1 colitis:1
stock_ABT r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_down	sentenced:1 1.6:1 investors:2 correlation:1 previously:1 700:1 terms:1 settlement:1 its:2 court:1 $:2 federal:1 pay:1 4:2 investing:1 announced:1 formally:1 may:1 million:1 beta:3 part:1 alone:1 world:1 safer:1 off-label:1 hedging:1 billion:1 off:2 drug:1 ignoring:2 ordering:1 filled:1 concepts:2 promotion:1 left:1
stock_ABT r_up	sentenced:2 billion:2 1.6:2 settlement:2 formally:2 $:4 federal:2 pay:2 million:2 700:2 drug:2 ordering:2 part:2 previously:2 court:2 promotion:2 off-label:2 its:4 announced:2
stock_ABT r_up	'':1 ``:1 benefited:1 's:1 civil:1 engaged:1 company:1 intervene:1 allegations:1 improper:1 n't:2 financially:1 drug:1 conduct:1 promotion:1 has:1 declined:1
stock_ABT r_up	therapy:2 because:2 says:2 revised:1 some:4 detail:1 stability:2 tablets:4 defects:2 letters:2 n't:2 bottles:6 voluntary:2 lots:4 had:2 three:4 comments:1 majority:2 potential:2 has:2 final:1 stock:1 customers:2 initiated:2 price:1 after:2 wholesale:2 walls:2 recalled:4 recalls:2 affect:2 beginning:1 third:2 created:2 --:6 recall:2 could:2 spokeswoman:2 shipped:2 thin:2 were:2 found:2 replacement:2
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_down	investors:1 over:1 companies:1 utilities:1 drug:1 should:1 favor:1 telecoms:1
stock_ABT r_up	help:1 developed:3 results:3 hopes:1 session:1 comments:1 20:1 $:1 late:2 choose:1 2015:1 has:1 eventually:1 therapy:1 updates:1 decide:2 2:1 --:3 companies:2 stock:1 20th:1 exceed:1 actively:2 trading:3 index:2 hepatitis:5 closed:1 assuming:1 new:4 recently:1 hours:1 reported:1 regulators:1 based:2 stage:2 suggested:1 could:1 larger:2 drug:3 guide:2 trial:5 studies:1 experimental:5 late-stage:1 into:2 positive:2 three:3 clinical:6 gained:1 selling:1 drugs:5 company:3 prices:1 95:2 analyst:1 10:1 regimen:6 12:1 15:1 up:1 patients:3 were:1 taking:2 annual:1 give:1 sales:1 helped:2 reports:1 climbed:2 trials:2 shares:2 also:1 details:1 fourth:1 higher:2 begin:1 added:2 's:3 after:1 most:3 virus:3 stocks:2 data:2 billion:1 light:1 points:6 green:1
stock_ABT r_up	health-care:2 gains:1 sectors:2 showing:1 rise:2 sales:1 reports:1 increase:1 also:1 market:1 lift:1 buoyed:2 investors:1 retail:1 data:1 bank:3 consider:1
stock_ABT r_down	hands:1 generally:1 over:2 move:1 results:3 rest:1 quarters:1 leads:1 session:1 shares:4 medical-products:2 spinoff:1 settlement:2 year-earlier:2 its:6 boosts:2 previous:2 excludes:2 style:1 trying:1 $:8 rose:1 workers:4 expectations:1 citing:1 program:2 candidates:1 employee:1 2013:5 details:1 town:1 them:1 global:1 affected:2 divisions:2 auto:1 watch:2 early:1 words:1 fall:3 report:1 one:1 hall:1 several:2 exits:1 --:4 notes:1 companies:4 taxes:1 consensus:1 good:1 night:1 went:1 quarter:1 view:2 exceed:1 says:2 parade:1 due:1 laying:1 energy:1 creation:1 estimates:1 unprofitable:1 jump:1 actively:1 trading:2 year:2 separating:2 close:2 margins:2 blue:1 index:1 said:1 profit:2 literally:1 views:1 recorded:2 legal:2 forecast:2 bailout:1 exit:2 vascular:1 got:1 allowing:1 seemed:1 cost-cutting:1 evolving:1 recently:1 business:4 reported:3 job:1 separation:2 put:1 times:1 beginning:1 half:1 gained:1 last:1 policy:1 named:2 could:1 double-digit:2 drug:2 surge:2 products:1 analysts:1 mixed:1 traded:2 maker:1 executives:1 among:1 adjusted:3 opposition:1 slipped:3 revenue:4 into:2 period:2 2nd:1 down:4 another:1 narrowed:2 throughout:1 pharmaceutical:3 figure:1 top:1 third-quarter:5 per-share:2 start:1 declines:1 more:2 nutrition:2 ``:1 insurer:1 company:6 debate:1 but:2 sales:4 quarterly:1 midst:2 expenses:2 surged:2 than:1 raising:1 he:1 11:2 '':1 exception:1 publicly:2 these:1 growth:3 lays:1 were:1 gave:1 investors:1 guidance:2 chip:1 health-care:5 550:6 fellow:1 weighed:2 his:1 midweek:1 heels:1 blockbuster:1 sell:1 needs:1 six:1 offensive:1 costs:3 5:2 earnings:8 which:2 outlook:1 layoffs:3 planned:2 even:2 's:12 plans:2 roster:1 reporting:1 helped:2 fell:1 eight:1 two:3 date:2 stocks:1 get:1 recent:1 lower:1 short:1 off:2 third:1 later:3 face:2 points:3 attacking:1
stock_ABT r_down	excessive:1 over:2 setback:1 session:1 including:2 its:1 death:2 21:1 also:1 rose:1 had:1 treatment:2 2010:1 details:1 hit:1 fall:4 clouds:1 --:3 eased:1 companies:2 sends:1 estimates:1 rate:2 actively:2 trading:3 year:1 edged:1 index:2 said:2 shares:5 forecast:3 3:1 safety:4 closed:1 full:1 recently:1 hours:1 excess:2 downgrade:1 path:1 generate:1 $:1 gained:1 prospects:1 study:4 annual:1 drug:6 trial:2 analysts:1 discontinued:2 experimental:2 lowers:1 among:2 two:1 down:1 reached:1 market:1 stoppage:1 due:2 clinical:2 forward:1 more:1 company’s:1 company:1 expected:1 than:1 rights:1 evaluating:1 were:1 1.4:1 medication:1 associated:1 deaths:1 sales:1 climbed:1 kidney:5 if:1 ratings:1 5.2:1 six:1 1:1 adverse:1 concerns:4 tumbling:1 earnings:3 which:1 gets:1 events:1 higher:1 's:5 users:2 after:2 halted:2 stocks:2 billion:1 lower:3 short:1 disease:2 points:6
stock_ABT r_down	among:1 excessive:1 down:1 rate:1 actively:1 including:1 edged:1 kidney:1 points:2 index:1 death:1 due:1 shares:1 1:1 concerns:1 safety:1 treatment:1 closed:1 clinical:1 's:2 users:1 after:1 hours:1 said:1 stocks:1 lower:1 companies:1 disease:1 drug:1 trial:1 fell:2 trading:1 discontinued:1 experimental:1
stock_ABT r_down	oncology:2 cancer:2 allows:2 milestone:2 sales:2 two:2 technology:4 targets:2 25:6 fee:2 $:8 addition:2 pay:2 objectives:2 utilize:4 per:2 any:2 potential:2 between:2 single-digit:2 net:2 220:2 worldwide:2 royalties:2 may:2 collaboration:4 million:4 upon:2 gain:2 upfront:2 additional:4 well:2 antibodies:2 target:2 rights:4 receive:2 expanded:4 companies:2 up:2 drug:2 products:2 payments:2 under:2
stock_ABT r_up	disclosure:1 raised:1 after:1 's:4 business:1 pharmaceutical:1 company:2 capital:1 negative:1 new:1 public:1 into:1 citing:1 planned:1 stable:1 separating:1 proprietary:1 outlook:1 its:3 structure:1
stock_ABT r_down	rating:1 saying:1 increasingly:2 over:2 sources:3 planning:3 shares:2 spinoff:7 its:8 adding:2 anticipation:4 $:13 investor:1 top-10:1 absence:1 8:2 weeks:2 worth:2 2013:2 details:3 modestly:1 updated:2 bonds:3 big:2 continues:2 sums:2 one:2 continued:4 --:12 doubled:2 large:2 18:2 higher:1 bond:4 deal:4 past:2 year:5 tender:1 biggest-ever:2 plans:2 even:2 deals:2 scale:1 comments:2 notches:1 new:5 issue:2 announced:3 core:2 business:3 multiple:6 sixth:1 million:2 cut:1 separation:2 put:2 beginning:1 leverage:1 pipeline:2 last:5 months:2 according:3 drug:2 became:2 planned:3 rose:2 patents:1 late-stage:2 revenue:2 highly:1 franchise:2 throughout:2 size:2 pharmaceutical:1 rated:1 additional:2 would:2 spending:2 top:1 third-quarter:2 next:7 expected:2 branded:1 more:6 diversity:1 offering:2 company:10 fund:5 part:3 syndicate:3 than:5 10:10 13:4 launches:4 up:4 value:2 excited:2 while:1 weakens:1 biotech:2 investors:2 have:2 spends:2 sell:3 potential:2 earnings:2 fourth:1 largest:2 commentary:1 several:2 stock:2 week:5 product:6 's:5 intended:2 price:2 measures:1 two:1 coming:2 grow:4 billion:4 sclerosis:4
stock_ABT r_down	caused:3 through:1 giant:1 $:2 had:1 window:1 worth:1 multibillion-dollar:1 advantage:1 bonds:1 made:1 nearly:1 report:1 now:3 three-day:1 lost:1 --:2 companies:2 borrow:1 deals:1 two:1 bond:4 deal:3 back:1 freeze:1 likely:3 expect:1 year:1 looking:1 market:3 above:1 announced:1 jobs:1 separation:1 dividend:1 last:1 ahead:1 according:2 expecting:1 analysts:1 billion-plus:1 narrow:1 one:1 brought:3 aimed:1 throughout:1 unit:3 rated:1 three:2 next:3 rates:1 way:3 expected:3 more:1 selling:1 interest:1 offering:4 company:1 tally:1 took:1 disruption:3 wake:1 subsidiary:1 10:2 12:1 up:1 were:3 following:1 midweek:3 investors:3 lock:1 health-care:1 pushed:1 investment-grade:1 triple:1 watched:1 finance:1 make:3 details:1 widely:1 week:3 's:5 plans:1 includes:1 helping:1 eight:1 issuance:2 billion:1 fund:1 borrowing:1 superstorm:2 mammoth:1 time:2 updates:1
stock_ABT r_down	borrow:1 jump:1 its:1 $:1 few:1 bonds:1 catalysts:1 long:1 looking:1 start:1 offers:1 falling:1 worth:1 stock:1 three-day:1 selling:1 roster:1 drugs:1 price:1 12:1 wake:1 nearly:1 freeze:1 billion:1 made:1 lost:1 up:1 time:1 following:1 issuance:1
stock_ABT r_up	being:1 years:1 planning:1 20:4 $:13 lining:1 late:1 hit:3 bonds:1 familiar:2 largest:1 early:1 preparing:1 background:1 quarters:1 investor:1 30-year:1 four-part:3 --:6 list:1 morning:1 bond:2 because:2 deal:9 companies:1 estimates:1 3.0:1 2.0:1 2.5:1 marketed:1 per:1 current:1 unit:3 between:1 terms:1 10-:1 operating:1 five-:1 based:1 debt:2 last:1 37:1 according:3 afternoon:1 survey:1 banker:1 postponed:1 extra:1 two:2 massive:1 market:3 working:1 three:1 featuring:1 more:1 ``:1 offering:4 company:1 delayed:1 but:1 demand:1 than:1 sizing:1 14:3 up:1 record:1 were:1 1.5:1 investors:1 share:1 '':1 orders:1 sell:1 information:1 maturities:1 potential:1 details:1 multibillion-dollar:2 income:1 =:5 analysts:2 week:1 added:1 's:5 price:2 included:1 billion:5 transaction:3 15.5:3 bankers:1 superstorm:1 time:3 corporate:1 order:1 came:1
stock_ABT r_down	it’s:1 campaign:1 being:1 health-care:1 ``:1 period:1 gravity:1 fix:1 because:1 investors:2 our:1 face:1 orders:1 market:2 hit:2 interest:1 overhaul:1 $:4 working:1 multibillion-dollar:1 decision:1 stake:1 two:2 been:1 writing:1 late:1 finally:1 unit:1 lot:1 survive:1 divergent:1 we:1 's:2 way:1 views:1 re-elected:1 big:1 problems:1 delayed:1 bankers:1 there’s:1 early:1 transaction:1 them:1 marketed:1 despite:1 20:1 those:1 billion:2 '':1 four-part:1 grueling:1 ahead:1 level:1 --:3 wins:1 morning:1 37:3 according:1 deal:3 've:1 either:1 time:3 bond:1 changes:1 writes:1 came:1 laws:1
stock_ABT r_down	among:2 says:2 certain:2 alternatives:2 another:1 its:3 expensive:2 away:2 other:2 low:2 conditions:2 available:2 's:1 business:2 drugs:2 pharmacy-benefit:2 treatments:2 applications:1 catalog:1 members:2 testosterone:2 taking:2 glaucoma:2 up:1 aim:2 acquisition:1 push:2 software:1 steer:2 latest:2
stock_ABT r_up	all:2 partial:4 deal:1 outstanding:2 tells:1 certain:2 cripple:1 back:8 now:1 month:2 tendered:2 manager:1 used:1 deadline:2 7.7:2 have:1 our:1 says:1 total:2 2.7:2 its:2 said:4 $:8 general:1 nuclear:1 had:6 due:4 been:2 while:2 sciences:1 offers:8 2019:2 systems:1 between:4 finding:1 2014:2 hardly:1 2010:1 2.95:2 buy:8 's:2 allegedly:1 government:1 any:2 offered:4 early:2 department:1 virus:1 part:2 same:1 alone:1 92:2 earth:1 billion:8 received:2 2040:4 facilities:1 we:1 notes:8 companies:1 up:4 morning:1 amount:2 so:1 were:4 other:1
stock_ABT r_up	over:2 results:2 quarters:1 four:2 per:1 its:8 based:1 $:4 treatment:3 mid-stage:1 weeks:4 hope:1 tests:4 combination:2 expects:2 early:2 therapy:2 now:1 condition:2 drop:1 companies:1 injectable:1 list:1 estimates:1 back:2 potent:1 trading:2 3.0:1 pain:2 2.0:1 2.5:1 said:2 jumped:2 hepatitis:2 current:1 conduct:1 new:2 announced:2 operating:1 article:1 appears:1 completing:2 drug:5 trial:3 survey:1 analysts:2 published:1 long-term:2 studies:1 experimental:1 late-stage:2 positive:4 weekend:2 rivals:1 clinical:1 more:1 firm:2 form:2 drugs:2 company:3 eliminates:1 part:1 known:2 than:1 present:2 regimen:2 12:4 showed:2 tolerate:1 up:2 patients:4 future:1 ongoing:2 can:1 were:2 inhibitor:2 study:1 1.5:1 share:1 containing:1 potential:1 which:1 income:1 =:5 difficult:1 's:1 plans:1 after:6 most:1 virus:1 uses:2 included:2 data:4 biotechnology:2
stock_ABT r_down	people:1 results:3 jump:3 frontrunner:1 hepatitis:3 world-wide:1 its:1 develop:1 deadly:1 shares:2 180:1 positive:1 treatment:1 affecting:1 new:1 firm:1 million:1 after:1 virus:1 liver:1 biotechnology:1 drug:3 race:1 announces:1 position:1
stock_ABT r_up	heart:1 1.5:1 companies:1 testing:1 reduce:1 results:1 highly:1 included:1 3.0:1 2.0:1 2.5:1 containing:1 based:1 per:1 current:1 clinical:1 income:1 '13:2 2013:1 analysts:2 's:2 risk:1 strokes:1 estimates:1 anticipated:1 early:1 operating:1 plan:1 report:1 quarters:1 whether:1 =:5 list:1 attacks:1 drug:1 large:1 trial:1 survey:1 can:1 cholesterol:1 share:1
stock_ABT r_up	sales:1 tablets:2 year:1 its:1 unit:1 sell:1 said:1 $:1 generic:2 had:2 research:1 late:1 market:1 strengths:1 selling:1 's:2 started:1 approval:1 billion:1 received:1 has:1 last:1 versions:2 --:1 annual:1 according:1 drug:1 1.26:1 anti-cholesterol:1 maker:1
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	indicted:1 jury:1 grand:1 ahead:1 insider:1 federal:1 proposed:1 others:1 three:1 alleged:1 player:1 announced:1 baseball:1 medical-device:1 were:1 trading:1 2009:1 company:1 acquisition:1 before:1
stock_ABT r_down	1.5:1 2.5:1 force:2 people:1 certain:1 move:1 estimates:1 sales:2 quarters:1 '':1 3.0:1 cuts:1 our:3 2.0:1 its:1 best:1 current:1 said:2 based:1 would:1 efficient:1 segments:1 per:1 strategy:1 spokesman:1 companies:1 allocate:1 statement:1 income:1 scope:1 =:5 shrink:1 resources:1 more:1 cost-cutting:1 ``:1 analysts:2 's:1 plans:1 evaluate:1 serve:1 but:1 we:2 part:1 operating:1 included:1 article:1 investments:1 areas:1 survey:1 effective:1 did:1 list:1 drug:1 maker:1 n't:1 patients:1 customers:1 can:1 published:1 share:1 reduced:1 latest:1
stock_ABT r_up	year-end:2 riskier:1 beat:2 away:1 caps:3 writes:1 want:1 small:3 end:1 stay:1 might:1 until:3
stock_ABT r_up	universities:1 banding:1 diseases:1 23:1 create:1 companies:1 together:1 one:1 order:1 drug:1 largest:1 tackle:1 world:1 stem:1 's:1 cells:1 adult:1
stock_ABT r_up	around:1 1.5:1 valued:1 's:1 deal:1 business:1 could:1 company:1 health-care:1 $:1 meter:1 billion:1 blood:1 suitor:1 last:1 more:1 remaining:1 glucose:1
stock_ABT r_down	1.5:1 companies:1 estimates:1 quarters:1 not:1 3.0:1 year:1 go:2 2.0:1 2.5:1 roiling:1 based:1 question:1 per:1 next:1 current:1 market:2 income:1 =:5 2013:2 more:1 big:1 share:1 but:1 operating:1 included:1 stocks:1 10:2 uncertainty:1 list:1 up:2 survey:1 analysts:2
stock_ABT r_down	1.5:1 says:1 list:1 over:1 estimates:1 quarters:1 chronic:1 experts:1 3.0:1 2.0:1 2.5:1 use:1 medications:1 based:1 per:1 current:1 treat:1 income:1 =:5 today:1 risks:1 pain:1 champion:1 share:1 longtime:1 operating:1 included:1 benefits:1 companies:1 survey:1 analysts:2
stock_ABT r_up	heart:2 raised:1 financial:1 significantly:1 reduce:4 primary:1 replace:1 surrounding:1 large:2 computer:1 dropped:1 questions:1 year:1 high-profile:1 patient:1 spin-off:1 its:2 goals:1 plans:1 pharmaceutical:1 said:3 strokes:1 does:1 seek:3 increasing:1 treatment:1 failed:4 health:1 safety:1 take:1 cardiovascular:1 new:1 effectiveness:1 price:1 500:1 stock:1 's:2 risk:5 combination:1 wo:1 big:1 company:1 after:2 component:1 updates:1 background:1 regulatory:2 approval:2 100:3 beginning:1 money-manager:1 older:1 --:5 6th:1 study:5 implications:1 attacks:1 drug:4 events:2 n't:6 reinforces:1 while:1 place:1 risks:1 aims:1 cholesterol:3 long-term:1 meet:1 adverse:1 medical:1 plan:1
stock_ABT r_up	pharmaceutical:1 said:1 's:1 company:1 money-manager:1 replace:1 computer:1 place:1 take:1 year:1 new:1 100:3 spin-off:1 500:1
stock_ABT r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_ABT r_up	own:1 spinoff:1 its:3 unit:1 pharmaceutical:1 said:1 would:1 began:1 new:1 company:1 development:1 life:1 business:1 separate:1 completed:1 after:1 focused:1 spin:1 off:1 14:1 medicines:1 months:1 drug:1 maker:1
stock_ABT r_down	outlook:3 improved:2 company:1 shares:2 offers:1 climb:3 2013:1 better-than-expected:1
stock_ABT r_up	$:1 spine-products:1 pay:1 offered:1 million:1 cash:1 fast-growing:1 orthopedics:1 foothold:1 maker:1 market:1
stock_ABT r_down	money:1 move:1 ``:1 back:1 days:1 '':1 held:1 accounts:1 downside:1 have:1 year:1 home:1 shining:1 funny:1 said:1 $:3 writes:1 there:1 reinvest:1 shares:1 actually:1 other:1 outside:1 much:1 permanently:1 earnings:4 lot:1 must-read:1 learned:1 include:2 we:1 reporting:1 's:6 plans:1 sitting:1 big:1 company:1 earlier:1 yesterday:1 most:1 increases:1 investments:1 29.1:1 billion:3 country:1 companies:1 cash:2 filing:1 securities:1 thing:1 stockpile:1 upside:1 overseas:1 spotlight:1
stock_ABT r_down	move:1 swings:3 their:1 amid:1 needle:1 handful:1 companies:1 while:1 reports:1 few:2 see:1 health:2 earnings:3 others:1 wild:3 barely:1 stocks:1 health-care:1 slew:1 stock:2
stock_ABT r_up	billion:1 10:1 owners:1 's:1 $:1 business:1 company:1 after:1 possible:1 least:1 eye-health:1 buyers:1 asking:1 leaning:1 toward:1 price:1 launching:1
stock_ABT r_up	aided:3 fourth-quarter:1 all:1 help:1 revenue:1 almost:1 house:1 executive:1 some:1 sales:1 intellectual:1 wider:1 need:1 portfolio:1 its:1 n't:1 needs:1 said:2 patent:1 while:1 shares:1 few:1 bolt-on:1 expected:1 new:1 has:1 smart:1 do:1 's:1 sinks:2 again:1 drugs:1 company:2 stem:1 suffering:1 management:1 buyout:3 falls:1 come:1 than:1 he:1 loss:1 off:1 did:1 deals:1 losses:2 large:1 skills:1 chief:1 talk:3 property:1 acquisition:1
stock_ABT r_down	biotech:1 stake:1 costly:1 billions:1 sale:1 '':1 cost:1 its:2 before:1 said:1 missed:1 delays:1 biosimilars:1 two:1 investment:1 health:1 systems:1 ``:1 multiple:1 plans:1 offer:1 outlined:1 after:1 anticipated:1 takeover:1 investor:1 made:1 versions:1 could:1 obstacles:1 sclerosis:1 days:1 drug:2 facing:1 savings:1 maker:1
stock_ABT r_down	adviser:1 cautions:1 his:2 says:1 tread:1 ministry:1 advisers:1 practice:1 share:1 experience:1 your:1 also:1 other:1 minister:1 want:1 carefully:1 you:1 faith:1 handy:1 comes:1 he:1
stock_ABT r_up	biotech:1 over:1 itself:1 existence:1 further:1 targets:1 provided:1 shareholders:1 said:1 would:1 detail:1 incentive:1 its:1 doubt:1 way:1 approach:1 casting:1 company:2 little:1 but:1 takeover:1 invested:1 hostile:1 sweeten:1 defends:1 remain:1 future:1 acquisition:1
stock_ABT r_up	operations:1 because:1 less:1 lines:1 tax:3 balances:1 60:1 2008:1 rate:1 including:1 parked:2 have:1 year:2 partly:1 total:1 down:1 out:1 grown:1 $:1 bottom:1 40:1 their:3 earnings:1 subsidiaries:1 offshore:2 shows:1 paying:1 's:2 big:1 reach:1 taxes:1 paid:1 they:2 report:1 multinationals:1 than:2 those:1 man:1 billion:1 10:1 last:2 14:1 16:1 shielded:1 average:1 annual:1 companies:3 analysis:1 --:1 portion:1 2004:1 growing:1 overseas:2 more:2 corporate:1 profits:2
stock_ABT r_down	acquisitions:1 said:1 door:1 like:1 pursue:1 markets:1 fast-growing:1 open:1 maker:1 more:1
stock_ABT r_down	roundup:1 heart:1 product:1 safe:1 's:3 around:1 effective:1 saying:1 there:1 show:1 enough:1 against:1 evidence:1 n't:1 recommended:1 analysis:1 news:1 device:1 approval:1 venture-capital:1
stock_ABT r_up	less:1 legal:1 year:1 still:1 7.9:1 $:1 top:1 40:3 total:1 new:1 more:1 earlier:1 's:3 though:1 company:1 million:1 than:2 received:1 valued:1 up:1 compensation:1 officer:1 2012:1
stock_ABT r_up	executive-pay:1 rewards:1 's:1 ahead:1 pressure:1 meetings:1 annual:1 some:1 sign:1 their:1 practices:1 shareholder:1 have:1 year:1 such:1 fixed:1
stock_ABT r_down	advisory:1 financial:1 have:1 investors:1 heart:1 51:1 over:2 executive:1 influence:1 '':3 preliminary:1 year:1 statements:1 clearly:1 benefits:1 narrowly:1 said:1 just:1 federal:1 pay:2 review:1 same:1 awarded:1 environment:1 their:2 only:1 stock-market:1 way:1 performance:4 increasing:1 conditions:1 more:1 flex:1 ``:3 muscles:1 's:1 says:2 tied:1 its:1 proxy:1 tying:1 half:1 device:1 president:1 than:2 committee:1 last:1 carried:1 vice:1 ever:1 taking:1 companies:3 according:1 35:1 compensation:3 risks:1 2009:1 root:1
stock_ABT r_up	among:1 reducing:1 investors:1 junk:2 biggest:1 '':1 want:1 easy-money:1 its:1 out:2 begin:1 stocks:4 holdings:1 won’t:1 their:1 which:1 policy:1 if:1 might:1 ``:1 most:1 ones:1 gain:1 now:2 casualties:1 reverses:1 low-quality:1 off:1 spigot:1 indefinitely:1 turns:1 continue:1 stand:2 policies:1 lose:1 writes:1
stock_ABT r_up	pharmaceutical:1 settlements:1 justices:1 generic-drug:1 patent:1 pay:1 brand-name:1 companies:1 challenges:1 which:1 voiced:1 drop:1 makers:1 concern:1
stock_ABT r_up	infringe:1 appeals:1 court:1 $:1 doctor:1 federal:1 company:1 million:1 patent-infringement:1 award:1 patent:1 n't:1 did:1 against:1 subsidiary:1 's:2 overturned:1 technology:1 ruling:1
stock_ABT r_down	shed:2 6.7:1 actively:2 trading:3 dropped:2 recently:1 21:1 shares:2 41:1 closed:1 's:2 after:1 hours:1 fell:2 stocks:2 lower:2 38:1 15:1 companies:2 points:6 were:1 110:1
stock_ABT r_up	even:1 good:1 's:2 beat:1 sometimes:1 times:2 crush:1 fund:1 bad:1 focusing:1 stocks:1 quality:1 market:1
stock_ABT r_down	firm:1 pharmaceutical:1 raised:1 12:1 7.3:1 $:3 offer:1 company:1 billion:2 share:1 up:2 drug:1 its:1 valuing:1 maker:1 year:1 offered:1 investment:1 earlier:1 around:1
stock_ABT r_up	billion:1 genomics:1 $:1 ripe:2 have:1 industry:1 profit:1 companies:2 opportunities:1 plenty:1 flurry:2 acquisition:1 investors:1 13.6:1 writes:1 mergers:2 shows:1
stock_ABT r_up	operations:1 fourth-quarter:1 major:1 futures:3 emerging:1 weight:1 15-month:2 issued:1 estimates:1 period:1 one:1 against:1 warning:1 reports:1 close:3 first-quarter:1 heavy:1 year-earlier:1 its:4 pharmaceutical:1 some:1 results:1 just:1 profit:1 contributions:1 quarterly:1 since:1 misses:3 been:1 yet:1 rally:1 charge:1 stock-market:1 low:2 weighs:2 performance:1 net:1 has:1 2011:1 remaining:1 inventory:1 lowest:1 disappoint:2 ends:2 reporting:1 's:4 business:1 earnings:4 rebound:1 after:1 healthy:1 yesterday:1 sales:1 among:1 sustainability:1 fell:1 fall:1 included:1 delivers:1 given:1 former:1 all-clear:1 lower:2 improved:1 movers:2 markets:1 suppliers:1 56:1 companies:1 slumps:1 maker:1 thinking:1 while:1 products:1 analysts:1 concerns:1 nutritional:1 signal:1 medical-device:1 reserve:1
stock_ABT r_up	roundup:1 venture-capital:1 around:1 analysis:1 news:1
stock_ABT r_down	comment:1 heart:1 previously:1 sales:4 one:2 helped:2 chronic:1 growth:3 including:1 year:3 first-quarter:1 exclusivity:1 throughout:1 percentage:1 its:2 kidney:1 pharmaceutical:2 said:1 treat:1 profit:1 beginning:2 top:1 expectations:1 increase:1 also:1 details:1 9.6:6 has:2 2013:1 earnings:1 spun:2 independent:2 rise:2 's:3 plans:1 business:2 company:2 arthritis:3 margins:1 expects:1 reported:1 low:1 leukemia:1 strong:2 continued:1 pegged:1 improve:1 prospects:1 several:1 off:2 lost:1 programs:1 --:3 double-digit:1 disease:1 drug:5 initiate:1 9th:1 rose:1 quarter:2 rheumatoid:1 first:2
stock_ABT r_up	her:1 political:1 chief:1 faces:1 test:1 independence:1 first:1
stock_ABT r_up	among:2 because:1 supersized:1 deal:3 wisdom:1 results:1 3.2:1 yield:1 first-quarter:1 payers:1 best:1 issuer:1 conventional:1 highest:1 $:3 pay:1 stalled:1 tend:1 bln:2 attractive:1 interest:1 largest:1 drawn:1 has:2 ever:1 500:1 fare:1 family:1 's:1 which:1 dividends:1 company:1 disagreement:1 priced:1 offers:1 weaker-than-expected:1 demand:2 prices:2 dividend:2 strong:2 valuation:1 analyst:1 those:1 billion:1 owners:1 announcing:1 17:3 auction:1 drug:1 finds:1 contrary:1 corporate:2 maker:1 bond:3
stock_ABT r_down	undervalued:1 33:1 since:1 up:1 but:1 start:1 looks:1 year:1 spinoff:1 still:1
stock_ABT r_up	rebuild:1 raised:1 secure:1 business:1 bid:1 drug:1 maker:1 pressure:1 takeover:1 multibillion-dollar:1 increasing:1 investor:1 its:3 independence:1
stock_ABT r_down	firm:1 pharmaceutical:2 approach:1 rejected:1 twist:1 most:1 struggle:1 latest:1 investor:1 recent:1
stock_ABT r_down	firm:1 coverage:1 initiated:1
stock_ABT r_up	raised:1 office:1 revenue:1 increasingly:1 stream:1 over:1 sights:1 involve:1 player:1 buy:1 corner:1 stint:1 pharmaceutical:1 $:1 no:1 next:1 much:1 new:1 has:2 might:1 royalties:1 his:1 offer:1 company:1 complicated:1 struggle:1 8:1 buyer:1 such:1 investor:1 than:1 bigger:1 he:1 billion:1 attempt:1 longer:1 third:1 bitter:1 drug:2 owns:1 found:1 its:2 maker:1
stock_ABT r_down	's:1 froth:1 avoiding:1 returns:1 here:1 three:1 manager:1 value:1 finding:1 years:1
stock_ABT r_up	emerging:1 cancer:1 revenue:1 declines:1 offset:1 share:1 sales:1 according:1 helped:1 baby:1 underlying:1 through:1 genes:1 first-quarter:1 its:3 market:1 previous:1 shareholders:1 said:1 $:6 rose:1 plans:1 ovarian:1 linked:1 3:3 program:3 5:1 board:1 new:1 has:3 markets:1 company:1 announced:1 buybacks:1 tests:1 testing:1 recently:1 returned:1 capitalization:1 dividends:1 completed:1 nutritional:1 reported:1 announce:1 key:1 formula:1 repurchase:1 approved:1 after:1 billion:4 replaces:1 monopoly:1 31:1 companies:1 cash:1 's:3 2002:1 1.8:1 products:2 were:1 quick:1 2008:1 out:1 other:1 patents:1 breast:1
stock_ABT r_up	because:1 partial:1 give:1 sales:1 settlements:3 argument:1 years:1 brought:1 embrace:1 against:1 sought:1 makers:1 pharmaceutical:1 court:1 lead:1 patent:2 pay:1 decision:1 government:2 least:1 should:1 delay:1 their:1 which:1 ruling:2 cheaper:1 has:1 more:1 's:2 generic-drug:1 provided:1 drugs:1 could:1 reversed:1 possible:1 scrutiny:1 versions:1 favorable:1 courts:1 earliest:1 ruled:1 case:1 drop:1 antitrust:1 did:1 industry:3 brand-name:1 companies:1 drug:2 n't:1 generic:1 can:1 entry:1 lawsuits:1 victory:1
stock_ABT r_up	give:1 settlements:1 competition:1 challenges:1 makers:1 pharmaceutical:1 lead:1 generic:2 decision:1 stave:1 should:1 delay:3 generics:2 strike:1 more:2 arrival:1 drugs:1 scrutiny:1 courts:1 ruled:1 off:1 industry:1 could:1 inexpensive:1 sale:2 drug:1 deals:1 patent:1 can:1 entry:1 jeopardy:2
stock_ABT r_down	professionals:1 right:1 patient:1 health-care:1 hepatitis:1 helping:1 virus:1 carrying:1 treatment:1 determine:1 test:1 identifies:1 has:1 type:1 approved:1
